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SUMMARY 
 
Blastocystis is a ubiquitous enteric protozoan found in the intestinal tract of 
humans and a wide range of animals. Accumulating evidence over the last decade 
suggests association of Blastocystis with gastrointestinal disorders involving diarrhea, 
abdominal pain, flatulence and vomiting. Despite new knowledge of Blastocystis cell 
biology, genetic diversity, and epidemiology, its pathogenic potential remains 
controversial. Numerous clinical and epidemiological studies either implicated or 
exonerate the parasite as a cause of intestinal disease. Clinical and experimental studies 
have associated Blastocystis with intestinal inflammation and it has been shown that 
Blastocystis has potential to modulate the host immune response. Blastocystis is also 
considered an opportunistic pathogen and high prevalence is reported in 
immunocompromised HIV patients. However, nothing is known about the parasitic 
virulence factors and early events following host-parasite interactions. Therefore, the aim 
of this study was to investigate the pathogenic potential of Blastocystis, by studying the 
interactions of Blastocystis with intestinal epithelial cell lines. This study reports that B. 
ratti WR1 induces apoptosis in IEC-6 cells in a contact-independent manner. 
Furthermore, it was found that B. ratti WR1 rearranges F-actin distribution, decreases 
transepithelial resistance, and increases epithelial permeability in IEC-6 cell monolayers. 
In addition, it was demonstrated that Blastocystis effects on transepithelial electrical 
resistance and epithelial permeability were significantly abrogated with metronidazole 
treatment, an antiprotozoal drug. Results suggest that Blastocystis-induced apoptosis in 
 xv  
host cells and altered epithelial barrier function might play an important role in its 
pathogenesis. 
 
 In the present study, the molecular mechanisms by which Blastocystis activates 
IL-8 gene expression in human colonic epithelial T84 cells were also investigated. This 
study demonstrates for the first time that cysteine proteases of Blastocystis can activate 
IL-8 gene expression in human colonic epithelial cells. Furthermore this study shows that 
NF-κB activation is involved in the production of IL-8. Findings show that the 
antiprotozoal drug metronidazole treatment can avert IL-8 production induced by 
Blastocystis ratti WR1. It was also shown for the first time that the central vacuole of 
Blastocystis may function as a reservoir for cysteine proteases that can degrade human 
secretory immunoglobulin A. These findings will certainly help to understand 
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1.1 INTRODUCTION 
 
Blastocystis is an enteric protozoan parasite of humans and many animals. It was 
first described in the medical literature in 1911 (Alexeieff 1911) and since then its 
pathogenic significance has always been uncertain. Blastocystis has been ignored as a 
pathogen due to its association with mild nature of gastrointestinal symptoms and also 
with many asymptomatic cases. In addition, lack of controlled experimental studies 
addressing the pathogenicity aspects underestimated its status as a gastrointestinal 
pathogen. Moreover, most conclusions were made from conflicting case reports which 
led to confusion and disagreements among researchers and clinicians. 
 
Blastocystis is commonly identified in stool specimens and it is one of the most 
common parasites that reside in the human intestinal tract. The disease it causes is called 
blastocystosis but most publications refer it to as Blastocystis infections. Clinical 
symptoms attributed to Blastocystis infections include recurrent watery diarrhea, mucous 
diarrhea, vomiting, abdominal cramps and flatulence. Blastocystis can infect both 
children and adults and its geographical distribution appears to be global with prevalence 
ranging from 30 to 50% in developing countries (Stenzel and Boreham 1996).  
 
At first, the name B. enterocola was proposed by Alexeieff (1911) and later it was 
isolated from human feces and the name B. hominis was coined (Brumpt 1912). Initially, 
it was described as harmless intestinal yeast. Its association with human disease was 
suggested by a number of reports and eventually work by Zierdt (1991) increased the 
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awareness of Blastocystis infections in humans. In spite of its description about a century 
ago, the exact pathogenesis mechanisms of Blastocystis infections are uncertain. A 
number of clinical and epidemiological studies implicate the parasite as a potential 
pathogen, while others exonerate it as an etiology of intestinal disease (Tan 2004; Leder 
et al. 2005). Significant progress has been achieved on descriptions of the morphology 
and genetic diversity of Blastocystis but most aspects of its life cycle, molecular biology, 
and pathogenicity remain unresolved (Stenzel and Boreham 1996; Tan 2004).  
 
1.2 TAXONOMY  
 
The taxonomic classification of Blastocystis is a controversial subject and there 
are many disagreements among researchers. Blastocystis was earlier described to be a 
yeast or a fungus (Alexeieff 1911; O'Connor 1919), a cyst of another protozoa (Bensen 
1909), or a degenerating cell (Swellengrebel 1917). Blastocystis was described as a 
protist on the basis of morphological and physiological features (Zierdt et al. 1967). 
These protistan features included presence of one or more nuclei, smooth and rough 
endoplasmic reticulum, Golgi complex, mitochondria-like organelles, inabilty to grow on 
fungal medium, ineffectiveness of antifungal drugs, and susceptibility to some 
antiprotozoal drugs. Later, Blastocystis was classified as a sporozoan (Zierdt 1991) and 
finally reclassified as a sarcodine. 
 
 Molecular sequencing studies of Blastocystis partial small-subunit rRNA (ssrRNA) 
showed that Blastocystis is not monophyletic with the yeasts, fungi, sarcodines, or 
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sporozoans (Johnson et al. 1989) and it was concluded that Blastocystis is not related to 
yeasts. In another study, the complete Blastocystis ssrRNA gene was sequenced and 
phylogenetic analysis suggested that Blastocystis should be classified within the 
Stramenopiles (also known as Heterokonta) (Silberman et al. 1996). Molecular 
phylogenetic analysis showed that Blastocystis is closely related to the Stramenopile 
Proteromonas lacerate (Arisue et al. 2002). Another study involving molecular analysis 
of Blastocystis ssrRNA, cytosolic-type 70-kDa heat shock protein, translation elongation 
factor 2, and the non-catalytic ‘B’ subunit of vacuolar ATPase confirmed that 
Blastocystis is a Stramenopile (Arisue et al. 2002). Stramenopiles characteristically 
possess flagella with mastigonemes. Interestingly, since Blastocystis does not have 
flagella and is non-motile, it was therefore placed in a newly formed Class Blastocystea 
in the Subphylum Opalinata, Infrakingdom Heterokonta, Subkingdom Chromobiota, and 
Kingdom Chromista (Cavalier-Smith 1998). In addition, elongation factor- 1α (EF- 1α) 
sequencing for phylogenetic analysis also showed that Blastocystis is not a fungus and 
suggested that it diverged before Trypanosoma, Euglena, Dictyostelium and other 
eukaryotes. Most studies in the past named Blastocystis species according to host origin 
and this may have resulted in confusion regarding specificity, cell biology and 
pathogenicity of the parasite. Recently, a consensus report on the terminology for 
Blastocystis genotypes was published (Stensvold et al. 2007b). Based on this report 
humans can be host to Blastocystis from a variety of animals including mammals 
(subtype 1), primates (subtype 2), rodents (subtype 4), cattle and pigs (subtype 5), and 
birds (subtype 6 and 7) (Noel et al. 2005; Yan et al. 2007). 
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1.3 SPECIATION AND GENETIC DIVERSITY 
 
Blastocystis has been isolated from an extensive range of hosts that includes 
primates, pigs, rodents, reptiles, insects and birds (Boreham and Stenzel 1993). 
Morphological differences among isolates are not significant and cannot be used for 
speciation, therefore other methods for instance karyotyping and molecular phylogenetic 
analysis have been used to differentiate Blastocystis from different hosts (Tan 2004). In 
the past, description of new species was based on host of origin and parasite 
ultrastructure (Belova 1992). Others used pulsed-field gel electrophoresis for karyotyping 
and speciated Blastocystis isolated from rats (Chen et al. 1997b), reptiles (Teow et al. 
1991), tortoise and rhino iguana (Singh et al. 1996). However, diverse intra-species 
karyotypes were observed and it was realized that karyotyping might not be a good 
method for the speciation of Blastocystis (Yoshikawa et al. 2004b). Consequently, there 
are arguments against assigning different species names, other than B. hominis, based on 
presumed host specificity and morphology (Tan 2004). 
 
 Recently, analysis of ssrRNA sequencing of 16 Blastocystis isolates from humans 
and other animals showed that isolates can be divided phylogenetically into seven distinct 
groups that are morphologically similar but genetically different (Arisue et al. 2003). 
Concurrently, other studies reported the presence of these distinct genotypes in a variety 
of other animal hosts (Abe et al. 2003a; Abe et al. 2003b; Yoshikawa et al. 2004a, b; 
Noel et al. 2005). Altogether, these studies strongly suggested that Blastocystis is a 
zoonotic parasite. More recently, it was shown in an extensive ssrRNA sequence analysis 
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that most of the 78 isolates of Blastocystis can be clearly grouped into seven clades 
referred to as groups I to VII (Noël et al. 2005). More importantly, Blastocystis isolates 
from both humans and animals were present in six of the seven groups. It was suggested 
that group I (subtype 1) comprised of zoonotic isolates of mammalian origin, group II 
(subtype 2) comprised of isolates of primates origin, group III (subtype 3) comprised of 
isolates of human origin, group IV (subtype 4) represented zoonotic isolates of rodent 
origin, group V (subtype 5) comprised of isolates from pigs and cattle and group VI 
(subtype 6) and VII (subtype 7) possibly comprised of zoonotic isolates of avian origins 
(Yoshikawa et al. 2004b, Noel et al. 2005, Yan et al. 2007). Overall, these studies 
suggested that Blastocystis is a zoonotic parasite and animal-to-animal, animal-to-human, 
and human-to-animal transmission can occur. 
 
 Random amplified polymorphic DNA (RAPD) analysis of 16 Blastocystis isolates, 
comprising eight isolates from symptomatic and eight asymptomatic patients, suggested a 
possible link between genotype with pathogenicity (Tan et al. 2006). However, other 
studies failed to show any correlation between genotype and pathogenesis of Blastocystis 
(Böhm-Gloning et al. 1997, Yoshikawa et al. 2004b). In a more recent study, correlation 
between the genotype and symptoms was evaluated using PCR subtyping and a 
significant correlation between subtype 2 and the asymptomatic group was found among 
both pediatric and adult patients (Dogruman-Al et al. 2008). 
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1.4 THE CELL BIOLOGY OF BLASTOCYSTIS 
 
Blastocystis is a highly polymorphic and pleomorphic protozoan and there are 
four major forms (vacuolar, granular, amoeboid and cyst) of the parasite reported from in 
vitro culture and fecal samples (Stenzel and Boreham 1996, Tan et al. 2002). There is 
little information on the transition of one form to another and available information is 
limited to the description of individual forms based mostly on microscopic studies. The 
extensive heterogeneity of various forms of Blastocystis has led to the misinterpretation 
of findings from different studies. Blastocystis contains typical organelles of eukaryotes 
and the most apparent structures in transmission electron microscopy are nuclei, Golgi 
apparatus and mitochondria-like organelles. It has been shown that Blastocystis nuclei are 
spherical to ovoid and a crescent-shaped chromatin mass is often observable at one end of 
the organelle (Tan et al. 2001). As Blastocystis is an anaerobe, the presence of 
mitochondria-like organelles needs to be elucidated and it was suggested that these may 
instead be hydrogenosomes (Boreham and Stenzel 1993, Tan et al. 2002, Stechmann et al. 
2008) as a number of typical mitochondrial enzymes were not found in Blastocystis. 
Hydrogenosomes are anaerobic organelles related to mitochondria first described in 
trichomonads (Lindmark and Müller 1973). In a recent study Stechmann et al. (2008) 
reported that Blastocystis organelles have metabolic characteristics of both anaerobic and 
aerobic mitochondria and of hydrogenosomes. They suggested that Blastocystis 
mitochondria-like organelles are convergently similar to organelles in the unrelated 
ciliate Nyctotherus ovalis.  
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 Vacuolar form 
 The vacuolar form is also known as the vacuolated or central body form and it is 
the most predominant form in axenized in vitro cultures, liquid cultures and stool samples 
(Fig. 1.1A). This form varies significantly in size, ranging from 2-200 µm in diameter 
with average diameters of cells usually being between 4-15 µm (Zierdt 1991). Vacuolar 
forms are spherical and contain a characteristic large vacuole surrounded by a thin rim of 
peripheral cytoplasm. Cellular organelles like nucleus, mitochondria-like organelles, 
Golgi are located within the cytoplasmic rim. Multiple nuclei can be seen in Blastocystis 
and an average of four nuclei is common (Zierdt 1973). The plasma membrane of 
Blastocystis has pits that appear to have a role in endocytosis (Stenzel et al. 1989). 
 
 The exact function of the central vacuole in the Blastocystis is currently unclear. It 
may act as storage organelle to participate in schizogony-like reproduction (Suresh et al. 
1994; Singh et al. 1995) or for the deposition of apoptotic bodies during parasite 
programmed cell death (Tan and Nasirudeen 2005). It was also suggested that the central 
vacuole may act as a repository for carbohydrates and lipids required for cell growth 
(Yoshikawa and Hayakawa 1996). 
 
 A surface coat or fibrillar layer of varying thickness often surrounds the organism. 
This surface coat is thick in freshly isolated parasites from feces but it gradually becomes 
thinner with prolonged laboratory culture (Cassidy et al. 1994). The exact role of the 
surface coat is not understood but it has been suggested to play a role in trapping and 
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degrading bacteria for nutrition (Zaman et al. 1997; Zaman et al. 1999) and protecting 
against osmotic shock (Cassidy et al. 1994).  
 
 Granular form 
 The granular form of Blastocystis is morphologically identical to the vacuolar 
form except that granules are present in the cytoplasm or more commonly within the 
central vacuole (Fig 1.1B). The size of this form ranges from 3-80 µm in diameter. 
Granules in the central vacuole may differ considerably in appearance and described as 
myelin-like inclusions, small vesicles, crystalline granules and lipid droplets (Dunn et al. 
1989). Bacterial remnants in lysosome-like compartments in the central vacuoles were 
also observed (unpublished observation). The granular form is commonly observed in 
non-axenized or older cultures (Tan 2004). 
 
 Amoeboid form 
 The amoeboid form (Fig. 1.1C) is rarely observed and there are conflicting reports 
about its description (McClure et al. 1980; Dunn et al. 1989). These forms have been 
observed in antibiotic treated cultures, old cultures or in fecal samples (Zierdt 1973). 
Amoeboid forms are smaller and its size ranges from 2.6-7.8 µm in diameter. Dunn et al. 
(1989) reported ameboid forms with extended pseudopodia but a central vacuole, Golgi 
and mitochondria were not seen. On the contrary, Tan et al. (2001) showed by 
transmission electron microscopy that this form possess a central vacuole, numerous 
Golgi bodies and mitochondria within the cytoplasmic extension of pseudopods 
suggesting that this is a highly active form. In contrast to amoebae, these pseudopodia do 
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not seem to be involved in locomotion. It was suggested that this form may be phagocytic 
in nature as ingested bacteria were found within the parasite in transmission electron 
microscopy analysis (Boreham and Stenzel 1993). 
 
 Cyst form 
 An environmentally resistant cyst form (Fig. 1.1D) is the most recently reported 
form of Blastocystis (Mehlhorn 1988; Stenzel and Boreham 1991; Zaman 1998) and it is 
considered significant for the fecal-oral transmission of infection (Yoshikawa et al. 
2004c). This form is in general much smaller and its size ranges from 2-5 µm in diameter. 
It is protected by a multi-layered cyst wall which is sometimes covered with a loose 
surface coat (Moe et al. 1996). Unlike vacuolar and granular forms, this form has been 
shown to survive in water for up to 19 days at normal temperatures (Moe et al. 1996). 
Another study has shown that Blastocystis cysts could survive up to 1 month at 250C and 
2 months at 40C (Yoshikawa et al. 2004c). Experimental infection studies in mice (Moe 
et al. 1997), rats (Yoshikawa et al. 2004c) and birds (Tanizaki et al. 2005) have shown 
that the cyst form is indeed the transmissible form of Blastocystis. 




































Fig. 1.1 Four morphological forms from axenic cultures of Blastocystis under phase-
contrast microscopy. 
(A) Vacuolar (V) and multivacuolar (MV) forms. Cells are showing extensive 
variations in their size. Bar = 10 µm. 
(B) Granular forms (G). One of the cells appears to be dividing (BF). Bar = 10 µm. 
(C) Amoeboid forms (arrow). Bar = 10 µm. 
(D) Cyst form. Refractile cyst (arrow) with loose fibrillar layers (arrowhead). Bar = 
5 µm. 
Adapted from Chen (1999).  
 




















Fig 1.2 Scanning electron micrographs of Blastocystis rat isolate. (A) Sphere shaped 
Blastocystis (arrow) can be seen in folds of large intestine of wistar rat. Bar = 10 µm. (B) 
An enlarged view showing a well rounded healthy Blastocystis cell (arrow) and another 
that appears to be a dying Blastocystis cell (arrowhead). Bar = 1 µm. (Chen 1999). 
 
 
 13  
1.5 LIFE CYCLE 
 
Many life cycles have been proposed for Blastocystis (Alexeieff 1911; Boreham 
and Stenzel 1993; Singh et al. 1995; Stenzel and Boreham 1996; Tan 2004); owing to a 
lack of controlled experimental studies and the pleomorphic nature of the organism. The 
first life cycle was proposed by Alexeieff (1911) and it described the involvement of 
binary fission and autogamy. Some of the reports suggest modes of division like 
plasmotomy and schizogony (Zierdt 1973; Singh et al. 1995). Most of these observations 
were based on microscopic analysis. Although Blastocystis had been isolated from 
laboratory animals (Fig 1.2), the lack of a suitable animal model was considered to be a 
major reason for the disagreement on its life cycle (Tan 2004). Recent studies have 
shown successful experimental infection of Blastocystis in chickens (Iguchi et al. 2007) 
and rats (Yoshikawa et al. 2004c; Iguchi et al. 2007; Hussein et al. 2008). Rats appear to 
be good animal models for Blastocystis infection but reproducibility of animal infection 
needs to be ascertained. 
 
 A life cycle proposed by Tan (2004) states that infection is initiated when cysts of 
Blastocystis are orally ingested by humans or animals (Fig 1.3). Ingested cysts develop 
into vacuolar forms in the large intestine and later reproduce by binary fission. Some of 
the vacuolar forms encyst and are passed through the feces and the cycle is repeated. The 
role of the amoeboid and granular form in the life cycle of Blastocystis is not understood 
and remains to be elucidated. More recently, Tan (2008) revised the life cycle and 
included findings from molecular typing suggesting that Blastocystis isolated from 
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humans actually comprise human and zoonotic genotypes of varying host specificities. A 
modified life cycle of Blastocystis must take into consideration the large reservoir of this 























































Fig. 1.3 Life cycle of Blastocystis as proposed by Tan (2004). Infection is initiated 
when cysts of Blastocystis are orally ingested by humans or animals. Ingested cysts 
develop into vacuolar forms in the large intestine and later reproduce by binary fission. 
Some of the vacuolar forms encyst and passed through the feces and cycle is repeated by 
fecal-oral route. The development of other forms is less well understood and is 








































Fig. 1.4 Revised life cycle of Blastocystis as proposed by Tan (2008). This life cycle 
also suggests existence of zoonotic genotypes of Blastocystis (Subtypes 1-4, 6 and 7) 
with different host specificities. Fecal cysts of Blastocystis infect human and animal hosts 
and develop into vacuolar forms in the large intestine. Cross-infection can occur among 
mammalian and avian isolates of subtype 1. Subtype 2, 3 and 4 comprises primate, 
human and rodent isolates, respectively. Subtype 5 comprises isolates from pigs and 
cattle whereas subtype 6 and 7 comprise avian isolates. This proposal suggests that 
certain animals act as reservoirs of Blastocystis for human infections; and humans can be 
potentially infected by six or more species of Blastocystis. (Adapted from Tan 2008). 
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1.6 ZOONOSES 
 
Over the last decade, Blastocystis is increasingly recognized as a cause of human 
gastrointestinal disease. Research interest on Blastocystis is on the rise and a Pubmed 
search indicates that in the last 5 years there is an increase in the number of articles on 
Blastocystis (from approximately 130 during 1998-2002 to approximately 220 during 
2003-2007) (PubMed). 
 
Recently, there have been reports that reveal many unexplored aspects of this 
pathogen’s pathogenesis. Blastocystis is now considered to have zoonotic potential and it 
is believed that animals like pigs and chicken constitute large reservoirs of this protozoan 
for human infection via the fecal-oral route (Tan 2004). Many reports have shown strong 
phylogenetic evidences that designate Blastocystis as a zoonosis (Abe et al. 2003c; 
Yoshikawa et al. 2004a; Noel et al. 2005). In an extensive phylogenetic study, it was 
shown that Blastocystis could be classified in seven different clades with six main groups 
comprising of isolates from both humans and animals (Noel et al. 2005). It was suggested 
that animals represent a large potential reservoir for human infections. Numerous 
Blastocystis isolates from humans are believed to be potentially zoonotic because they 
have similar or fairly similar genotypes to isolates found in a variety of other animal and 
bird species. It has been reported that a number of genotypes from human isolates can 
infect chickens and rats (Iguchi et al. 2007; Hussein et al. 2008). 
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Blastocystis possesses a number of features that increase the chances of 
waterborne transmission and environmental contamination and thus demands zoonosis 
control. These include an extensive range of hosts and low host specificity, a 
transmissible cyst form that is resistant to adverse environmental conditions and a lack of 
knowledge of specific disinfection and treatment strategies.  
 
Blastocystis is also very common among many animal species. It was suggested 
that humans are host for numerous Blastocystis genotypes isolated from animals (Noel et 
al. 2005). It has been reported in mammals, birds, reptiles, amphibians, annelids, and 
arthropods. In particular, some animals showing high prevalence include laboratory rats 
(60%; Chen et al. 1997a), pigs (70-95%; Abe et al. 2002), and birds (50-100%; Abe et al. 
2002; Lee and Stenzel 1999). In Brisbane, Australia, Blastocystis has been detected in 
fecal samples from domestic dogs and cats (Duda et al. 1998). The prevalence was very 
high; with 70.8% dogs and 67.3% cats infected with Blastocystis.  
 
In an extensive study, the prevalence of Blastocystis sp. was examined in fecal 
samples collected from cattle, pigs, and various zoo animals in Japan (Abe et al. 2002). A 
high prevalence of Blastocystis infection was reported in farm animals (95% in pigs; 71% 
in cattle), and in zoo animals (85% in primates; 80% in pheasants; 56% in ducks). In this 
study, Blastocystis isolates from various animals were morphologically indistinguishable 
from Blastocystis isolated from humans. 
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PCR-based characterization of Blastocystis isolates was reported from dogs and 
humans living in a localized endemic community in Thailand (Parkar et al. 2007). This 
phylogenetic study provided molecular-based evidence to support zoonotic transmission 
of Blastocystis infections from dogs, possums and primates in a community. It was 
reported that people working closely with animals were at significantly higher risk of 
Blastocystis infections suggesting that infection can be acquired from animals and work 
place safety is important for prevention of infection (Rajah Salim et al. 1999). It was 
found in this study that 41% of animal handlers were positive for Blastocystis in contrast 
to 17% of individuals who did not work with animals. 
 
Human populations exposed to poor hygiene practices, contaminated food and 
water appeared to be at risk of Blastocystis infections (Tan 2008). Outbreaks of 
waterborne Blastocystis infections have been documented recently in some studies 
(Karanis et al. 2007). Blastocystis cysts have been detected in Scottish and Malaysian 
sewage treatment facilities; and viable cysts, found in the effluent, provided evidence that 
Blastocystis infections have potential for waterborne transmission (Suresh et al. 2005). 
Evidence is growing that contaminated water and food play an important role in the 
transmission of Blastocystis to humans. In a study (Cruz Licea et al. 2003), Blastocystis 
was detected from 41.7% of food vendors and risk analysis showed that it was associated 
with poor personal hygiene habits. This report suggested that customers were at risk of 
acquiring Blastocystis infection from food vendors. 
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1.7 SYMPTOMS AND SIGNS 
 
Many epidemiological studies suggest that Blastocystis infection is associated 
with intestinal disorders (Barahona Rondon et al. 2003; Miller et al. 2003; Leelayoova et 
al. 2004; El-Shazly et al. 2005). On the contrary, a number of reports suggested that this 
parasite does not cause any disease (Rosenblatt 1990; Senay and MacPherson 1990; 
Udkow and Markell 1993). 
  
The clinical symptoms and signs associated with Blastocystis infections are 
mainly diarrhea, abdominal pain, cramps, nausea as well as non-specific gastrointestinal 
signs that includes bloating, vomiting, anorexia, weight loss and flatulence (Qadri et al. 
1989; Doyle et al. 1990; Nimri and Batchoun 1994; Stenzel and Boreham 1996). 
Although most cases of Blastocystis are mild and chronic, profuse watery diarrhoea 
(Logar et al. 1994) and fever (Gallagher and Venglarcik, 1985) has also been reported in 
acute cases. There are reports that suggest the association of Blastocystis with irritable 
bowel syndrome (Giacometti et al. 1999; Yakoob et al. 2004), a functional bowel 
disorder characterized by abdominal pain and changes in bowel habits. 
 
Interestingly, some studies have also reported symptoms like itching (Garavelli 
and Scaglione 1990) and joint pain (Lee et al. 1990). Numerous case reports have 
suggested association of Blastocystis with cutaneous disorders like chronic urticaria 
(Armentia et al. 1993; Biedermann et al. 2002), angioedema (Micheloud et al. 2007) and 
palmoplantar pruritis (Kick et al. 2002). Recently in a case study of Blastocystis infection, 
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it was reported that acute urticaria was associated with amoeboid forms of Blastocystis 
subtype 3 (Katsarou-Katsari et al. 2008). 
 
Numerous reports suggested that HIV and immunocompromised patients are 
more likely to acquire Blastocystis-associated intestinal disease and suggested that this 
parasite is opportunistic (Brites et al. 1997; Ok et al. 1997; Florez et al. 2003; Rao et al. 
2003; Hailemariam et al. 2004). Diarrhoea and other gastrointestinal symptoms were 
reported in these Blastocystis infected immunocompromised patients. Blastocystis was 
observed to be the most common parasite isolated from patients undergoing 
chemotherapy for hematological malignancies and it was suggested to be associated with 
diarrhoea, abdominal pain and flatulence (Tasova et al. 2000). 
 
Many cases of Blastocystis infections appear to be asymptomatic and it is 
common to detect large number of Blastocystis in stool samples from patients who do not 
show any sign of disease. It appears that absence of clinical symptoms might be due to 
infections with nonpathogenic genotypes of Blastocystis, however, whether this disease is 
genotype linked or not is still an unresolved issue. In a study involving PCR-RFLP 
ribotyping of Blastocystis isolates, it was observed that subtypes 1, 2 and 4 were 
associated with symptoms whereas subtype 3 was associated with asymptomatic 
infections (Kaneda et al. 2001). In an another genotyping study, subtype 1 was found in 
patients with gastrointestinal symptoms, subtype 7 was found in asymptomatic and 
subtypes 3 and 6 were found in both groups of patients (Hussein et al. 2008). On the 
contrary, some studies have indicated that there is no association between symptoms and 
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Blastocystis genotypes (Böhm-Gloning et al. 1997; Yoshikawa et al. 2004b). In summary, 
studies suggest that subtype 1 might be associated with disease and subtype 3 may be 
non-pathogenic; however there is a need for more studies with larger sample sizes to 
resolve this issue. In addition, it is evident that Blastocystis infections can cause a variety 
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1.8 CLINICAL FEATURES 
 
The clinical significance of Blastocystis is presently ambiguous. There are many 
reports that either implicate or exonerate this organism as a cause of gastrointestinal 
disease. This parasite can be found in the intestinal tract of both healthy individuals and 
patients exhibiting gastrointestinal symptoms (Stenzel and Boreham 1996).  
 
Many case reports have suggested the association of Blastocystis with a variety of 
clinical features including terminal ileitis (Tsang et al. 1989), colitis (Russo et al. 1988), 
ulcerative colitis (Jeddy and Farrington 1991), and infective arthritis (Lakhanpal et al. 
1991). Interestingly, various reports associate Blastocystis infections with cutaneous 
lesions particularly urticaria (Giacometti et al. 2003; Cassano et al. 2005; Gupta and Parsi 
2006) suggesting host allergic response to some unknown parasitic factors.  
 
Fecal leukocytes (Cohen 1985; Diaczok and Rival 1987) and rectal bleeding has 
been reported in Blastocystis infections (Al-Tawil et al. 1994).  Enlargement of liver and 
spleen was also reported in a study (Garavelli and Scaglione 1990). Blood analysis of a 
number of patients showed eosinophilia (Garavelli and Scaglione 1990; Lambert et al. 
1992). There are reports that associated Blastocystis with intestinal disorders in HIV or 
immunocompromised patients (Ok et al. 1997; Cirioni et al. 1999; Florez et al. 2003; Rao 
et al. 2003; Hailemariam et al. 2004) suggesting that Blastocystis is an opportunistic 
organism. 
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Inflammation and edema of intestinal mucosa has been reported in Blastocystis 
infections (Russo et al. 1988; Garavelli et al. 1991; Zuckerman et al. 1994). In 
Blastocystis infected patients, endoscopy results showed that there was no invasion of the 
colonic mucosa (Kain et al. 1987; Dawes et al. 1990; Zuckerman et al. 1990). On the 
other hand, Al-Tawil et al. (1994) reported the presence of colonic ulceration and 
infiltration of superficial lamina propria by Blastocystis. Intestinal permeability was 
reported to be significantly increased in Blastocystis patients and it was suggested that 
Blastocystis infections may damage the intestinal wall (Dagci et al. 2002). 
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1.9 PATHOGENESIS 
 
Very few in vivo and in vitro studies have addressed the pathogenicity aspects of 
Blastocystis infections. Live Blastocystis cells and parasitic lysates isolated from 
symptomatic and asymptomatic individuals caused significant cytopathic effects on 
Chinese Hamster Ovary (CHO) cells (Walderich et al. 1998). Another study showed that 
Blastocystis reduced Escherichia coli or LPS-induced secretion of IL-8 and it was 
proposed that Blastocystis is capable of modulating host immune responses at initial 
stages of infection (Long et al. 2001). This suggested that Blastocystis may down-
regulate host immune responses in order to improve survival in the gut.  
 
Other isolated clinical reports described intestinal inflammation and edema in 
patients infected with Blastocystis (Kain et al. 1987; Russo et al. 1988; Garavelli et al. 
1992). One study reported significantly increased intestinal permeability after 
Blastocystis infections (Dagci et al. 2002). A number of studies have described 
experimental infections involving rats, mice, guinea pigs and chickens (Phillips and 
Zierdt 1976; Pakandl 1992; Moe et al. 1997; Abou El Naga and Negm 2001; Yoshikawa 
et al. 2004c; Tanizaki et al. 2005; Iguchi et al. 2007; Hussein et al. 2008). However, 
reproducibility of these animal models needs to be ascertained. In experimentally infected 
mice, histological examination of the cecum and colon revealed intense inflammatory cell 
infiltration, edematous lamina propria, and mucosal sloughing (Moe et al. 1997). Lesions 
on the ileocecal mucosa were reported in mice experimentally infected with Blastocystis 
(Zhang et al. 2006). Experimentally, it has been shown that Blastocystis infection can be 
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established with oral inoculation of cysts in mice (Moe et al. 1997) and rats (Yoshikawa 
et al. 2004c). Wistar rats were successfully infected with oral inoculation of Blastocystis 
cysts recovered from feces of another infected rat and it was demonstrated that an oral 
dose of as low as ten cysts was sufficient to establish infection. These studies indicated 
that the fecal cyst form was responsible for fecal-oral transmission of the parasite. 
Clinical reports and experimental studies indicate that Blastocystis is not invasive but it is 
capable of causing gastrointestinal pathogenesis. Experimentally, it was shown that germ 
free guinea pigs can be infected by oral or intracecal inoculations and heavy infections 
caused diarrhoea and cecal hyperemia (Phillips and Zierdt 1976). Recently, Blastocystis 
isolates from symptomatic and asymptomatic humans were experimentally tested for 
their infectivity in rats (Hussein et al. 2008). It was reported that Blastocystis isolates 
from symptomatic patients induced moderate to severe pathological changes in infected 
rats but isolates from asymptomatic individuals caused mild pathological changes. 
Authors suggested that subtype 1 was pathogenic, while subtypes 3 and 4 consisted of 
both pathogenic and non-pathogenic variants.  
 
 Interestingly, accumulating reports suggest an association between Blastocystis 
infections and cutaneous lesions. The mechanism is possibly that of typical cutaneous 
allergic hypersensitivity where parasitic antigens induce the activation of specific clones 
of Th2 lymphocytes (Pasqui et al. 2004). Eventually, cytokines release and the 
consequent IgE production may lead to an allergic reaction. Moreover, it was also 
suggested that some Blastocystis virulence factors may activate the complement pathway 
with the production of anaphylotoxins (Valsecchi et al. 2004). These anaphylotoxins, 
 27  
upon interaction with basophils and mast cells induce histamine production which may 
result in cutaneous disorders. 
 
A number of earlier reports suggested that Blastocystis disease is dependent on 
parasite load however recent studies suggest that clinical outcome of Blastocystis 
infection is multifactorial and depends on parasite genotype, parasitic load, and host 
immune status (Tan 2008). In a number of cases, Blastocystis infections appear to be self-
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1.10 DIAGNOSIS 
 
Because of its uncertain pathogenesis, reasonable clinical significance is seldom 
given to Blastocystis infections. Generally, diagnosis and other important aspects of 
Blastocystis infections are not included in the curriculum of medical studies and thus 
diagnosis of Blastocystis remains a challenging task for a diagnostic laboratory. Although 
an experienced laboratory technician can perform diagnosis in direct fecal smears, most 
diagnostic laboratories do not have expertise on identification of this parasite and there is 
a need for training to enable identification of all forms of Blastocystis in fecal samples. 
Identification of Blastocystis in direct fecal smears is relatively difficult as the parasite 
can be confused with yeast, cyclospora, or fat globules.  
 
In the past, laboratory diagnosis of Blastocystis was based on the identification of 
vacuolar and granular forms in direct fecal specimens (Katz and Taylor 2001). Direct 
microscopy of fecal specimens is performed by wet mounts with Lugol’s iodine or 
permanent fixed smears with Giemsa, acid-fast, trichrome and Field’s staining. Rather 
than the characteristic vacuolar form, the cyst form may predominate fecal samples.  Cyst 
forms might be difficult to identify by direct microscopy because of their small size (3-5 
µm) but these can be effectively concentrated by density-gradient methods (Zaman 1996). 
Diagnostic labs should therefore include the fecal cyst form as an indicator of 
Blastocystis infection. 
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  Many researchers suggest that when all other known bacterial, viral or parasitic 
causes of symptoms are absent and Blastocystis is present in large numbers it should be 
treated as a pathogen. More than five organisms per high power field (×400 
magnification) should be considered as a heavy infection. For confirmative diagnosis in 
stool samples, in vitro culture in Jones’ medium is a method of choice (Suresh and Smith 
2004). It was reported that in vitro culture of fecal samples was six times and twice more 
sensitive than direct fecal smears and trichrome staining methods respectively 
(Termmathurapoj et al. 2004). However, it was also reported in this study that the in vitro 
culture method failed to detect some parasites suggesting that not all Blastocystis isolates 
can be readily cultured in laboratory. Blastocystis can be cultured in various mediums 
including Jone’s medium, Boeck and Drbohlav’s inspissated medium or diphasic agar 
slant medium with Jone’s as a medium of choice for patient samples. Diphasic agar slant 
medium was reported to be good for the culture of Blastocystis from pigs, cattle and 
chickens (Abe et al. 2003b; Abe 2004). In axenized cultures, cell densities of up to 2.5 
×107 can be achieved (Ho et al. 1993) and doubling time may vary from 6 to 23 h, 
depending on type of medium and isolate (Boreham and Stenzel 1993). Colony growth of 
Blastocystis has been shown on solid medium and cultures were viable for up to 2 weeks 
(Tan et al. 2000). 
 
Molecular approaches, particularly PCR-based diagnosis have been described for 
Blastocystis (Stensvold et al. 2007a). PCR amplification using subtype specific primers is 
suggested to be useful for identifying and genotyping Blastocystis from patient samples. 
Knowledge of the genotype can be extremely valuable if certain Blastocystis genotypes 
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are found to be more virulent than others. A recent study has demonstrated that PCR-
based detection of Blastocystis from fecal specimens is more sensitive than in vitro 
propagation (Parkar et al. 2007). Recently, a sensitive and specific real-time light cycler 
PCR assay was developed to detect a 152 bp sequence in an uncharacterized region of the 
Blastocystis genome and 11 strains of Blastocystis from subtypes 1, 3, and 4 were with 
this method (Jones et al. 2008). Using this method, Blastocystis was detected in stool 
samples that were found Blastocystis negative during microscopy and conventional PCR. 
In addition, this method showed no cross-reactivity with other common gastrointestinal 
pathogens. 
 
Other methods like enzyme-linked immunosorbent assay (ELISA) and 
immunofluorescence detection have not been comprehensively investigated for 
Blastocystis. Although development of monoclonal antibodies against Blastocystis has 
been reported (Tan et al. 1996), antigenic diversity of Blastocystis seems to be a limiting 
factor in the use of immunological methods. Blastocystis infections have been reported to 
induce IgG and IgA responses in patients and detected by indirect fluorescent antibody 
test (IFA) and ELISA (Zierdt and Nagy 1993; Zierdt et al. 1995; Hussain et al. 1997; 
Kaneda et al. 2000; Mahmoud and Saleh 2003). ELISA titers ranged from 1:50-1:1,600 
(Zierdt et al. 1995) and it was observed that high titers were associated with symptomatic 
infections of Blastocystis (Zierdt and Nagy 1993; Zierdt et al. 1995; Hussain et al. 1997; 
Mahmoud and Saleh 2003). In a recent study using ELISA, secretory IgA, serum IgA and 
serum IgG levels were detected in Blastocystis infected patients with and without clinical 
symptoms (Mahmoud and Saleh 2003). It was found that serum from only symptomatic 
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patients had significantly higher antibody levels. On the other hand, Kaneda et al. (2000) 
reported asymptomatic patients with serum antibodies to Blastocystis and high levels 
were observed in chronic cases. Overall, it may be desirable to develop specific 
monoclonal antibodies against different genotypes and evaluate different serological 
assays for the diagnosis of Blastocystis infections.  
 
Diagnosis of blastocystosis has been reported with the help of invasive diagnostic 
techniques like endoscopy but it has not been evaluated. Blastocystis colonization in the 
lower ileum and cecum of a patient was detected in the microscopic examinations of the 
lumen fluids aspirated during endoscopy (Matsumoto et al. 1987). As Blastocystis can be 
detected in feces and no characteristic intestinal lesions are associated with infection, 
invasive diagnostic techniques are not recommended for routine examinations. 
 
In brief, a number of methods have been described for the diagnosis of 
Blastocystis. Direct microscopy of stained fecal smears is useful and it should be 
supplemented with numbers of parasites observed per high power field to help clinicians 
ascertain parasitic load. For confirmatory diagnosis, microscopic examination should be 
supplemented by in vitro culture and/or PCR-based methods. 
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1.11 TREATMENT AND PROGNOSIS 
 
Due to ambiguity surrounding the pathogenesis of Blastocystis and the non-specific 
nature of symptoms, the need to treat Blastocystis infections has been disputed. In most 
cases, treatment with antiprotozoal drugs, in particular metronidazole, is warranted if no 
other cause of symptoms is observable (Nigro et al. 2003; Cassano et al. 2005; 
Moghaddam et al. 2005). Metronidazole is a nitroimidazole drug used primarily for 
infections caused by obligate anaerobes. After uptake by anaerobic organisms, it is 
reduced by the pyruvate:ferredoxin oxidoreductase system in the mitochondria. Reduced 
intermediate products interact with intracellular targets and disrupt DNA helical structure 
and inhibit nucleic acid synthesis. Whether the mode of action of metronidazole on 
Blastocystis is similar to that described for other protozoan parasites is currently 
unknown. It has been shown that metronidazole induces programmed cell death in 
Blastocystis with a number of features similar to apoptosis in higher eukaryotes 
(Nasirudeen et al. 2004). In Blastocystis infections, various dosage of metronidazole has 
been recommended in different studies (Waili 1987; Qadri et al. 1989; Garavelli and 
Libanore 1990; Nassir et al. 2004; Guirges and Al- Moghaddam et al. 2005). In summary, 
treatment regime ranges from 250-750 mg three times a day for 5 to 10 days, 200 mg four 
times per day for 7 days or 2 gm/day for 5 days. There have been reports where 
metronidazole has been used successfully in combination with other drugs particularly 
paromomycin (Pasqui et al. 2004) and co-trimoxazole (Andiran et al. 2006). Some 
studies also reported that metronidazole was not efficacious in eliminating Blastocystis 
infection from patients (Cohen 1985; Schwartz and Houston 1992). In vitro studies have 
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reported that different Blastocystis isolates show variable sensitivities to metronidazole 
(Haresh et al. 1999). In particular, cysts of Blastocystis have been shown to be resistant to 
high concentrations (up to 5 mg/ml) of metronidazole (Zaman and Zaki 1996). Overall, 
treatment failures may occur due to extensive genetic heterogeneity and differences in the 
susceptibility of different forms of Blastocystis to drugs.  
 
In addition to metronidazole, many other drugs have been used to treat 
Blastocystis infections with high or reasonable efficacy. Among these are furazolidone, 
quinacrine, ornidazole, tinidazole, ketoconazole, and trimethoprim-sulfamethoxazole (co-
trimoxazole) (Reviewed in Stenzel and Boreham 1996). Recently, a number of studies 
reported that the broad spectrum antiparasitic drug nitazoxanide is effective for use in 
Blastocystis infections (Cimerman et al. 2003; Rossignol et al. 2005).  
 
There is a lack of controlled studies involving large numbers of patients and 
extensive studies are needed to verify the efficacy of different drugs on Blastocystis 
infections. Thus far, metronidazole seems to be drug of choice for blastocystosis, even 
though there are some evidences of treatment failure. In such cases, other drugs should be 
employed empirically. Chemotherapy should be employed when symptoms are persistent 
and no other pathogen than Blastocystis is detected. In mild cases of Blastocystis 
infections, intervention may not be required as infection is usually self-limiting (Babb 
and Wagener 1989; Doyle et al. 1990; Markell 1995).  
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1.12  EPIDEMIOLOGY, PEVENTION AND CONTROL 
 
Blastocystis is reported to be one of the most common protozoans found in fecal samples 
of both symptomatic patients and asymptomatic individuals (Cirioni et al. 1999; Taamasri 
et al. 2000; Windsor et al. 2002). Recently, there is a significant increase in prevalence 
reports which has helped us to better understand the distribution of genotypes, mode of 
transmission and pathogenicity aspects. Blastocystis has a worldwide distribution and 
findings of many surveys reported it to be most frequently isolated protozoan parasite 
(Pegelow et al. 1997; Taamasri et al. 2000; Florez et al. 2003; Baldo et al. 2004). 
Prevalence of Blastocystis infection is higher in developing countries than in developed 
countries (Stenzel and Boreham 1996; Tan et al. 2002) and occurrence as high as 60% 
were reported from some developing countries (Pegelow et al. 1997). Occurrence of 
Blastocystis varies from country to country. A low prevalence of 0.5% has been reported 
among asymptomatic healthy individuals in Japan (Horiki et al. 1997). A moderate 
prevalence of 14-21% and 23% was reported in Thailand (Yaicharoen et al. 2005) and 
United States (Amin 2002) respectively. A high prevalence of 40.7% and 60% was 
reported in Philippines (Baldo et al., 2004) and Indonesia (Pegelow et al. 1997) 
respectively. High incidences (36.9-44%) of Blastocystis were also observed in Thai 
military personnel (Taamasri et al. 2002; Leelayoova et al. 2004). Prevalence of 
Blastocystis may vary widely within various geographical regions of the same country. In 
Thailand, a prevalence of 0.8% and 45.2% was reported from Nan province (Waikagul et 
al. 2002) and Pathum Thani province (Saksirisampant et al. 2003) respectively. 
Variations in the same geographical region may represent true differences between 
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communities or living conditions. Nevertheless, these reported variations might be due to 
lack of a standardized diagnostic methodology and difficulty in identifying parasitic 
forms other than the common vacuolar form. Recent studies have used PCR-based 
approaches to further elucidate genotype information which has shed light on the 
distribution of Blastocystis genotypes in humans and animals. Studies have found that 
Blastocystis subtype 3 was the most common subtype among isolates from countries 
including Turkey (Ozyurt et al. 2008), Greece (Menounos et al. 2008), Singapore (Wong 
et al. 2008), Japan, Pakistan, Bangladesh, and Germany (Yoshikawa et al. 2004b). In 
summary, studies suggest that there is no association between specific genotype and 
geographic origin; and due to its predominance in urbanized countries, subtype 3 is 
probably the subtype of human origin. 
 
It has been observed that humans with compromised health and poor hygiene are 
more susceptible to Blastocystis infections. Blastocystis infections are also of special 
clinical interest to developed countries as millions of travelers going to developing 
countries are at risk of acquiring infection (Sohail and Fischer 2005). Blastocystis 
infections are more common during hot weather and during the pre-monsoonal months 
(Stenzel and Boreham 1996). 
 
Based on current knowledge, it is generally accepted that Blastocystis is 
transmitted by the fecal-oral route. This assumption is strengthened by animal infection 
studies (Yoshikawa et al. 2004c; Tanizaki et al. 2005) and reports showing high 
prevalence of Blastocystis in population living in poor hygiene (Nimri 1993; Cruz Licea 
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et al. 2003). Therefore, control measures should consist of good hygiene practices and 
community sanitary facilities.  
 
Because Blastocystis is generally regarded as a zoonotic parasite, animals and 
their fecal material represent a risk for human infection. Contamination of food, water, 
and environment by animal fecal material should be prevented. High prevalence of 
Blastocystis has been shown in pets particularly dogs and cats and it was suggested that 
these domestic animals could be an important source of infection to humans (Duda et al. 
1998). Routine antiparasitic treatment practice for pet animals may be useful to eliminate 
the parasite. Animal handlers must take additional precautions for their personal hygiene 
and may go for stool examination especially if experiencing any gastrointestinal 
symptoms. In unhygienic and high Blastocystis prevalence areas, sterilization of water is 
recommended. Currently, the best sterilization method is to boil water as chemical 
methods of water sterilization have not been extensively studied for Blastocystis. 
Travelers to high prevalence areas should ensure that they consume clean water and 
cooked food. Blastocystis has been found in sewage (Suresh et al. 2005) and there is 
growing evidence for waterborne transmissions (Leelayoova et al. 2004; Hakim et al. 
2007; Karanis et al. 2007) which makes it necessary to develop preventive measures to 
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1.13 OBJECTIVES OF THE PRESENT STUDY 
 
The pathogenesis of Blastocystis is, to date, controversial and inconclusive. 
Whether it is a pathogenic or a commensal intestinal parasite; or it has potential to be a 
pathogen in particular circumstances is currently debatable. Several epidemiological and 
clinical case reports have associated Blastocystis with a variety of gastrointestinal 
symptoms but only a small number of controlled experimental studies have been carried 
out to investigate the pathogenesis of this organism. Even though, there is no suitable 
animal model available, there is scarcity of in vitro studies that have addressed this issue.  
 
In vitro models are used extensively in biomedical research and they have 
contributed tremendously to the understanding of basic cellular processes and interactions. 
The study of host-pathogen interactions in intestine presents significant methodological 
problems and in vitro model systems were developed in an attempt to circumvent these 
limitations. In vitro intestinal cell culture models simulate the human physiology of 
intestinal tract and represent a highly reproducible experimental system. White (2001) 
stated that in vitro models mimic in vivo drug clearance profiles and represent a 
significant tool for carrying out pharmacodynamic studies in a more cost-effective, timely, 
and easily controlled manner. Intestinal in vitro cell culture methods were suggested to be 
easy and elegant ways to study cell interactions, cellular behavior, and cell signaling 
pathways (Simon-Assmann et al. 2007). Many intestinal epithelial cell lines including 
Caco-2, T84, HT-29 and HCT-8 have been extensively used in various in vitro models 
for studies involving host pathogen interactions, infection, immunology, 
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pharmacodynamics of drugs and cell biology. Cell lines (transformed cells) have the 
advantage over in vivo models as they allow the study of cell types in isolation which 
helps in understanding the responses of a particular cell type. Cell lines are easy to 
maintain and can be passaged many times without loss in their characteristics. As a result 
of their differentiation characteristics, many of these cell lines have been exploited 
extensively as substitutes for normal intestinal cells. Even though all variables seen in 
vivo can not be incorporated in in vitro experiments, they do provide valuable 
information (White 2001). The key benefit involving in vitro models is that single 
variable experiments can be performed under highly controlled conditions. 
 
The authors of the most extensive review on Blastocystis (Stenzel and Boreham 
1996) stated in their conclusion “Our current knowledge of Blastocystis hominis and the 
putative disease it causes is insufficient to determine the significance of the parasite in 
humans”. Because of the limited information on Blastocystis virulence factors, it was 
investigated in the current work if Blastocystis possesses any protease activity as 
proteases are considered to be virulence factors in many protozoan parasites. Many of 
these proteases in particular cysteine type are likely to play crucial roles in host–parasite 
interactions (Sajid and McKerrow 2002; Mottram et al. 2004). Interactions of 
Blastocystis proteases with human secretory immunoglobulin A and intestinal epithelial 
cell lines were further investigated. Blastocystis infections are associated with 
gastrointestinal symptoms but nothing is known about its pathophysiology. An 
association between disruption of intestinal barrier function and diarrhea has been 
described in other diseases (Madara 1988; Madara 1990) and thus in present study; the 
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effects of the Blastocystis exposure on intestinal epithelial monolayer permeability and 
transepithelial resistance were studied.  
 
In this study, using in vitro model systems, aim was to investigate various aspects 
of Blastocystis pathogenicity with particular focus on interactions with the intestinal 
epithelium. For most experiments, parasitic lysates were used. To ensure that damaging 
effects on intestinal epithelial cells are Blastocystis specific, live Blastocystis cells were 
also used in all experiments. 
 
Specific objectives of this study were:- 
 
1. To study the protease activity of Blastocystis. 
2. To investigate if Blastocystis can degrade human secretory immunoglobulin A 
(S-IgA). 
3. To investigate if Blastocystis can induce apoptosis in intestinal epithelial cells. 
4. To study the effects of Blastocystis on intestinal epithelial tight junctions and 
barrier function. 
5. To investigate if Blastocystis is capable of inducing proinflammatory cytokine 
interleukin-8 response from intestinal epithelial cells and to study parasitic 
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2.1 INTRODUCTION 
 
In recent years, there has been an increased interest in the proteases of pathogens. 
Proteases or peptide hydrolases catalyze the cleavage of peptide bonds in the proteins or 
peptides. Proteases from many protozoan and other pathogens have been described and 
their importance in host-pathogen interactions is well understood in a number of diseases 
(McKerrow et al. 1993; Sajid and McKerrow 2002). In protozoan parasites, proteases 
have been reported to have important roles in host cell invasion and egress, encystation, 
excystation, catabolism of host proteins, differentiation, cell cycle progression, 
cytoadherence, and both stimulation and evasion of host immune responses (Reviewed in 
Klemba and Goldberg 2002). Serine and cysteine proteases depend on the nucleophilic 
character of the serine and cysteine side chains respectively, and directly attack the 
peptide bond to form a transient covalent enzyme-substrate intermediate (Klemba and 
Goldberg 2002). Aspartic proteases and metalloproteases use a water molecule for 
nucleophilic attack and do not form a covalent intermediate. Proteases, in particular 
cysteine (thiol or sulfhydryl proteases), are known to have cytopathic effects and they 
were reported to function as virulence factors of many protozoan parasites (Sajid and 
McKerrow 2002).  
 
High protease activity was reported in Trichomonas vaginalis and it was found 
that this activity is mainly due to parasitic cysteine proteases (Coombs and North 1983). 
Protease activity of T. vaginalis was suggested to contribute to its adherence to host cells 
and protease inhibitors were shown to prevent this interaction (Arroyo and Alderete 
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1989). It was also reported that these proteases in T. vaginalis are located in lysosomes 
(Lockwood et al. 1988). Parasitic proteases differ in their pH dependence and sensitivities 
to different protease inhibitors. Knowledge of pH dependence of proteases can aid us in 
understanding their actual activity in in vivo physiological and pathological conditions. 
 
Numerous other protozoans were reported to have cysteine proteases as their 
major proteases. Entamoeba histolytica, the cause of amoebiasis, has cysteine proteases 
that can damage host tissue and helps in parasite invasion and cytotoxicity was prevented 
with the use of protease inhibitors (McGowan et al. 1982; Gadasi and Kobiler 1983). 
High protease activity, in particular of the cysteine type, was also reported in G. lamblia 
and Lindmark (1988) showed that the proteases are localized in lysosome-like subcellular 
structures. In summary, numerous pathogenic protozoan parasites exhibit significant 
protease activity and these proteases may have important roles in parasite survival, 
multiplication and pathogenicity. 
   
Blastocystis is a protozoan parasite found in intestinal tract of humans and many 
other animals. Pathogenicity aspects of Blastocystis are thus far ambiguous and there are 
many conflicting reports that either implicate or exonerate the parasite as a cause of 
gastro-intestinal disease. Numerous studies have also suggested zoonotic potential of 
Blastocystis (Yoshikawa et al. 2004a; Noel et al. 2005). Despite considerable progress in 
understanding of the morphology and epidemiology of Blastocystis, virulence factors of 
this parasite remain unidentified.  
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In this chapter, the protease activity and specificity of Blastocystis were 
investigated. For the first time, the protease activity of Blastocystis ratti WR1 and 
Blastocystis hominis B is reported and it was observed that this parasite possesses high 
protease activity, in particular of the cysteine protease type. It is also demonstrated that 
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2.2 MATERIALS AND METHODS 
 
2.2.1 Parasite culture  
 
For this study, two isolates of Blastocystis; Blastocystis ratti WR1 and 
Blastocystis hominis B were used. Parasites were cultured in pre-reduced Iscove’s 
Modified Dulbecco’s Medium (IMDM) supplemented with 10% inactivated horse serum 
and incubated anaerobically at 370C in an ANAEROJAR (Oxoid, UK) as described 
previously (Ho et al. 1993). After washing and dilution in PBS, counting of the parasites 
was performed using a haemocytometer. Viability of 5 days old parasites was 
microscopically determined and healthy cultures with >95% viability were used for all 
experiments. 
 
2.2.2 Preparation of lysate 
 
For the analysis of protease activity by azocasein assay, parasites were washed 
two times in PBS (pH 7.4) and lysates were prepared by 3 freeze-thaw cycles in liquid 
nitrogen and 370C water bath respectively. Lysates of 4×106 parasites were used for each 
sample, except in studies with concentration dependent activity where different amounts 
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2.2.3 Azocasein assay for the measurement of protease activity of Blastocystis 
 
Protease activity of Blastocystis was measured by the azocasein assay as 
previously described (Scholze and Tannich 1994) with a few minor modifications. To 
activate proteases, parasitic lysates were preincubated with 2mM dithriothreitol (DTT) 
(Sigma) at 370C for 10 min. 100µl of 5mg/ml azocasein (Sigma) solution (in PBS, pH 7.4) 
and incubated with 100µl of lysate at 370C for 1h. To stop reaction, 300µl of 10 % 
trichloroacetic acid was added and samples were incubated for 30 min on ice. To remove 
undigested azocasein, samples were centrifuged at (5000×g, 5 min). The resulting 
supernatant was transferred to a new clean tube containing 500µl of NaOH (525mM). 
Finally, absorbance of the sample was measured at 442nm on a spectrophotometer 
(Tecan Magellan). For some controls, to see if azocasein digestion is due to Blastocystis 
proteases, parasitic lysates were boiled at 900C for 15 min to inactivate proteases.  For 
experimental positive controls, 100 µl trypsin (2.5mg/ml) was used.  
 
2.2.4 Protease inhibition 
 
  To determine the types of proteases that are present in both WR1 and B isolates of 
Blastocystis, effects of protease inhibitors on the protease activity of Blastocystis were 
studied by adding one of the following inhibitors during 1h incubation of parasitic lysate 
with azocasein: E-64, iodoacetamide, EDTA, PMSF (all 1mM); and pepstatin A 
(100µg/ml). All inhibitors were purchased from Sigma except pepstatin A (CHEMICON), 
iodoacetamide (M P Biomedicals, LLC) and PMSF (BDH) (Table 2.1).  




Protease inhibitor Specificity Concentration used 
E-64 Cysteine protease inhibitor 1mM 
Iodoacetamide Cysteine protease inhibitor 1mM 
EDTA Metallo-protease inhibitor 1mM 
PMSF Serine protease inhibitor 1mM 
Pepstatin A Aspartic protease inhibitor 100µg/ml 
 




2.2.5 Determination of optimum pH for protease activity 
 
To determine the pH dependence of the protease activity of both isolates of 
Blastocystis in azocasein assays, 1 h incubation with parasitic lysate was performed in 
buffers of different pH containing 1mM DTT. The pH of these buffers ranged from 3.0 to 
8.5. The following buffers were used: 0.1M Glycine/HCl (for pH 3.0), 0.1M sodium 
acetate/acetic acid (for pH 4.0 and 5.5), 0.1M sodium phosphate (for pH 7.0 and 7.6) and 
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2.2.6 Secretory product extraction 
 
 To extract secretory components of Blastocystis, 5 day old parasites were washed 
twice in PBS (pH 7.4) and re-suspended in incubation buffer (PBS with 10 mM HEPES, 
and 0.05% L-ascorbic acid, pH 6.2) and incubated at 37°C for 3h, as reported previously 
for Trichomonas (Sommer et al. 2005). After incubation, parasites were examined 
microscopically for their viability and found to be viable and healthy. After incubation, 
the suspension was centrifuged at a low speed (2,000rpm for 10min, 40C) so that no 
leakage of parasitic products occurs. To remove any debris, supernatant was again 
centrifuged at high speed (6,000rpm for 10min, 40C) and resulting supernatant was 
filtered using 0.22µm filters and kept at -80°C for further analysis. 
 
2.2.7 Cellular localization of cysteine proteases 
 
After discovering that Blastocystis possesses high cysteine protease activity, 
cellular localization of cysteine proteases of living Blastocystis was determined as 
described previously (Scholze and Tannich 1994). Briefly, cells were incubated at room 
temperature in phosphate-buffered saline (pH 7.0) containing 5mM of the substrate Arg-
Arg-4-methoxy-2-naphtylamide and 2.5mM 5-nitro-2-salicylaldehyde. After 2h, cells 
were spun down and washed 4 times in PBS at 2500rpm. Smears were made on a glass 
slide and viewed under a fluorescence microscope using 360-430nm excitation and 550-
600nm emission. For inhibition of cysteine proteases, parasites were preincubated for 1h 
in PBS containing iodoacetamide (50µM). 
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2.3 RESULTS 
 
2.3.1 Protease activity of Blastocystis  
 
Azocasein assay was employed for the determination of parasitic protease activity. 
Azocasein consists of casein conjugated to an azo-dye and serves as a substrate for 
proteolytic enzymes. Degradation of casein liberates free azo-dye into the supernatant 
that can be quantitatively analyzed.  Fig. 2.1 shows the protease activity of B. ratti WR1 
represented in azocasein units. One azocasein unit is defined as the amount of enzyme 
producing an increase of 0.01 OD units per h.  Lysates of B. ratti WR1 showed 
significant protease activity (35.3 ± 3.2; P < 0.01) in comparison to control (0.8 ± 0.1). A 
significant inhibition of protease activity of WR1 lysate was observed with the use of 
cysteine protease inhibitors iodoacetamide (4.1 ± 0.8; P < 0.01) and E-64 (9.8 ± 2.9; P < 
0.01) (Fig. 2.1). Partial inhibition was noticed with aspartic protease inhibitor pepstatin A 
(25.1 ± 1.3; P = 0.058) and insignificant inhibition was seen with metallo-protease 
inhibitor EDTA and serine inhibitor PMSF. These findings suggested that protease 
activity of B. ratti WR1 is mainly due to cysteine proteases of the parasite. 
 
Figure 2.2 represents protease activity of B. hominis B and it shows that lysate has 
significantly high protease activity (45.7 ± 2.6; P < 0.01) in comparison to control (0.7 ± 
0.2). A significant inhibition of protease activity of B. hominis B lysate was observed 
with the use of cysteine protease inhibitors iodoacetamide (9.1 ± 2.0; P < 0.01) and E-64 
(13.1 ± 1.3; P < 0.01) (Fig. 2.2). Serine protease inhibitor PMSF also inhibited protease 
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activity (37.8 ± 2.2; P = 0.03 versus control). Metallo-inhibitor EDTA and aspartic 
inhibitor pepstatin A showed no inhibition. The results suggest that B. hominis B 
proteases mainly consist of cysteine and serine proteases. 
 
The effect of parasite concentration on the rate of azocasein hydrolysis was also 
measured. As expected, results for both isolates show that azocasein degradation is 
proportional to parasite concentration (Fig. 2.3 and 2.4). 
 
2.3.2 Optimum pH for Blastocystis protease activity 
 
To determine optimum pH for protease activity in azocasein assay, incubation 
with parasitic lysates was performed in 0.1M Glycine/HCl (pH 3.0), 0.1M sodium 
acetate/acetic acid (pH 4.0 and 5.5), 0.1M sodium phosphate (pH 7.0) and 0.1M Tris-HCl 
(pH 8.5). Protease activity of both isolates B. ratti WR1 and B. hominis B showed pH 
dependence and it was highest at pH 7 and lowest protease activity was observed at 
acidic 3 pH (Fig. 2.5 A and 2.5 B).  
 
2.3.3 Protease activity of Blastocystis secretory products 
 
To investigate if Blastocystis secretory products have similar protease activity as 
lysates, Blastocystis secretory products were extracted by incubating live parasites in 
incubation buffer. Secretory products of B. ratti WR1 showed significant protease 
activity (17.1 ± 1.8; P < 0.01) in comparison to control (1.3 ± 0.4) (Fig. 2.6). Secretory 
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products of B. hominis B also showed significantly high protease activity (27.2 ± 2.9; P < 
0.01) in comparison to control (1.7 ± 0.7) (Fig. 2.6). 
 
2.3.4 Cysteine proteases are confined to the central vacuole 
 
 To determine cellular localization of cysteine proteases, live parasites were 
incubated in PBS containing substrate Arg-Arg-4-methoxy-2-naphtylamide and 5-nitro-
2-salicylaldehyde. 5-nitro-2-salicylaldehyde forms an insoluble adduct with the 
proteolytically released napthylamine derivative. Fluorescent microscopy results for B. 
ratti WR1 (Fig. 2.7) showed that fluorescence is clearly localized within the central 
vacuole of the parasite. The central vacuole localization of cysteine proteases is evident 
in the exceptionally large Blastocystis cells which are surrounded by smaller cells (Fig 
2.7, second column). Blastocystis is a pleomorphic protozoan and sizes can significantly 
vary (up to 50-100 times larger parasites can be observed in the same culture). In figure 
2.8, fluorescence is also limited to central vacuole of B. hominis B suggesting that 
cysteine proteases are mainly contained in the central vacuole of the parasite. For both 
isolates, almost no fluorescence was observed when parasites were pretreated with 































Fig. 2.1 Protease activity of B. ratti WR1 and effect of inhibitors. Protease activity 
was determined with azocasein as a substrate. Lysates from 4×106 parasites were used for 
each sample. The assay was performed with/without protease inhibitors as described in 
Material and Methods. A significant inhibition of protease activity can be noticed with 
cysteine protease inhibitors (iodoacetamide and E-64) and less significant inhibition is 
seen with aspartic inhibitor pepstatin A. Metallo-protease inhibitor EDTA and serine 
inhibitor PMSF show no inhibition. One azocasein unit is defined as the amount of 
enzyme producing an increase of 0.01 OD units/h. Values are means ± SD (n = 3). # P < 




























































































































Fig. 2.2 Protease activity of B. hominis B and effect of inhibitors. Protease activity 
was determined with azocasein as a substrate. Lysates from 4×106 parasites were used for 
each sample. The assay was performed with/without protease inhibitors as described in 
Material and Methods. A significant inhibition of protease activity can be noticed with 
cysteine protease inhibitors (iodoacetamide and E-64). Serine protease inhibitor PMSF 
also inhibited protease activity. Metallo-inhibitor EDTA and aspartic inhibitor pepstatin 
A show no inhibition. One azocasein unit is defined as the amount of enzyme producing 
an increase of 0.01 OD units/h. Values are means ± SD (n = 3). # P < 0.01 versus negative 



































































































































Fig. 2.3 Histogram showing the effect of parasite concentration on the rate of 
azocasein hydrolysis by B. ratti WR1. The azocasein assay was performed as described 
in Material and Methods. Lysates from varying concentration of Blastocystis ratti WR1 
were used for azocasein assay. A dose dependent increase in protease activity can be 
observed. Values are averages from three independent experiments with duplicate 






































































Fig. 2.4 Histogram showing the effect of parasite concentration on the rate of 
azocasein hydrolysis by B. hominis B. The azocasein assay was performed as described 
in Material and Methods. Lysates from varying concentration of Blastocystis hominis B 
were used for azocasein assay. A dose dependent increase in protease activity can be 
observed. Values are averages from three independent experiments with duplicate 









































































Fig. 2.5 Protease activity of B. ratti WR1 (A) and B. hominis B (B) at different pH. 
Azocasein was used as a substrate and incubation with parasitic lysates was performed in 
0.1M Glycine/HCl (pH 3.0), 0.1M sodium acetate/acetic acid (pH 4.0 and 5.5), 0.1M 
sodium phosphate (pH 7.0) and 0.1M Tris-HCl (pH 8.5). For both isolates, highest 
protease activity was observed at 7 pH whereas lowest activity was at acidic 3 pH. Values 
are averages from three independent experiments with duplicate samples in each. 
Standard deviations are indicated with error bars. All values are significantly different (P 
































































































Fig. 2.6 Protease activity of B. ratti WR1 and B. hominis B secretory products. 
Parasites were incubated for 3 hours in incubation buffer to extract secretory fraction as 
described in Materials and Methods. Protease activity of secretory product was 
determined with azocasein as a substrate. Secretory products of both isolates show 
significant protease activity. Secretory fraction of B. hominis B shows comparatively 
higher protease activity than that of B. ratti WR1. Values are means ± SD (n = 3). *P < 




































































































































Fig. 2.7 Representative fluorescence, light, and merged micrographs show activity 
and localization of cysteine proteases in live parasites of B. ratti WR1. Live parasites 
were incubated in PBS containing substrate Arg-Arg-4-methoxy-2-naphtylamide and 5-
nitro-2-salicylaldehyde. 5-nitro-2-salicylaldehyde forms an insoluble adduct with the 
proteolytically released napthylamine derivative. Blue color fluorescence is an indication 
of in situ protease activity (arrowhead, first column). Higher magnification (400×) picture 
in second column shows unusually large Blastocystis cells surrounded by smaller cells. It 
can be noticed that fluorescence is limited only to the central vacuole (arrow) of the 
parasite. Treatment of parasites with cysteine inhibitor iodoacetamide resulted in 
diminished fluorescence (third column). Control parasites without cysteine protease 
substrate showed no fluorescence (fourth column). (Magnification in first, third and 



















































































Fig. 2.8 Representative fluorescence, light, and merged micrographs show activity 
and localization of cysteine proteases in live parasites of B. hominis B. Live parasites 
were incubated in PBS containing substrate Arg-Arg-4-methoxy-2-naphtylamide and 5-
nitro-2-salicylaldehyde. 5-nitro-2-salicylaldehyde forms an insoluble adduct with the 
proteolytically released napthylamine derivative. Blue color fluorescence is an indication 
of in situ protease activity (arrowhead, first column). Higher magnification (400×) picture 
in second column shows unusually large Blastocystis cell. It can be noticed that 
fluorescence is limited only to the central vacuoles (arrow) of the parasite. Treatment of 
parasites with cysteine inhibitor iodoacetamide resulted in diminished fluorescence (third 
column). Control parasites without cysteine protease substrate showed no fluorescence 



















































 59  
2.4 DISCUSSION 
 
Results from the protease profile study showed that B. ratti WR1 and B. hominis 
B possess high protease activity. Inhibition of protease activity of Blastocystis showed 
that these proteases consist mainly of cysteine proteases. The active-site thiol group of 
cysteine proteases can function only under reduced conditions (McKerrow et al. 1993) 
and because Blastocystis is an anaerobic enteric protozoan, these cysteine proteases may 
have important roles in its life cycle. Most other pathogenic protozoans including 
Entamoeba, Giardia, Trichochmonas, Leismania, Trypanosoma, and Plasmodium are 
known to possess cysteine proteases (reviewed in North 1982; McKerrow et al. 1993) 
that have been shown to be important for the development, differentiation, and 
pathogenicity of these parasites. These cysteine proteases can be promising 
chemotherapeutic or vaccine targets for many parasites (Sajid and McKerrow 2002). 
Based on protease activity, it was observed that B. ratti  WR1 showed less cysteine 
protease activity than that for B. hominis B. High protease activity has been reported in 
amebic clones of high virulence (Espinosa-Cantellano and Martinez-Palomo 2000) and it 
would be important to study if high protease activity is associated with virulence in 
Blastocystis.  
 
Furthermore, in a parallel investigation, gelatin-SDS-PAGE analysis was 
performed and it was found that majority of Blastocystis proteases were of cysteine type, 
with molecular weight ranging between 20 to 33 kDa (Sio et al. 2006). Interestingly, 
Entamoeba histolytica is also reported to have cysteine proteases within this range (22-29 
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kDa) and these have been reported to be responsible for the hydrolysis of extracellular 
matrix proteins (Keene et al. 1986). 
 
Intestinal permeability was found to be increased in patients with Blastocystis 
hominis infections and it was suggested that Blastocystis can damage the intestinal wall 
(Dagci 2002). Other reports describe adherence of Blastocystis and colonic ulcerations on 
the intestinal mucosa (Al-Tawil et al. 1994). Findings suggest that cysteine proteases 
activity of Blastocystis may possibly contribute to its pathogenicity. Proteolytic activity 
of B. ratti WR1 and B. hominis B proteases was found to be highest at neutral pH. This is 
in agreement with the pH of human large intestine where Blastocystis colonizes. This 
finding suggests that Blastocystis proteases can have maximum in vivo activity at neutral 
pH in the large intestine of humans. Significantly, it was shown that Blastocystis 
secretory products also possess protease activity. Proteases can be found inside the 
protozoan cell, on the plasma membrane or in the parasitic secretions (Que and Reed 
2000). Entamoeba histolytica has been reported to have cysteine proteases that were 
present in parasitic secretions and suggested to play role in its pathogenesis (Ocadiz et al. 
2005). Blastocystis is suggested to be a non-invasive organism and finding that it has 
secretory proteases has relevance to its prospective in vivo pathogenesis. 
 
Inhibitors of cysteine proteases have already been shown to be effective against 
numerous protozoan parasites in vitro (North 1994) suggesting that proteases might be 
potential targets for specific antiprotozoal drugs. As cysteine proteases are found to be 
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essential for the life cycle and pathogenicity of many parasites, they might be potential 
chemotherapeutic or vaccine targets (Sajid and McKerrow 2002). 
 
Blastocystis is a polymorphic organism and its recognized forms are vacuolar, 
granular, amoeboid, and cyst forms. The vacuolar form, also referred to as vacuolated or 
central vacuole form, is the most common form observed in axenized cultures. It has a 
characteristic large central vacuole and a thin rim of peripheral cytoplasm (Tan 2004). 
Vacuolar forms are spherical and most of the parasite’s volume is occupied by the central 
vacuole. The exact role of central vacuole in Blastocystis is not clear to date but it has 
been suggested that it may act as a storage organelle for the deposition of apoptotic 
bodies during programmed cell death of the parasite (Nasirudeen et al. 2001). Other 
reports suggest that the central vacuole may have a role in schizogony-like reproduction 
(Dunn et al. 1989; Suresh et al. 1994). Results from this study suggest for the first time 
that central vacuole may also function as a reservoir for cysteine proteases. A number of 
studies on protozoans including T. cruzi have shown that the major protease activity is 
located in the lysosomes (De Souza 1984; Souto-Padrón et al. 1990). Findings suggest 
that central vacuole might be an unusually big lysosome in Blastocystis. Preliminary 
results from our laboratory using Lyso tracker staining are in agreement with this 
suggestion. It was observed that Blastocystis central vacuole containing cysteine 
proteases are located in close proximity with the plasma membrane of parasite. It will be 
interesting to know how the extracellular trafficking of these proteases occurs.  
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Interestingly, in adverse conditions like insufficient nutrition or in old cultures, 
many granular forms are seen which is characterized by granules in central vacuole. 
There is a need to further elucidate if cysteine proteases have a role in the formation of 
granules in central vacuoles. 
 
In this chapter, it was demonstrated for the first time, the protease activity of 
Blastocystis ratti WR1 and Blastocystis hominis B and found that this parasite possesses 
high protease activity, in particular of the cysteine protease type. It was also showed that 
the central vacuole of Blastocystis contains cysteine proteases. The pathogenicity of 
Blastocystis is until now unknown and further characterization of Blastocystis proteases 





































EFFECTS OF BLASTOCYSTIS ON HUMAN 





















Adherence of pathogens to the host surface, for example gastrointestinal mucosal 
surface, is a significant step in host pathogen interactions. Once the pathogen adheres to 
the host surface, it is able to initiate certain biological processes like proliferation, toxin 
secretion and cell invasion that can result in disease.  
 
At the mucosal surfaces of gastrointestinal tract, immunoglobulin A (IgA) is the 
predominant immune defense against ingested pathogens and their toxins. IgA is vital for 
limiting mucosal adhesion and colonization by microorganisms and neutralizing a range 
of microbial toxins (Renegar and Small 1999; Russel et al. 1999; Chintalacharuvu et al. 
2003). In the body, IgA is produced in more amounts than all other immunoglobulin 
classes combined and is mainly found in mucosal secretions in the form of secretory IgA 
(S-IgA). S-IgA is made of IgA dimer or tetramer covalently joined to the secretory 
component which is an epithelium-derived polyimmunoglobulin receptor.  
 
Two subclasses of IgA, IgA1 and IgA2, are found in humans. They are different 
in their structure as IgA2 lacks 16 proline-rich amino acid sequence in its hinge region 
which makes it more resistant to proteases. The distribution of the two IgA subclasses 
may vary in different secretions and it was reported that 70% IgA1 and 30% IgA2 is 
found in the gut (Olbricht et al. 1986). However, some reports mentioned that IgA2 may 
predominate in the distal parts of gastrointestinal tract and it can be as high as 60% 
(Kilian et al. 1996). 
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IgA in secretions has been reported to have many functions including inhibition of 
adherence and colonization of pathogens by agglutination, trapping antigen in the mucus 
layer, inhibition of antigen penetration, neutralization of viruses, and neutralization of 
bacterial toxins and enzymes (Kilian et al. 1996). In general, IgA is quite resistant to most 
proteolytic enzymes of host and pathogen origin. However, numerous pathogens can 
evade the IgA immune response and adhere to the host cell surface by secreting IgA 
proteases. These IgA proteases cleave IgA in the hinge region and produce intact Fab and 
Fc fragments and thus interfere with IgA mediated inhibition of attachment (Plaut 1983). 
Although cleaved Fab fragments can still bind to the pathogen surface, loss of Fc 
fragment prevents most antigen-elimination mechanisms (Kilian et al. 1996). 
 
 IgA proteases have been described in protozoan parasites (Kelsall and Ravdin 
1993; Provenzano and Alderete 1995), bacteria (Kilian et al. 1980; Plaut 1983) and they 
are known to mostly cleave secretory IgA at defined site in proline-rich sequence of 
hinge region. On the other hand, many other parasitic and bacterial proteases do not show 
similar unique substrate specificity and they may cause extensive degradation of the 
entire IgA molecule (Kilian et al. 1996) as observed for Entamoeba histolytica (Kelsall 
and Ravidin 1993) IgA proteases have been implicated as virulence factors in the 
pathogenesis of mucosal infections (Kilian et al. 1996). 
 
 Blastocystis is a zoonotic enteric protozoan (Yoshikawa et al. 2004a; Noel et al. 
2005) that colonizes the large intestine of humans and many other animals. There are 
many reports associating Blastocystis with gastrointestinal and other clinical symptoms 
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including recurrent watery diarrhea, mucous diarrhea, constipation, nausea, vomiting, and 
bloating (Qadri et al. 1989; Doyle et al. 1990; Nimri and Batchoun 1994). Despite its 
description about a century ago (Alexeiff 1911), little is known about its colonization 
strategies and association with clinical symptoms.  
 
Findings in previous chapter that Blastocystis possesses high levels of protease 
activity prompted us to investigate if it does possess IgA degrading proteases. These 
proteases, if present, may shed new light on Blastocystis host-pathogen interactions. In 
this chapter, it is demonstrated for the first time that Blastocystis has proteases that can 




3.2 MATERIALS AND METHODS 
 
3.2.1 Culture of Blastocystis 
  
 Two axenic isolates of Blastocystis, B. ratti WR1 and B. hominis B were used in 
this study. Parasites were cultured in pre-reduced Iscove’s Modified Dulbecco’s Medium 
(IMDM) supplemented with 10% inactivated horse serum and incubated anaerobically at 
370C in an ANAEROJAR (Oxoid, UK) as previously described in chapter 2. Parasite 
viability was microscopically determined and cultures with >95% viable parasites were 
used for this study. Counting of parasites was performed using a haemocytometer. 
  
T. vaginalis was cultured in Hollander’s medium containing 10% foetal-calf 
serum and used as a positive control. 
 
3.2.2 Preparation of conditioned medium and cell lysates  
 
For the IgA study, four-to five-day old Blastocystis cultures were harvested by 
centrifugation at 400g and the clear culture supernatant was designated as the conditioned 
medium. The conditioned medium was centrifuged at 2000rpm (10 minutes, 40C) to 
remove any suspended cells. The cell pellet was washed with PBS (pH 7.4), resuspended 
in 1ml PBS and cell lysates were obtained by repeated freeze-thaw action in liquid 
nitrogen and 370C water bath respectively. The protein content of the cell lysates and 
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conditioned medium was estimated using a commercially available Bradford protein 
assay kit (Bio-Rad). Cell lysates of T. vaginalis were also prepared as for Blastocystis. 
 
3.2.3 Assay of IgA degradation by Blastocystis  
 
For IgA degradation assays, 30µg of parasite protein (cell lysate) and conditioned 
medium were each incubated with 1µg of secretory-IgA (US Biological) for two hours at 
370C. This secretory-IgA is a natural mixture of both IgA subtypes (IgA1 and IgA2). 
After incubation, the reaction was stopped by addition of SDS sample buffer containing 
2-β-mercaptoethanol and the mixture was boiled for 15 minutes. Approximately 30µg of 
various protein preparations were electrophoresed in 12% polyacrylamide gels (Laemmli 
1970). After SDS-PAGE, the proteins were electroblotted onto a nitrocellulose membrane 
(Amersham). The membrane was blocked overnight at 40C in 5% milk-PBST and 
detected with 1:50,000 dilution of goat polyclonal anti-IgA heavy chain antibody 
conjugated to horseradish peroxidase (CHEMICON) for 1h at room temperature. This 
anti-IgA antibody was human α chain specific and can react with IgA1 and IgA2. Blots 
were developed on Hyperfilm ECL (Amersham) using chemi-luminescent ECL Plus 
Detection Reagent (Amersham).  
 
In other experiments, B. hominis B was used to determine the effects on subtypes 
of IgA, 30µg of parasitic lysate or conditioned medium were incubated with IgA1 (2µg) 
or IgA2 (2µg), for 2h at 37°C. Western blot was performed as described for IgA except 
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that membrane was probed with 1:25,000 dilutions of a HRP-conjugated goat polyclonal 
antibody cocktail (mixture of anti-IgA, IgM, IgG; US Biological). 
 
In some experiments, IgA breakdown was quantified by determining 
Immunoblots using a gel documentation and analysis system (Gel Doc XR, Bio Rad). 
The % of heavy chain remaining intact after exposure to Blastocystis samples is 
calculated as follows: % remaining heavy chain = (optical density of remaining heavy 
chain/ optical density of total heavy chain) × 100. In experiments with proteinase 
inhibitors, degree of inhibition was calculated as follows: % inhibition = [(% remaining 
heavy chain with inhibitor - % remaining chain without inhibitor)/ (100- % remaining 
heavy chain without inhibitor)] × 100.  
 
3.2.4 Inhibition of IgA proteinase activity 
 
  The proteinase inhibitors used consisted of 25mM EDTA (BDH), 2 mM 
phenylmethylsulfonyl fluoride (PMSF) (BDH), 2mM idoacetamide (IA) (M P 
Biomedicals, LLC), and 0.8mM pepstatin A (CHEMICON). Parasite preparations were 
incubated with the inhibitors for 1h at room temperature before IgA, IgA1 or IgA2 was 
added and incubated for another 2h. The reaction was stopped with SDS sample buffer 






3.2.5 Immunoglobulin substrate SDS-PAGE assay 
 
To further study the Blastocystis immunoglobulin degrading proteases and their 
molecular weights, immunoglobulin substrate SDS-PAGE assay was performed. This 
SDS-PAGE method requires the inclusion of substrate (IgA1 or IgA2) in an acrylamide 
gel. IgA1 (100 µg/3ml) or IgA2 (100 µg/3ml) were copolymerized into 16% 
polyacrylamide gel. 2 µg lysate proteins were incubated with sample buffer (without 
mercaptoethanol) at room temperature for 20mins before loading. Samples were not 
boiled so that protease activity is retained. Electrophoresis was performed at a constant 
current of 30mA/gel for 1.5 h. After electrophoresis, each lane of gel was cut into strips 
for further treatment. To renature proteases, gels were incubated in reducing buffer 
(12.5% Triton-X, 100mM sodium acetate, 1mM DTT) for 2 hours without inhibitors and 
with inhibitors EDTA (2mM), Iodoacetamide (30µM), pepstatin A (30µM) and PMSF 
(2mM) (37 °C, shaking). The gel was stained in 0.025% commassie blue for 2 hours with 
shaking. Destaining was done in destaining solution I (40% methanol, 7% acetic acid) for 













3.3.1  Blastocystis lysates and conditioned medium degrade secretory IgA 
 
Lysates of Blastocystis isolates WR1 and B (Fig. 3.1) were able to degrade human 
secretory IgA over 2 h at 370C. A significant loss of intact heavy chain and increase of 
IgA fragments was noticed. After exposure to WR1 and B lysate, only 31% and 39% IgA 
heavy chain remained intact respectively (Table 3.1). Positive control T. vaginalis lysate 
(Fig. 3.1, lane 7) showed degradation of secretory IgA (Provenzano and Alderete 1995). 
IgA degradation activity for conditioned medium of WR1 (Fig. 3.1, lane 2) was also 
noticed with 47% intact heavy chain remaining after treatment. Conditioned medium 
from B. hominis isolate B also degraded IgA with 64% heavy chain remaining (Table 3.1). 
Condition medium shows less extensive IgA degradation pattern than that of lysate which 
might be due to some proteases that are not secreted but are present only in the lysate. 
 
3.3.2 Effect of protease inhibitors on degradation of secretory IgA 
 
Degradation of secretory IgA by WR1 lysate was inhibited significantly (99%) by 
aspartic-specific inhibitor pepstatin A (Fig. 3.2, lane 6) and also by cysteine-specific 
inhibitor IA (57%) (Fig. 3.2, lane 5). With WR1 lysate, negligible inhibition (10%) was 
noticed by serine-specific inhibitor PMSF and an unexpected increase in degradation of 
IgA was observed with metallo-specific inhibitor EDTA. In contrast, degradation of IgA 
by B isolate was inhibited most by IA (79%) (Fig 3.2, lane 10) followed by aspartic-
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specific inhibition by pepstatin A (52%) and less significant inhibition was noticed by 
serine (10%) and metallo-specific inhibitors (23%). The effects of inhibitors on 
Blastocystis proteinase activity are summarized in Table 3.2. 
 
 
3.3.3 Degradation of IgA1 and IgA2 
 
Human secretory immunoglobulin A has two subtypes, IgA1 and IgA2. IgA1 and 
IgA2 differ in their structure and distribution in the gut. The effects of Blastocystis 
hominis B exposure on subtypes IgA1 and IgA2 were studied. As showed in the fig. 3.3, 
exposure of Blastocystis hominis B lysate to immunoglobulins resulted in the degradation 
of the heavy chain of IgA1. In IgA1 exposed to lysates, a big band (~50 kDa) and a small 
band (~42 kDa) cleaved from heavy chain can be observed. The 42 kDa band is faint 
which might be due to small amounts of degraded heavy chain fragments of this 
molecular weight. Exposure of Blastocystis hominis B lysate to IgA2 resulted in 
significant loss of heavy chain and a small cleaved band (~45 kDa) is observed (Fig 3.4). 
Additionally, the conditioned medium showed proteolytic activity for both subtypes of 
IgA as well and loss of heavy chain can be seen. No degradation was observed in controls 
exposed to PBS only. In addition to heavy chain, in results (Fig. 3.3 to Fig. 3.8), light 
chain of IgA1 and IgA2 (~23 kDa) can be observed. This is because the antibody used for 
these experiments can also detect light chains of IgA1 and IgA2. Differences in the band 
intensity of light chains was also observed which may be due to some cleaved fragments 
of the heavy chain the might have stacked at the same region of the light chain (Fig. 3.3 
to Fig. 3.8). 
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A concentration-dependent assay was performed to study the effect of varying 
amount of Blastocystis lysate on IgA1 and IgA2 degradation. As the dose of lysate 
increased, degradation of IgA1 and IgA2 gradually increased as shown by loss of band 
intensity of the heavy chain (Fig. 3.5 and 3.6). Exposure to 50 µg of Blastocystis lysate 
resulted in complete loss of heavy chain in both IgA1 and IgA2. 
 
3.3.4 Effect of protease inhibitors on degradation of IgA1 and IgA2 
 
Various protease inhibitors were used to investigate types of specific proteases 
that are responsible for degradation of IgA1 and IgA2. It was observed that cysteine 
proteinase inhibitor iodoacetamide completely inhibited the degradation of both IgA1 and 
IgA2 and no cleaved fragment of heavy chain can be seen (Fig. 3.7 and 3.8). Some 
inhibition effect was also observed with aspartic-specific inhibitor pepstatin A. However, 
the inhibition effect was not as pronounced as Iodoacetamide, as small cleaved fragments 
of heavy chain can still be seen. Metallo-specific inhibitor EDTA and serine-specific 
inhibitor PMSF did not show any significant inhibition, as loss of heavy chain and 
cleaved fragments were of the same pattern as of lysate. A slight increase in degradation 
of IgA2 heavy chain is observed with EDTA (Fig. 3.8) which is consistent with 






3.3.5 Immunoglobulin substrate SDS PAGE assay 
 
An immunoglobulin substrate SDS-PAGE assay was performed to further study 
Blastocystis immunoglobulin degrading proteases and their molecular weights. This SDS-
PAGE method requires the inclusion of substrate (IgA1 or IgA2) in an acrylamide gel. 
Immunoglobulin substrate is digested by proteases after electrophoresis and clear bands 
can be observed against a dark background after Coomassie Brilliant blue staining. 
 
Three protease bands were similarly observed in both IgA1 and IgA2 gels, one 
higher molecular weight band (~70kDa) and two lower molecular weight band (~17kDa 
and 19kDa) (Fig. 3.9 and 3.10). Both 17kDa and 19kDa proteases were completely 
inhibited by cysteine proteinase inhibitor iodoacetamide. The 19kDa band was partially 
blocked by aspartic-specific inhibitor pepstatin A. The 70kDa protease was inhibited by 
serine specific inhibitor PMSF in IgA1 and IgA2 gels. In addition, two protease bands 
(~27kDa and 30kDa) were also observed in IgA1 gel only (Fig. 3.9). These 27kDa and 
30kDa proteases were completely inhibited by cysteine proteinase inhibitor 
iodoacetamide and aspartic-specific inhibitor pepstatin A. A smear of lower bands (below 























Fig. 3.1 Degradation of human secretory IgA by cell lysate and conditioned medium 
of B. ratti WR1 and B. hominis B. 30µg of parasitic protein or conditioned medium 
were incubated with S-IgA (1µg) for 2h at 370C, and subjected to SDS-PAGE and 
immunoblotting with antibody to human IgA heavy chain. Lane 1, IgA with WR1 lysate 
showing loss of intact IgA heavy chain into lower molecular-weight immunoreactive 
fragments. Lane 2, IgA with WR1 conditioned medium showing degradation of IgA. 
Lane 3, WR1 lysate only (negative control). Lane 4, conditioned medium  only (negative 
control). Lane 5, IgA only showing intact heavy chain. Lane 6, T. vaginalis lysate only. 
Lane 7, IgA with T. vaginalis lysate (positive control) showing degradation of IgA. Lane 
8, IgA with B lysate. Lane 9, IgA with B conditioned medium. (MW, molecular weight; 






% of secretory IgA intact heavy chain remaining after incubating 
with parasitic lysate and conditioned medium 
Blastocystis 
isolates 
 Parasitic lysate Conditioned medium 









Table 3.1. Percentage of secretory IgA intact heavy chain remaining after incubation 
with the lysates and conditioned medium of Blastocystis (Representative results from 3 































Fig. 3.2 Effect of proteinase inhibitors on IgA degradation by lysates from B.ratti 
isolate WR1 (lane 2-6) and B. hominis isolate B (lane 7-11). Parasitic lysates were 
incubated with inhibitors for 1h at 370C before IgA was added. Lane 1, IgA alone. Lane 2 
and 7, IgA with lysates of B.ratti isolate WR1 and B. hominis isolate B respectively 
showing degradation of IgA. 25 mM EDTA (lane 3 & 8), 2 mM PMSF (lane 4 & 9), 2 
mM Iodoacetamide (lane 5 & 10), and 0.8 mM pepstatin A (lane 6 & 11) treatment 







% inhibition with different proteinase inhibitors Blastocystis 
isolates 
EDTA PMSF IA Pepstatin A 
B. ratti  WR1 -9 10 57 99 
B. hominis B 23 10 79 52 
 
Table 3.2 Degrees of inhibition by different proteinase inhibitors on IgA degradation by 
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Fig. 3.3 Representative results showing degradation of human IgA1 by B. hominis B 
parasitic lysates and conditioned medium. 30µg of parasitic protein or conditioned 
medium were incubated with IgA1 (2µg) for 2h at 370C, and subjected to SDS-PAGE in 
12% acrylamide gel and immunoblotting with antibody to anti-IgA antibody as described 
in Materials and Methods. Incubation with parasitic lysate resulted in the degradation of 
the heavy chain of IgA1. In IgA1 exposed to lysates significant loss of heavy chain, a big 
band (~50kDa, black arrow) and a small band (~42kDa, white arrow) cleaved from heavy 
chain can be observed. Lane 1 and 4 show intact heavy chain of IgA1. Conditioned 
medium also shows proteolytic activity as loss of heavy chain and a small cleaved band 
(arrowhead) from heavy chain can be seen. Lane 2 and 5 are the controls to show that 
only lysate and medium respectively do not cross react with antibody. (MW, molecular 

















































Fig. 3.4 Representative results showing degradation of human IgA2 by B. hominis B 
parasitic lysates and conditioned medium. 30µg of parasitic protein or conditioned 
medium were incubated with IgA2 (2µg) for 2 h at 370C, and subjected to SDS-PAGE in 
12% acrylamide gel and immunoblotting with antibody to anti-IgA antibody as described 
in Materials and Methods. Incubation with parasitic lysate resulted in the degradation of 
the heavy chain of IgA2. In lane 3, IgA2 exposed to lysate shows significant loss of 
heavy chain, a small band (~45kDa, arrow head) cleaved from heavy chain can be 
observed. Lane 1 and 4 show intact heavy chain of IgA2. Conditioned medium also 
shows proteolytic activity as significant loss of heavy chain. Lane 2 and 5 are the controls 
to show that only lysate and medium respectively do not cross react with antibody. (MW, 

















































Fig. 3.5 Representative results showing concentration-dependent degradation of 
human IgA1 by B. hominis B parasitic lysates. Varying amount of Blastocystis hominis 
B lysate (from 1µg to 50µg) were incubated with IgA1 (2µg) for 2h at 370C, and 
subjected to SDS-PAGE in 12% acrylamide gel and immunoblotting with antibody to 
anti-IgA antibody as described in Materials and Methods. Degradation of heavy chain 
gradually increased as shown by loss of band intensity. Exposure to 50µg of Blastocystis 
lysate resulted in complete loss of heavy chain of IgA1. (MW, molecular weight; HC, 


























































Fig. 3.6 Representative results showing concentration-dependent degradation of 
human IgA2 by B. hominis B parasitic lysates. Varying amount of Blastocystis hominis 
B lysate (from 1µg to 50µg) were incubated with IgA2 (2µg) for 2h at 370C, and 
subjected to SDS-PAGE in 12% acrylamide gel and immunoblotting with antibody to 
anti-IgA antibody as described in Materials and Methods. Degradation of heavy chain 
gradually increased as shown by loss of band intensity. Exposure to 50µg of Blastocystis 
lysate resulted in complete loss of heavy chain of IgA2. (MW, molecular weight; HC, 





















































Fig. 3.7 Effect of proteinase inhibitors on IgA1 degradation by lysates from B. 
hominis B. Parasitic lysates were incubated with inhibitors for 1h at 370C before IgA1 
was added and incubated for 2h at 370C, and subjected to SDS-PAGE in 12% acrylamide 
gel and immunoblotting with antibody to anti-IgA antibody as described in Materials and 
Methods. Lane 1 shows intact heavy chain of IgA1. Exposure to parasitic lysate resulted 
in degradation of heavy chain and cleaved fragments can be seen (arrowhead, lane 3). 
Cysteine proteinase inhibitor iodoacetamide completely inhibited the degradation of IgA1 
and no degradation of heavy chain can be seen (Lane 4). Some inhibition is seen with 
aspartic-specific inhibitor pepstatin A (Lane 6). Metallo-specific inhibitor EDTA and 
serine-specific inhibitor PMSF do not show any significant inhibition, as loss of heavy 
chain and cleaved fragments similar to lysate can be seen. (MW, molecular weight; HC, 
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Fig. 3.8 Effect of proteinase inhibitors on IgA2 degradation by lysates from B. 
hominis B. Parasitic lysates were incubated with inhibitors for 1h at 370C before IgA2 
was added and incubated for 2h at 370C, and subjected to SDS-PAGE in 12% acrylamide 
gel and immunoblotting with antibody to anti-IgA antibody as described in Materials and 
Methods. Lane 1 shows intact heavy chain of IgA2. Exposure to parasitic lysate resulted 
in degradation of heavy chain and cleaved fragments can be seen (arrowhead, lane 3). 
Cysteine proteinase inhibitor iodoacetamide completely inhibited the degradation of IgA1 
and no fragments of heavy chain can be seen (Lane 4). Some inhibition is seen with 
aspartic-specific inhibitor pepstatin A (Lane 6). Serine-specific inhibitor PMSF do not 
show any significant inhibition, as loss of heavy chain and cleaved fragments similar to 
lysate can be seen. An unexpected increase in heavy chain degradation is observed with 
metallo-specific inhibitor EDTA (Lane 7). (MW, molecular weight; HC, heavy chain; 
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Fig. 3.9 Analysis of B. hominis B proteases by IgA1 substrate SDS-PAGE. This SDS-
PAGE method requires the inclusion of substrate (IgA1) in an acrylamide gel. 
Immunoglobulin substrate is digested by proteases after electrophoresis and clear 
protease bands can be observed against a dark background after Coomassie Brilliant Blue 
staining. Protease bands can be seen as clear bands against a dark background. One 
higher molecular weight band (~70kDa, black arrow) and two lower molecular weight 
band (~17kDa and 19kDa, arrowhead) can be seen. The 17kDa and 19kDa proteases are 
completely inhibited by cysteine-inhibitor iodoacetamide (Lane 5). The 70kDa protease 
was inhibited by serine specific inhibitor PMSF (Lane 3). In addition, two faint protease 
bands (~27kDa and 30kDa, white arrow) visible which are completely inhibited by 
aspartic specific inhibitor pep A and cysteine-inhibitor iodoacetamide. A smear of low 
molecular weight proteases (below 17kDa; lane 1, 2 and 3) can be seen which is also 
completely inhibited by aspartic specific inhibitor pep A and cysteine-inhibitor 
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Fig. 3.10 Analysis of B. hominis B proteases by IgA2 substrate SDS-PAGE. This 
SDS-PAGE method requires the inclusion of substrate (IgA2) in an acrylamide gel. 
Immunoglobulin substrate is digested by proteases after electrophoresis and clear 
protease bands can be observed against a dark background after Coomassie Brilliant blue 
staining. One higher molecular weight band (~70kDa, black arrow) and two lower 
molecular weight band (~17kDa and 19kDa, arrowhead) can be seen. The 17kDa and 
19kDa proteases are completely inhibited by cysteine-inhibitor iodoacetamide (Lane 5). 
The 70kDa protease was inhibited by serine specific inhibitor PMSF (Lane 3). A smear 
of low molecular weight proteases (below 17kDa; lane 1, 2 and 3) can be seen which is 
completely inhibited by aspartic specific inhibitor pep A and cysteine-inhibitor 
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Proteases have not been previously studied in Blastocystis, even though such 
enzymes are known to be virulence factors in many protozoal and bacterial infections 
(Plaut 1983; Que and Reed 2000). Evidence of human IgA degradation by protozoan 
proteases has previously been reported for E. histolytica (Quezada-Calvillo and Lopez-
Revilla 1986; Kelsall and Ravdin 1993) and T. vaginalis (Provenzano and Alderete 1995). 
It was determined that various Blastocystis proteases contribute to the breakdown of IgA 
suggesting that this is a mechanism by which the parasite can persist in gut. Conditioned 
medium also showed the ability to cleave IgA suggesting active secretion of parasitic IgA 
proteases. Degradation of IgA by Blastocystis lysate and condition medium was inhibited 
by cysteine and aspartic-specific inhibitors indicate that Blastocystis cysteine and aspartic 
proteinases were mainly accountable for IgA degradation in B and WR1 isolates 
respectively. The contribution of metallo and serine proteinases to immunoglobulin A 
degradation was not significant.  
 
Altogether, results from degradation experiments established that Blastocystis can 
significantly degrade both subtypes of immunoglobulin A, IgA1 and IgA2. This finding 
differs from most pathogenic bacterial IgA protease, which can not cleave IgA2 due to 
the absence of proline-rich vulnerable sequence in hinge region (Plaut 1983). This 
suggests that Blastocystis proteases do not specifically target the hinge region of IgA; and 
other sites in the heavy chain may be the target of these proteases. In dose dependent 
experiments, complete loss of heavy chain was observed suggesting that the heavy chain 
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has been degraded into fragments too small to be detected by antibody. The conditioned 
medium also showed IgA1 and IgA2 degradation activity, indicating that these proteases 
can be secreted by the parasite.  
 
Findings from the protease inhibition experiments showed that iodoacetamide was 
most significant inhibitor for both IgA1 and IgA2 degradation by B. hominis B. 
Iodoacetamide can covalently bind to cysteine residues and is used as a cysteine protease 
inhibitor. The results show that most of the IgA proteases are cysteine proteases. To a 
lesser extent, pepstatin A also inhibited degradation of IgA1 and IgA2. Pepstatin A is a 
very specific aspartic protease inhibitor and probably there are few aspartic proteases that 
are involved in the degradation of immunoglobulins. The significant activity of cysteine 
protease and aspartic protease was also confirmed in the immunoglobulin substrate SDS 
PAGE assay. Inhibition with serine-inhibitor PMSF and metallo-inhibitor EDTA did not 
result in any significant inhibition. Interestingly, the presence of EDTA has an effect in 
increasing the degradation of IgA2. Possibly, this is because of an upstream regulator 
protein, which can inactivate the immunoglobulin degrading proteases in the presence of 
metal ions. As soon as the metal ions are chelated by EDTA the regulator protein is 
inactivated and activity of proteases is enhanced.  
 
The results show that Blastocystis hominis B contains at least five IgA1 degrading 
proteases (~17kDa, 19kDa, 27kDa, 30kDa and 70kDa proteases) and three IgA2 
degrading proteases (~17kDa, 19kDa, and 70kDa proteases). The 17kDa and 19kDa 
proteases can be blocked completely by iodoacetamide, which suggests that it is a 
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cysteine protease. The 27kDa and 30kDa proteases can be blocked by both pepstatin A 
and iodoacetamide. Since pepstatin A is a very specific inhibitor, these 27kDa and 30kDa 
proteases seems to be aspartic proteases that probably also contain an essential cysteine 
residue. The 70kDa protease seems to be a serine protease as it was blocked by serine-
inhibitor PMSF in IgA2 substrate gel. The smear of lower bands (below 17kDa) was 
completely blocked by pepstatin A and iodoacetamide, but the resolution of bands was 
not high enough to draw any conclusion.  
 
Blastocystis seems to have similar IgA protease profiles to Trichomonas vaginalis. 
T. vaginalis, the causative agent for trichomoniasis, was reported to have IgA degrading 
proteases (Provenzano and Alderete 1995). These T. vaginalis proteases were mainly 
cysteine proteases and suggested to be a parasitic virulence factor. Blastocystis proteases 
degrade both IgA1 and IgA2 and this may suppress the host intestinal immune response. 
This might create an immune defective milieu that can indirectly help other pathogens to 
establish infections or may enhance the chances of their survival. In summary, the present 
study demonstrates for the first time that Blastocystis possesses proteases that can 


















































The primary site for Blastocystis colonization is the intestine and in the previous 
chapter, it was suggested that proteases produced by Blastocystis contribute to its 
colonization and pathogenesis. Recently, a variety of intestinal pathogens were found to 
induce apoptosis in intestinal epithelial cells and their association with pathogenicity was 
suggested (Fiorentini et al. 1998; Kim et al 1998; Crane et al. 1999; Valenti et al. 1999; 
Huston et al. 2000; McCole et al 2000; Chin et al. 2002). Studies have reported that 
pathogens can modulate host cell apoptosis process and this can play important roles in 
the pathogenesis of various diseases (Gao et al. 2000). A complex interaction of parasitic 
virulence factors and host cell surface receptors is required for the induction of host cell 
apoptosis (Gavrilescu and Denkers 2003).  
 
Apoptosis (programmed cell death) is a form of cell death distinguishable from 
necrosis and involves a series of biochemical events (mainly caspase activation) that lead 
to a range of morphological changes, including blebbing, changes in plasma membrane, 
loss of cellular attachment, cell shrinkage, chromatin condensation, and chromosomal 
DNA fragmentation. Most of the time, unlike necrosis, apoptosis occurs without any 
accompanying inflammation. Caspases are cysteine protease and their activation in the 
host cell is considered essential for apoptosis to occur (Riedl and Shi 2004). Towards the 
end of apoptosis, the cell fragments into membrane bound vesicles that are efficiently 
ingested by neighboring immune cells (Wyllie et al. 1980). Apoptosis is considered a 
tightly regulated event that removes unwanted cells and it is prevalent in all multicellular 
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organisms. Gastrointestinal epithelial cells have a high turnover and apoptosis plays an 
important role in maintaining the balance between cellular proliferation and death; 
however, enhanced apoptosis in intestinal epithelial cells may lead to disturbed gut 
homeostasis and gastrointestinal symptoms (Ramachandran et al. 2000). 
 
Induction of apoptosis by pathogens may play an important role in the 
commencement of infection, survival of pathogens or in escape from the host immune 
system; and in some infections, induction of apoptosis might be a host response to reduce 
microbial replication (Ojcius et al. 1998). Overall, induction of host cell apoptosis can be 
both advantageous and disadvantageous for the pathogen. Pathogens can benefit by 
modulation of apoptosis which can result in 1) substantial host cell deletion 2) initiation 
of inflammation and 3) inhibition of apoptosis (Zychlinsky et al. 1997). Massive 
depletion of host cells by apoptosis may assist in the invasion and replication of pathogen. 
Salmonella and Shigella cause gastrointestinal disease and they are known to induce 
apoptosis in macrophages (Siebers and Finlay 1995, Rathman et al. 1997). Moreover, 
depletion of host cell (e.g. intestinal epithelial cells) by apoptosis may provide other 
bystander pathogens a more conducive environment for invasion or multiplication. On 
the contrary, numerous pathogens including Toxoplasma gondii and Leishmania 
donovani can inhibit host cell apoptosis to ensure their own survival in the infected cells 
(Heussler et al. 2001). Apoptosis of macrophages by Shigella is accompanied by 
secretion of proinflammatory cytokine IL-1β leading to inflammation (Zychlinsky et al. 
1997). This inflammatory response results in tissue destruction and therefore provides 
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opportunities for further tissue invasion. Hence, knowledge of host cell apoptosis 
modulation helps us to better understand host-pathogen interactions.  
 
In vitro studies have demonstrated that Blastocystis is capable of causing 
significant cytopathic effects on Chinese Hamster Ovary cells (Walderich et al. 1998) but 
the exact nature of cell death mechanisms are not understood. This study was aimed to 
investigate the interactions of Blastocystis ratti WR1, an isolate of zoonotic potential, 
with a non-transformed rat intestinal epithelial cell line, IEC-6. Here, it is reported for the 





4.2 MATERIALS AND METHODS 
 
4.2.1 Intestinal epithelial cell culture 
 
To investigate if Blastocystis can induce apoptosis of intestinal epithelial cells, a 
non-transformed rat intestinal epithelial cell line, IEC-6 (ATCC) was used. Cell stocks of 
IEC-6 were maintained in T-75 flasks in a humidified 370C incubator with 5% CO2. For 
this study, cell cultures within 5-15 passages were used. The cell culture medium consisted 
of DMEM (Sigma) with 10% heat inactivated fetal bovine serum (Hyclone), 1% sodium 
pyruvate (Gibco), and 0.1% bovine insulin (Sigma). The culture medium was changed 
every 2-3 days. Trypan Blue assay was used to assess the viability of cells and cell cultures 
with >95% viability were used for all experiments. To remove cells from flask or culture 
plates, trypsinization was performed with 0.25% trypsin-EDTA (Gibco). A seeding density 
of 2 × 105 cells/ml was used for the experiments. Confluent IEC-6 cell monolayers were 
grown on 12-well tissue culture plates (Costar), or to poly-L-lysine treated 12 mm glass 
coverslips. Poly-L-lysine coating of coverslips is described in appendix III.  
 
Additionally, human colonic carcinoma epithelial cells T84 (ATCC) were also used. 
T84 cells growth medium consisted 1:1 mixture of Dulbecco modified Eagle medium and 





4.2.2 Parasite culture and lysate preparation 
 
Blastocystis ratti WR1 was used for this study. Parasites were cultured in pre-
reduced Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 10% 
inactivated horse serum (Gibco) and incubated anaerobically at 370C in an ANAEROJAR 
(Oxoid, UK) as previously described (Ho et al. 1993). Parasites (5 days old) were harvested 
and washed 2 times in ice cold IEC-6 complete media at 500 × g for 10 min at 40C. 
Resulting pellet was resuspended in IEC-6 cell complete media. The parasites were counted 
with a hemocytometer and concentration was adjusted to 1×107 parasites/ml. Parasites were 
examined microscopically for their viability in IEC-6 complete media and found to be 
viable for >48 h in IEC-6 growth conditions. To prepare parasitic lysates, three freeze-thaw 
cycles in liquid nitrogen and 370C water bath were respectively performed. Lysates were 
microscopically checked for the complete cell lysis. 
 
4.2.3 Experimental planning and inoculation protocol 
 
For all experiments, a density of 1 × 107 parasites/ml was used. A cell density of 
1×107 Blastocystis cells/ml was used for all experiments. Studies for other protozoan 
parasites have used similar or even higher concentration of parasites (up to 2×107 cells/ml 
for Giardia intestinalis) (Chin et al. 2002). Although titers of naturally occurring infections 
are not known for Blastocystis, a concentration of 1×107 Blastocystis cells/ml was used 
based on previous studies on protozoan parasites like Giardia (Teoh et al. 2000). Either live 
parasites or equivalent parasitic lysate were added to IEC-6 monolayers grown in 12 well 
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plates (2ml inoculum), 24 well plates (1 ml inoculum). For experiments, 2-3 days old 
confluent monolayers of IEC-6 were used and culture medium was changed 24 h before the 
experiment. In some experiments, to inhibit caspases, cell monolayers were pretreated for 2 
h with either general caspase inhibitor Z-VAD-fmk (50µM) or caspase-3 inhibitor Z-
DEVD-fmk (120µM) prior to addition of parasites or lysate. To investigate if apoptosis of 
IEC-6 cells requires direct contact with parasites, cells were grown in 12 well plates and 













Fig. 4.1 Simplified diagrammatic representation of Millicell-HA membrane inserts 
used for the parasite-host cell contact-independent experiments. IEC-6 cells were 
grown on the culture plate well base, and live Blastocystis ratti WR1 parasites were 
added to the apical compartment (filter insert) to study contact-independent effects on 
host cells. The small pore size (0.4 µm) does not allow Blastocystis to pass through filter 
but secretory components can pass and interact with IEC monolayer grown on the base. 
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4.2.4 DAPI staining for nuclear fragmentation and condensation 
 
IEC-6 cells were grown on poly L-lysine coated 12 mm glass coverslips and 
coincubated with B. ratti WR1 live parasites or parasitic lysate.  After 24 h of incubation, 
monolayers were washed with PBS and fixed with 2 % (w/v) paraformaldehyde in PBS 
(pH 7.4). After fixation, cells were washed twice with PBS and stained with 0.5µg/ml of 
DNA binding dye DAPI (4’, 6-diamidino-2-phenylindole; Sigma) for 5 min in the dark (at 
room temperature). After staining with DAPI, cells were washed in PBS and mounted on a 
glass slide with fluorescent mounting medium (VECTASHIELD). Stained cells were 
viewed under a fluorescence microscope (Olympus BX60, Japan) for changes in nuclear 
morphology and counted. 
 
4.2.5 Annexin V binding assay for expression of phosphatidylserine molecules on 
cell surface 
 
As an early marker of apoptosis, annexin V binding assay was performed. IEC-6 cells 
were grown in 12 well culture plates. Grown monolayers were then coincubated with B. 
ratti WR1 live parasites or parasitic lysate for 5 h. Expression of phosphatidylserine 
molecules on plasma membrane was analyzed by using an annexin V-fluorescein 
isothiocyanate (FITC) apoptosis detection kit (BD Pharmingen) following the 
manufacturer’s instructions. Within the kit, propidium iodide (PI) was used for the 
exclusion of dead cells from apoptotic cells. After annexin V staining, samples were 
analyzed by flow cytometry (Dako Cytomation Cyan LX) using 488 nm excitation and a 
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515 nm bandpass filter for FITC detection and a 600 nm filter for PI detection. In the dot 
plot, a region was defined that represents the apoptotic cell population showing annexin + 
and PI ¯  staining (lower right quadrant). 
 
4.2.6 Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate 
nick-end labelling (TUNEL) 
 
IEC-6 cells were cultured on poly L-lysine coated 12 mm glass coverslips. Grown 
cell monolayers were coincubated with B. ratti WR1 live parasites or lysate for 12 h. To 
detect in situ DNA fragmentation, terminal deoxynucleotidyl transferase-mediated 
deoxyuridine triphosphate nick-end labelling (TUNEL) was performed using the in situ 
cell death detection kit (Roche) following the manufacture’s instructions. The samples 
were analyzed by a fluorescence microscope and apoptotic cells were counted. 
 
4.2.7 Caspase-3 activity 
 
To analyze caspase-3 activity, the ApoAlertTM Caspase Fluorescent Assay Kit (BD 
Pharmingen) was used. IEC-6 cells were grown in 12 well culture plates and coincubated 
with B. ratti WR1 live parasites or parasitic lysate for 6, 12, 24 h. After coincubation, cells 
were washed twice with ice cold PBS and harvested using a cell scraper. After washing, 
cells were resuspended in 50µl of chilled cell lysis buffer and incubated on ice for 10 min. 
Cell homogenates were centrifuged (13000 rpm) for 10 min to precipitate cellular debris. 
Resulting supernatants were transferred to new tubes. After this, 50µl of 10mM DTT in 
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1ml of 2× reaction buffer mix followed by 5µl of 1mM caspase-3 substrate (DEVD-AFC; 
50µM final concentration) was added to each sample and incubated in a water bath (1 h at 
370C). Samples were transferred to a 96 well plate and analysis was done by measuring 
absorbance in a fluorometer (SpectraMax) with a 400 nm excitation filter and 505 nm 
emission filter. Caspase-3 activity was expressed as relative fluorescence units (RFUs). 
 
4.2.8 Positive control 
 
In some of the abovementioned apoptosis assays, 0.25 µM staurosporine (Sigma) 






4.3.1 Blastocystis induces apoptosis in IEC-6 cells  
 
To investigate whether Blastocystis has potential to induce apoptosis in intestinal 
epithelial cells, range of experiments was performed. These experiments involved (a) DAPI 
staining to detect chromatin condensation and nuclear fragmentation, (b) Annexin V 
binding assay to analyze externalization of phosphatidylserine molecules during the early 
phase of apoptosis, (c) TUNEL for the analysis of internucleosomal nicks in DNA during 
the late stages of apoptosis and  (d) Caspase-3 assay to analyze the presence of active 
caspase-3. In addition, caspase inhibitors were used to confirm findings. Results from all 
experiments consistently revealed that exposure of IEC-6 cells to B. ratti WR1 live parasite 
and parasitic lysates induces significant levels of apoptosis in IEC-6 cells. Moreover, the 
results showed that the secretory products of Blastocystis can induce apoptosis and 
parasite-host cell contact is not essential. 
 
4.3.1.1 Cellular detachment 
 
For proper growth, function and survival, most of the cells require attachment to 
each other and subsequent proliferation on the extracellular matrix (ECM). This 
dependence is known as ‘anchorage dependence’ of cells. Without attachment, cells often 
undergo apoptosis, a process known as ‘anoikis’ (Frisch and Ruoslahti 1997). Anoikis is 
a well documented form of programmed cell death in freshly isolated human intestinal 
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epithelial cells (Grossmann et al. 1998). IEC-6 cell monolayers were coincubated with B. 
ratti WR1 live parasites and parasitic lysates for 6 h and viewed by inverted phase-
contrast microscopy. Results show that cellular detachment is significantly higher in 
monolayers exposed to live parasite and parasitic lysate compared to normal looking cell 
monolayers in control monolayer (Fig. 4.2). Monolayers treated with positive control 
(staurosporine) were disrupted and extensive cell detachment was observed. It has been 
reported that cellular detachment occurs due to caspases which can degrade cytoskeletal 
proteins and some proteins in ECM, resulting in the detachment of cells (Huppertz et al. 
1999, Ramesh et al. 2000) and suggests that the induction of caspase activity is an early 
event in the apoptotic pathway.  
 
4.3.1.2 Changes in nuclear morphology 
 
Distinguishing nuclear morphological changes in the cells undergoing programmed 
cell death were considered as important indicator of apoptosis (Kerr et al. 1972). Staining 
of cells with nuclear binding dye DAPI detects changes in the nuclear morphology. IEC-6 
cell monolayers exposed to Blastocystis showed characteristic apoptotic nuclear 
condensation and fragmentation (Fig. 4.3). IEC-6 cells exposed to B. ratti WR1 live 
parasites and parasitic lysates for 24 hours, showed highly condensed and fragmented 
nuclei in apoptotic cells. Monolayers of control IEC-6 cells showed healthy intact nuclei 
with normal chromatin distribution. Cells coincubated with live parasites (7.6% ±1.4, P 
<0.05 versus control) and parasitic lysate (13.5% ±2.4, P <0.05 versus control) showed 
about 4 and 7 fold respective significant increase in percentage of apoptotic cells compared 
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with the control (2.0% ±0.5) (Fig 4.4). Cells in contact-independent assay also showed a 
significant increase in apoptotic cells (5.9% ±0.7, P <0.05 versus control) suggesting that 
parasitic secretory products have potential to induce apoptosis. In addition, to provide 
direct evidence that apoptosis of IEC-6 cells by Blastocystis involved caspase-3, 
pretreatment of cells with a caspase-3 inhibitor Z-DEVD-fmk before exposure to parasitic 
lysate significantly inhibited apoptosis (5.3% ±1.1, P <0.05 versus parasitic lysate 
treatment). 
 
4.3.1.3 Externalization of phosphatidylserine molecules on cell surface 
 
Externalization of phosphatidylserine (PS) on the outer leaflet of the plasma 
membrane is one of the main features of apoptosis and it is generally assumed that PS 
exposure is a result of caspase activation, another hallmark of apoptosis (Ferraro-Peyret 
et al. 2002). Annexin V, a 35-36 kDa protein, in the presence of calcium ions, binds with 
high affinity to PS molecules (Raynal and Pollard 1994). Annexin V-FITC and 
propidium iodide double staining can effectively detect viable, apoptotic and necrotic 
cells in a mixed population (Vermes et al. 1995). 
 
In this method, annexin+ and PI¯  stained cells represent apoptotic cell population in 
flow cytometry dot plots (lower right quadrants, Fig. 4.5). IEC-6 cells exposed to 
Blastocystis for 5 hours showed a marked increase in percentage of apoptotic cells. Cells 
coincubated with live parasites (19.3 %, Fig. 4.5B) and with parasitic lysate (34.2 %, Fig. 
4.5C) relative to the control (5.8 %, Fig. 4.5A) in the lower right quadrants. The population 
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dots in B, C, E and F compared to A in figure 4.5, show an overall shift in the population of 
cells from the lower left quadrant towards the lower right quadrant. This shift indicates the 
increase in the percentage of apoptotic cells with preservation of plasma membrane 
integrity. Pretreatment with general caspase inhibitor Z-VAD-fmk prior to coincubation 
with parasitic lysate significantly prevented the apoptosis of IEC-6 cells (8.4 %, Fig. 4.5D). 
Moreover, a significant increase in the number of apoptotic cells induced by live parasites 
in a contact-independent manner was observed (14.6%, Fig. 4.5E). This observation 
suggests that some secretory products of B. ratti WR1 may induce apoptosis of IEC-6 cells 




Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-
end labelling (TUNEL) was performed as a late marker for the detection of endonuclease 
activity and analysis of apoptosis in IEC-6 cells exposed to Blastocystis. The low 
molecular weight DNA fragments and single strand breaks (also called as ‘nicks’) in high 
molecular weight DNA can be detected by labeling free 3’-OH end with modified 
nucleotides in an enzymatic reaction. TUNEL is reported to be a good assay for detecting 
DNA fragmentation when used in combination with other techniques (Huppertz et al. 
1999).  
 
Results from fluorescent microscopy revealed labeling of distinctly fragmented 
DNA (Fig. 4.6). IEC-6 cells exposed to B. ratti WR1 live parasites and parasitic lysate 
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showed distinct increase in fluorescence in comparison to the cells of negative control. 
Flow cytometry was performed for the quantification and results showed significantly 
higher percentages of TUNEL labeled cells exposed to live parasites (16.7% ±2.6, P 
<0.05 versus control) and parasitic lysate (21.8% ±4.9, P <0.05 versus control) as 
compared to the negative control (2.0% ±0.5). Overall, TUNEL and in DAPI staining 
results clearly suggest that Blastocystis causes DNA fragmentation in IEC-6 cells. 
 
4.3.1.5 Increase in caspases-3 activity 
 
Caspases are cysteine proteases that are essential for the execution of apoptosis 
(Riedl and Shi 2004) and they control the dismantling and clearance of dying cells. 
Caspase-3 (also called as CPP32, apopain, YAMA) has been identified as being a key 
mediator of apoptosis in mammalian cells (Kothakota et al. 1997), during which cells 
undergo morphological changes particularly DNA fragmentation, chromatin 
condensation, and apoptotic body formation. There was a significant increase in caspase-
3 activity in IEC-6 cells exposed to B. ratti WR1 live parasites and parasitic lysates (Fig. 
4.7). Caspase-3 activity was observed to peak at 12 h after incubation. After 12 h, activity 
of caspase-3 decreased up to 24 h. Importantly, a significantly high caspase-3 activity 
was seen in IEC-6 cells coincubated with live parasites in a contact-independent manner, 
using Millicell-HA filters. This finding was consistent with DAPI staining and annexin V 
binding results (Fig. 4.4 and 4.5) providing evidence that B. ratti WR1 can induce 
apoptosis of IEC-6 cells in a contact-independent manner. Additionally, to prove that 
Blastocystis induced apoptosis of IEC-6 cells involved caspase-3,  IEC-6 monlayers were 
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pretreated with caspase-3 specific inhibitor, Z-DEVD-fmk, before coincuabation with 
parasitic lysate. Caspase-3 activity was found to be completely inhibited with the use of 
Z-DEVD-fmk (Fig. 4.7). Overall findings suggest that caspases-3 is actively involved in 
Blastocystis induced apoptosis of IEC-6 cells. 
 
 
4.3.2 Blastocystis induces apoptosis in T84 cells  
 
In addition to the non-transformed rat intestinal epithelial cell line IEC-6, it was 
investigated if Blastocystis could induce apoptosis in human colonic carcinoma epithelial 
cells (T84). T84 Cells were grown on poly-L-lysine coated glass coverslips and incubated 
for 24 h with B. ratti WR1 live parasite or parasitic lysate. Cells coincubated with live 
parasites and parasitic lysate show nuclear condensation and fragmentation (Fig. 4.8). A 
significant increase in percentage of apoptotic cells in T84 monolayers exposed to live 
parasite (8.3% ±1.6) and parasitic lysate (14.6% ±2.7) was noticed in comparison to the 

















































Fig. 4.2 Representative light microscopy pictures of apoptotic cells showing cellular 
detachment from stratum. Confluent IEC-6 cell monolayers were grown on 12-well 
tissue culture plates and coincubated with B. ratti WR1 live parasites and parasitic lysates 
for 6 h and viewed by inverted phase-contrast microscopy. Overall observation shows 
that cellular detachment (shiny spots) is much higher in monolayers exposed to live 
parasite (B) and parasitic lysate (C) compared to a normal looking cells in control 
monolayer (A). In the positive control (D), the monolayer integrity was disrupted and 










































Fig. 4.3 Fluorescence photomicrographs after DAPI staining shows apoptosis of 
IEC-6 cells. Cells were grown on glass coverslips and incubated for 24 h with either 
culture media (A), B. ratti WR1 live parasite (B), parasitic lysate (C), and 0.25 µM 
staurosporin as positive control (F). Cells coincubated with live parasites, parasitic lysate 
and staurosporin show nuclear condensation and fragmentation (arrow). Parasite-host cell 
contact independent assay also shows apoptosis of cells (D). Pretreatment with a caspase-

































Fig. 4.4 Histograms showing percentage of apoptotic cells after DAPI fluorescence 
assay. IEC-6 monolayers were grown on glass coverslips and incubated for 24 h with 
either culture medium, B. ratti WR1 live parasite, parasitic lysate, or 0.25 µM 
staurosporin. Cells coincubated with live parasites and parasitic lysate show a significant 
increase in percentage of apoptotic cells in comparison to the negative control. Contact 
independent assay also shows significant increase in apoptotic cells suggesting that 
secretory products of Blastocystis has potential to induce apoptosis. Pretreatment of cells 
with a caspase-3 inhibitor Z-DEVD-fmk significantly inhibited the apoptosis. For each 
sample, 1000 cells were counted at 400× magnification. Values are means ± standard 
deviations (n = 3 per group). *, P < 0.05 versus negative control; #, P < 0.05 versus 


























































































Fig. 4.5 Flow cytometry analysis of annexin V-FITC and propidium iodide staining. 
Representative dot plots of controlcells (A), cells incubated for 5 hr with B. ratti WR1 live 
parasites (B), with parasitic lysate (C), with lysate after pretreatment with caspase inhibitor Z-
VAD-fmk (D), with live parasite on Millicell-HA filter for contact-independent assay (E), and 
with 0.25µM staurosporin as a positive control (F). B, C, E and F show a significant increase in 
annexinV+ and PI¯  apoptotic cell population (lower right quadrant). 2×104 cells from each 







































Fig. 4.6 TUNEL for the detection of in situ DNA fragmentation. IEC-6 cells were 
cultured on poly L-lysine coated 12 mm glass coverslips. To detect in situ DNA 
fragmentation, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate 
nick-end labelling (TUNEL) was performed. Fluorescence micrographs of cells grown on 
glass coverslips and coincubated for 12 h with culture medium (A), B. ratti WR1 live 
parasite (B), parasitic lysate (C) and staurosporin (D). A significant number of TUNEL 
positive cells (green fluorescence) can be seen in B, C and D. Histogram shows TUNEL 
positive cell population determined by flow cytometry shows a significant increase in 
TUNEL positive IEC-6 cells after coincubation with live parasite and parasitic lysates. 





































































Fig. 4.7 Line chart showing caspase-3 activity of IEC-6 cells. IEC-6 cells were grown 
in 12 well culture plates and coincubated with B. ratti WR1 live parasites or parasitic 
lysate. Caspase-3 activity was measured at 6, 12 and 24 h time points as using a Caspase-
3 Fluorescent Assay Kit. A significant increase in caspase-3 activity was observed in 
cells treated with live parasite, parasitic lysates and positive control (0.25 µM 
staurosporin) after 6 and 12 h. Caspase-3 activity was gradually reduced at 24h. 
Pretreatment of cells with caspase-3 inhibitor Z-DEVD-fmk significantly reduced the 
caspase-3 activity. Values are means ± standard deviations (n = 3 per group). *, P < 0.05 
































































































































































































































Fig. 4.8 Fluorescence photomicrographs and histogram showing  apoptosis of 
human colonic carcinoma epithelial cells (T84) after DAPI staining. Cells were 
grown on glass coverslips and incubated for 24 h with either culture media (A), B. ratti 
WR1 live parasite (B), or parasitic lysate (C). Cells coincubated with live parasites and 
parasitic lysate show nuclear condensation and fragmentation (arrow). From the 
histogram, a significant increase in percentage of apoptotic cells in T84 monolayers 
exposed to live parasite and lysate can be noticed in comparison to the negative control. 
For each sample, 1000 cells were counted. Values are means ± standard deviations (n = 3 















































Here, it was demonstrated for the first time that B. ratti WR1 can induce apoptosis 
in intestinal epithelial cells. The apoptosis of IEC-6 cells also occurred in a contact-
independent manner and suggests that Blastocystis may be secreting certain virulent 
factors that can initiate the apoptotic pathway in IEC-6 cells.  
 
Apoptosis can occur in response to infection with numerous invasive and non-
invasive pathogens (McCole et al. 2000). It was reported recently that many protozoan 
parasites including G. lamblia, C. parvum, E. histolytica and other pathogens particulary 
L. monocytogenes, E. coli, C. difficile (Fiorentini et al. 1998; Kim et al. 1998; Crane et al. 
1999; Valenti et al. 1999; Huston et al. 2000; McCole et al. 2000; Chin et al. 2002) can 
induce apoptosis of intestinal epithelial cells. The cytopathic effects of Blastocystis were 
reported earlier and it was shown to be able to kill host cells in vitro (Walderich et al. 
1998), but the mechanism of cell death was not investigated. Findings from this study 
demonstrate that B. ratti WR1 can cause apoptosis of intestinal epithelial cells and 
parasite-enterocyte contact is not required. These results suggest that Blastocystis has the 
potential to cause in vivo pathogenic effects without adhering to the gut mucosa. On the 
other hand, studies have shown that intestinal pathogens in particular E. histolytica and C. 
parvum, and enteropathogencic E. coli usually establishes contact with the host cells to 
cause apoptosis (Crane et al. 1999; Huston et al. 2000; McCole et al. 2000).  
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Although the ability of Blastocystis to adhere to the intestinal epithelium has not 
been established, the majority of studies suggest Blastocystis to be a non-invasive 
protozoan parasite (Stenzel and Boreham 1996; Tan 2004). Hence, finding that 
Blastocystis has the ability to cause apoptosis without adhering to the gut mucosa is 
important for its pathogenicity. Numerous intestinal protozoans are reported to secrete 
parasitic factors, for example proteases, that are accountable for their virulence 
(Rosenthal 1999). It was also shown in previous chapter that Blastocystis-secreted 
proteases can degrade human secretory immunoglobulin A and they were suggested to be 
parasitic virulence factors. Invasion does not necessarily lead to host cell apoptosis and 
there are pathogens that can invade but do not induce apoptosis (Crane et al. 1999). 
Further investigations and characterization of Blastocystis secretory products can 
subsequently shed more light on its pathogenesis. 
 
Clostridium difficile, a cause of diarrhea and colitis in human, produces toxin B 
that can cause apoptosis in intestinal cells with nuclear fragmentation and chromatin 
condensation (Fiorentini et al. 1998). It was reported that H. pylori colonization causes 
increased apoptosis of gastric cells and it was prevented by the removal of organism 
(Moss et al. 1996). Purified lipopolysaccharide of H. pylori has also been reported to 
induce apoptosis of epithelial cells in vitro (Wagner et al. 1997).  
 
Findings suggest that Blastocystis induces moderate levels of apoptosis in 
intestinal epithelial cells; and this may limit the host inflammatory response, which might 
be detrimental to the survival of the parasite. Ideally, it seems that induction of apoptosis 
 113 
of host intestinal cells would not be beneficial to a non-invasive parasite like Blastocystis 
as it may possibly result in the loss of colonization sites for the parasite. This 
unintentional initiation of host cell apoptosis might be a host response against some 
parasitic factors like proteases which are essential for parasite’s own growth and life-
cycle. Extension of these findings in suitable animal model would greatly help to 
elucidate this issue. 
 
Apoptosis or necrosis of intestinal epithelial cells can lead to altered intestinal 
barrier function (Bojarski et al. 2000). Findings showed that the inhibition of caspases in 
IEC-6 cells with Z-VAD-fmk has apparently no significant effect on TER and 
permeability changes induced by Blastocystis. Giardia lamblia parasitic factors have 
been reported to increase epithelial permeability by inducing enterocyte apoptosis (Chin 
et al. 2002).  This difference in observation may be due to low percentage of apoptosis 
induced by Blastocystis. In addition, Blastocystis may have induced non-apoptotic cell 
death, such as necrosis, autophagy or paraptosis (Broker et al. 2005) that may have 
resulted into increased epithelial permeability. 
 
 In summary, results from the present study report for the first time that 
Blastocystis induces apoptosis in enterocytes and there is active involvement of caspase-3.  
In addition, it was demonstrated that this apoptosis may occur in a contact-independent 
manner and suggested that Blastocystis may secrete virulent factors that can initiate the 
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Intestinal permeability was reported to be considerably increased in B. hominis 
patients and it was suggested that Blastocystis infections may damage the intestinal wall 
(Dagci et al. 2002). Many gastrointestinal disorders particularly bacterial enteritis, celiac 
disease and inflammatory bowel disease are reported to be associated with a breakdown of 
epithelial barrier function (Bjarnason et al. 1995; Chin et al. 2002). The main function of 
intestinal mucosa is to provide a barrier that keeps luminal contents separate from the 
interstitium. This barrier function can be compromised in many diseases and may result in a 
leaky barrier and gastrointestinal symptoms including diarrhea.  
 
Recently it was known that cytoskeleton and tight junctions play important roles in 
regulating the mucosal barrier function (Clayburgh et al. 2004). The cytoskeleton, in 
particular the actin microfilaments, is key in maintaining cell shape and regulating tight 
junction permeability. The organization of actin filaments is crucial for the assembly of 
intestinal tight junctions (Madara et al. 1986) and its disorganization may lead to increased 
epithelial permeability. Intestinal barrier function is critically regulated by tight junctions 
which consist of a number of transmembrane proteins, particularly claudins and occludin, 
and cytoplasmic peripheral membrane proteins, including zonula-occludens-1 (ZO-1), 2 and 
3 and cingulin (Clayburgh et al. 2004). Many tight junctions proteins interact with F-actin 
and these interconnections are considered to stabilize the tight junction. Intestinal pathogens 
for example Giardia lamblia and Escherichia coli were reported to rearrange F-actin 
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distribution in intestinal epithelial cells and compromise barrier function (Gerhard et al. 
1998).  
 
ZO-1 is a 220-kDa peripheral membrane protein that interacts with tight junctional 
occludin at its N terminus and with cytoskeletal F-actin at its C terminus. ZO-1 plays an 
intermediary role between the cytoskeleton and the tight junction and thus has importance in 
regulating paracellular permeability (Fig 5.1) (Chin et al. 2002). ZO enterotoxins (Zot) 
released by some pathogens bind to Zot receptors expressed on mature intestinal epithelial 
cells and in turn cause the displacement of tight junctional proteins including ZO-1 (Fasano 
et al. 1991). Studies have shown that disruption of ZO-1 integrity can increase epithelial 
permeability and decrease transepithelial electrical resistance (TER) (Youakim and Ahdieh 
1999).  
 
TER is the measurement of electrical physical resistance provided by a cell 
monolayer. To measure TER, an electrical pulse of known amplitude is passed across the 
epithelium and the corresponding transepithelial voltage deflection is measured.  Ohm's law 
is used to calculate electrical resistance and it is corrected for system and fluid resistance. 
Transepithelial electrical resistance is thought to be well correlated with the change in 
paracellular permeability of the cell monolayer (Madara 1988). Generally, transepithelial 
electrical resistance decreases during many gastro-intestinal infections and it is inversely 
proportional to the permeability of epithelial monolayer.  In conclusion, understanding the 
pathogen’s effects on regulation of barrier function may yield new insights into the 
pathogenesis of disease that it causes. 
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In chapter 4, it was shown that Blastocystis can cause apoptosis of IECs and it has 
been suggested that epithelial cell apoptosis caused by the protozoan G. lamblia can 
contribute to the disorders of intestinal permeability (Chin et al. 2002). In following 
experiments, aim was to characterize the effects of Blastocystis on tight junctions and the 
cytoskeleton of intestinal epithelial cells. In addition, it was investigated if Blastocystis can 
modulate the permeability of the intestinal epithelium. 
 



























Fig 5.1 A simplified schematic of tight junctions. Tight junction protein ZO-1 interacts 
with actin filaments and the occludin-claudin complex. Displacement of ZO-1 or 
abnormalities in the distribution of F-actin may affect tight junction integrity and thus barrier 
function.  
 119  
5.2 MATERIALS AND METHODS 
 
5.2.1 Culture of non-transformed rat intestinal cell line 
 
All experiments were performed with a non-transformed rat intestinal epithelial cell 
line, IEC-6 (ATCC). IEC-6 cell were cultured and maintained as described in chapter 4. The 
culture medium was replenished every 2-3 days. Cell viability was analyzed by Trypan Blue 
assay and only cell cultures with >95% viability were used. Cells were trypsinized with 
0.25% trypsin-EDTA (Gibco) and 2 × 105 cells/ml seeding density was used. Cells were 
grown to confluency on poly-L-lysine treated 12 mm glass coverslips. For transepithelial 
resistance (TER) and monolayer permeability assays, cells were grown on 0.6 cm2 Millicell-
HA filters (Millipore) using 24 well tissue culture plates (costar) (Fig 5.2A).  
 
For the ZO-1 study, HCT8 (ATCC) human ileocecal epithelial cells were grown in 
RPMI 1640 medium containing 10% FBS, 1 mM sodium pyruvate, and 2 mM l-glutamine 
(HCT8 medium). HCT8 cells were grown at 37°C in a 5% CO2 environment. Problems of 
IEC-6 detachment from coverslips during harsh immunostaining procedure were 
experienced and thus HCT8 cells were used for ZO-1 study. HCT8 cells also exhibit tight 
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5.2.2 Parasite culture and preparation of lysate 
 
Blastocystis ratti isolate WR1 was cultured as described in chapter 4. Five days old 
parasites at log phase were washed 2 times in ice cold IEC-6 complete media at 500 × g for 
10 min at 40C. The pellet was resuspended in IEC-6 cell complete media, parasites were 
counted with a hemocytometer and concentration was adjusted to 1×107 parasites/ml. 
Parasites were examined microscopically for their viability in IEC-6 and HCT8 complete 
medium and found to be viable for >48 h in IEC-6/HCT8 growth conditions. Parasitic lysates 
were prepared by 3 freeze-thaw cycles in liquid nitrogen and 370C water bath respectively. 
 
5.2.3 Inoculation protocol and experimental planning 
 
A density of 1 × 107 parasites/ml was used for inoculation. Either live parasites or 
parasitic lysate were added to the apical side of confluent monolayers grown on 0.6 cm2 
Millicell-HA filters (400 µl). For phalloidin-FITC staining, 2-3 days old confluent 
monolayers were used. For TER and epithelial permeability experiments, monolayers grown 
on Millicell-HA filters were used 5-6 days after seeding when they reached peak electrical 
resistance of ~30 Ω/cm2. In some TER and permeability assays, antiprotozoal drug 
metronidazole (10 µg/ml, Sigma) was added in medium prior to addition of live parasites. 
Monolayers were washed twice with cold Hanks Balanced Salt Solution (HBSS, Gibco) 
before addition of parasite or lysate suspension.  
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5.2.4 Phalloidin-FITC staining of F-actin 
 
IEC-6 cells were grown on poly L-lysine coated glass coverslips and confluent 
monolayers were coincubated with live parasites, parasitic lysate or 5 µg/ ml cholera toxin as 
positive control for 24 and 48 hrs. After incubation, cells were washed with PBS and fixed in 
3.7% paraformaldehyde in PBS for 5 min. Cells were washed with PBS and dehydrated with 
acetone, permeabilized with 0.1% TritonX-100 in PBS and washed again in PBS. Cells were 
stained with 50 µg/ml phalloidin-FITC conjugate solution in PBS for 40 min at room 
temperature and then washed 5-6 times with PBS to remove unbound phalloidin conjugate. 
Coverslips were mounted on glass slides with fluorescent mounting medium (Vectashield) 
and viewed by confocal microscopy (Olympus Fluoview FV500). 
 
5.2.5 Tight junctional ZO-1 immunostaining 
 
HCT-8 cells were grown on LabTek chamber slides (NUNC). 4-5 days old 
confluent monolayers were used to determine the effects of Blastocystis ratti WR1 on tight 
junctional ZO-1 integrity. Cells were coincubated with live parasite or parasitic lysates for 
24 h. Monolayers were washed and fixed with fresh 2% paraformaldehyde in PBS (2 h, RT) 
and washed three times with PBS (5 min, RT). Cells were permeabilized with 0.4% Triton 
X-100 (15 min, room temperature) and washed three times with PBS (5 min, RT). 
Nonspecific binding was blocked with pure FBS (Gibco) (10 min, RT) and washed three 
times with PBS (5 min, RT). After this, the monolayers were incubated (37°C, 1 h, 
humidified chamber) with rabbit polyclonal anti-ZO-1 antibody (1:200 in PBS; Zymed) 
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and washed three times with PBS (5 min, RT). Next, the monolayers were incubated (37°C, 
1 h, dark humidified chamber) with Goat anti-rabbit IgG conjugated to FITC (1:200 in PBS; 
Sigma) and washed three times with PBS (5 min, RT). Lastly, monolayers were mounted 
with fluorescent mounting medium (Vectashield) and visualized by confocal microscopy 
(Olympus Fluoview FV500). 
 
5.2.6 Measurement of transepithelial resistance 
 
Transepithelial resistance was determined with a Millipore Electrical Resistance 
system (Millipore-ERS) (Fig 5.2B). IEC-6 monolayers were grown on 12mm Millicell-HA 
filters and TER was tested on alternate days until it reached peak TER (~30Ω/cm2) by day 6 
(Fig. 5.2). Parasites or lysate were added to the apical side of confluent monolayers grown on 
Millicell-HA filters and coincubated for 12, 24 and 48 hr. After coincubation, monolayers 
were washed 2 times with HBSS to ensure that parasites would not affect TER measurements. 
400µl warm (370C) complete media was added to the apical compartment and TER was 
measured with Millipore-ERS. To avoid fluctuations in temperature, TER was measured at 
370C with the aid of a heating plate. Epithelial resistance was expressed in Ω/ cm2. The 

























Fig. 5.2 Simplified diagrammatic representation of Millicell-HA filter inserts and 
Millipore electrical resistance system. (A) IEC-6 cells were grown on the filter insert, and 
live Blastocystis ratti WR1 or parasitic lysates were added to the apical compartment to 
study transepithelial resistance and permeability. (B) Experimental setup for the 
measurement of transepithelial resistance showing Millipore electrical resistance system 
and an electrode with a short and a long leg. To measure TER, electrodes are immersed in a 
way that the shorter electrode is in the apical compartment of the culture plate insert and 
the longer electrode is in the outer well. The shorter electrode should not contact cells 
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5.2.7 Determination of epithelial permeability by Lucifer yellow 
 
To confirm confluence of cell monolayers grown on Millicell-HA filters, 
transepithelial resistance was measured with Millipore-ERS (Fig. 5.2). After reaching peak 
transepithelial resistance (~30Ω/cm2), the effect of Blastocystis on epithelial barrier function 
was assessed with Lucifer yellow (482 MW, Molecular Probes). In brief, after 24 h of 
coincubation, apical and basolateral compartments were washed gently 3 times with HBSS. 
300µl of Lucifer yellow (100µg/ml in HBSS) was added to apical compartment and 500µl of 
HBSS was added to the basolateral compartment. After 3 h of incubation at 370C in a 
humidified incubator with 5% CO2, 250µl of sample was taken from the basolateral 
compartment. Fluorescence absorbance was determined using wavelengths of 485nm 
excitation and 535nm emission. Values were expressed as percent Lucifer yellow passage 
across the cell monolayer. 
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5.3 RESULTS 
 
5.3.1 Rearrangement of F-actin 
 
The cytoskeleton, in particular the actin microfilaments, is key in maintaining cell 
shape and regulating tight junction permeability. The organization of actin filaments is 
crucial for the assembly of intestinal tight junctions (Madara et al. 1986). Phalloidin, a fungal 
toxin, binds to F-actin with high affinity and stabilizes it. Phalloidin-FITC conjugate was 
used to detect changes in F-actin distribution. When IEC-6 monolayers were coincubated 
with B. ratti WR1 live parasites, elongation of cortical actin filaments, actin disruption, and 
formation of stress fibers in the cytoplasmic zone was noticed (Fig. 5.3). A more pronounced 
formation of stress fibers and actin condensation was noticed in the monolayers incubated 
with parasitic lysate and cholera toxin (positive control) (Fig. 5.3 B and C). IEC-6 
monolayers in controls showed normal actin distribution in the cortex zone of cells with 
negligible stress fiber formation in the cytoplasmic area (Fig. 5.3 D). IEC-6 cells incubated 
with live parasites and parasitic lysate for 24 h showed significantly high percentage of cells 
showing stress fibers formation (34.3% and 36.4%) in comparison to controls (5.7%) (Table 
5.1). After 48 h coincubation, the percentage of cells showing stress fiber formation was 
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5.3.2 ZO-1 displacement from tight junctions 
 
In tight junctions, ZO-1 acts as an intermediary junction between the cytoskeleton 
(F-actin) and the tight junctional proteins (occludin) thus have importance in regulating 
paracellular permeability. HCT8 monolayers were exposed to the Blastocystis ratti WR1 
live parasites and parasitic lysates and performed ZO-1 immunostaining. Results (Fig. 5.4) 
show that ZO-1 protein from tight junctions is displaced in cells exposed to live parasite 
and parasitic lysates whereas control monolyers showed continuous pericellular 
organization of ZO-1 typical of a healthy cell. Significantly high percentage of cells 
showed ZO-1 displacement after exposure to live parasite (45.7 ± 4.8) and parasitic lysate 
(65.0 ±  7.0) in comparison to control cells (9.9 ± 2.1) (for both, P <0.05 Vs control; Table 
5.2). In Blastocystis ratti WR1-exposed cells, migration of ZO-1 towards the nuclei was 
observed. 
 
5.3.3 Decrease in transepithelial resistance 
 
F-actin rearrangement has been associated with reduced TER in a number of studies 
(Hecht et al. 1988; Teoh et al. 2000). Hence, experiments were conducted to investigate if 
rearrangement of F-actin induced by Blastocystis is associated with changes in TER. IEC-6 
cell monolayers achieved a peak average resistance of ~30Ω/cm2 after about 6 days from 
seeding. B. ratti WR1 caused a significant decrease in transepithelial resistance of IEC-6 
monolayers in a time dependent manner (Fig. 5.5). Epithelial resistance of monolayers 
coincubated with B. ratti WR1 live parasites dropped from 32.2 ±1.1 to 27.2 ±1.1 Ω/cm2 by 
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12 h, from 32.8 ±1.5 to 24.2 ±2.6 Ω/cm2 by 24 h and dropped further from 32.6 ±1.7 to 22.4 
±2.6 Ω/cm2 by 48 h (for all, P <0.05 in comparison to control). A similar significant decrease 
in TER was observed with parasitic lysate which suggested that parasitic soluble and non-
soluble products are capable of inducing a decrease in TER. To show that the effect on 
transepithelial resistance was due to live parasites, antiprotozoal drug metronidazole 
(10µg/ml) was added in the incubation medium as the drug has been reported to induce 
Blastocystis cell death (Nasirudeen et al. 2004). Addition of metronidazole to monolayers 
coincubated with live parasites, significantly prevented a reduction in TER after 24 h, 
bringing the levels of TER close to control values (P <0.05 in comparison to monolayers 
incubated with live parasites only). In contrast, a significant reduction in TER was noted in 
monolayers coincubated with live parasites only (Fig. 5.6). 
 
To test if Blastocystis-induced apoptosis of IEC-6 cells plays an important role in 
inducing a reduction in TER, monolayers were pretreated with general caspase inhibitor Z-
VAD-fmk before coincubation with parasites. Results show that the inhibition of caspases in 
IEC-6 cells did not significantly prevent reduction of TER (P =0.07 in comparison with 
monolayers incubated with parasites only, Fig. 5.6). 
 
5.3.4 Increase in epithelial permeability 
 
The effects of B. ratti WR1 live parasites and parasitic lysate on permeability of IEC-
6 monolayers were analyzed by measuring apical to basolateral flux of Lucifer yellow. IEC-6 
cells exposed to B. ratti WR1 live parasites or parasitic lysates disrupted the monolayer 
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barrier function as evidenced by an increased flux of Lucifer yellow across the monolayer 
(Fig. 5.7). There was a significant increase in the flux of Lucifer yellow in monolayers 
coincubated for 24 h with live parasites (22.4% ±1.2, P <0.05), and with parasitic lysates 
(22.1% ±1.2, P <0.05) in comparison to control monolayers (17.2% ±0.6). Pretreatment of 
IEC-6 monolayers with general caspase inhibitor Z-VAD-fmk prior to coincubation with live 
parasites, did not significantly decrease Lucifer yellow flux (20.6% ±0.3, P =0.2 in 
comparison to live parasite treated monolayers) across monolayers as compared to parasite 
free control (17.2% ±0.6). This suggests that Blastocystis-induced apoptosis of intestinal 
epithelial cells might not play a major role in disrupting epithelial permeability but there are 
other factors responsible for this effect. 
 
To prove that changes in permeability of IEC-6 cell monolayer was due to the effect 
of live parasites of Blastocystis, antiprotozoal drug metronidazole was added during 
coincubation and it was found that it significantly abrogated the increased flux of Lucifer 


































Fig. 5.3 Effect of B. ratti WR1 exposure on actin cytoskeleton. IEC-6 cells were grown 
to confluency on poly-L-lysine treated 12 mm glass coverslips, stained with fluorescein-
phalloidin and analyzed by confocal microscopy. Prominent formation of stress fibers 
(arrow) can be noticed in monolayers coincubated with B. ratti WR1 live parasite (A), 
parasitic lysate (B), and 5 µg/ ml cholera toxin (C) as positive control. Negative control (D) 








with WR1 live 
parasite (%) 
Cells coincubated 





Cells coincubated with 
5µg/ml cholera toxin 
(positive control) (%) 
24 hrs 
incubation 
34.3 36.4 5.7 42.8 
48 hrs 
incubation 
37.2 45.7 7.8 60.7 
 
Table 5.1. Percentage of IEC-6 cells showing stress fiber formation in response to 































Fig. 5.4 Representative confocal scanning laser micrographs illustrating ZO-1 
integrity in human HCT-8 epithelial monolayer. HCT-8 cells were grown on 
LabTek chamber slides. Monolayers were fixed, permealized and immunostained 
with rabbit polyclonal anti-ZO-1 antibody. Control monolayer (C) exhibits typical 
ZO-1 pericellular organization at the periphery of enterocytes. Monolayers 
incubated with whole parasite (A) or parasitic lysate (B) exhibit focal disruption of 
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Table 5.2 Percentage of HCT-8 cells showing displacement of ZO-1 at pericellular 

































Fig. 5.5 Effect of B. ratti WR1 on transepithelial resistance of IEC-6 cell monolayers. 
Confluent monolayers of IEC-6 cells were grown on Millicell-HA filters and coincubated 
for indicated times with live parasite, parasitic lysate or growth media (negative control). 
Thereafter, transepithelial resistance (TER) was measured using Millipore electrical 
resistance system. Live parasite and lysate-treated monolayers showed a significant drop in 
TER after 12, 24 and 48h. Values are means ± standard deviations (n = 3 per group). *P < 
































































































Fig. 5.6 Effect of caspase inhibition and metronidazole on B. ratti WR1-induced decrease in 
transepithelial resistance of IEC-6 monolayers. Confluent monolayers of IEC-6 cells were grown 
on Millicell-HA filters and incubated for 24h with live parasite, live parasites after 
pretreatment of cells with broad spectrum caspase inhibitor Z-VAD-fmk, or live parasites 
along with antiprotozoal drug metronidazole. Monolayers incubated with growth media 
served as negative control. Thereafter, transepithelial resistance (TER) was measured using 
Millipore electrical resistance system. Treatment with caspase inhibitior does not 
considerably abolish Blastocystis-induced effect but metronidazole treatment abolished the 
effect significantly. Values are means ± standard deviations (n = 3 per group). *, P = 0.07; 
































































































Fig. 5.7 Flux measurement with Lucifer yellow. Confluent monolayers of IEC-6 cells 
were grown on Millicell-HA filters and incubated for 24h with live parasite, live parasites 
after pretreatment of cells with broad spectrum caspase inhibitor Z-VAD-fmk, or live 
parasites along with antiprotozoal drug metronidazole. Monolayers incubated with only 
growth media served as negative control. Permeability was determined by measurement of 
Lucifer yellow fluxes across the monolayer. Mean values of two experiments ±SD are 
shown. Significant increase in epithelial permeability can be noticed after incubation with 
live parasite and parasitic lysate in comparison to control monolayer. Caspase inhibition 
does not considerably abolish the Blastocystis-induced effect on permeability but 
metronidazole treatment abolished the effect significantly. Values are means ± standard 


























































 134  
5.4 DISCUSSION 
 
In this study, it was demonstrated that B. ratti WR1 rearranges F-actin distribution, 
displaces ZO-1, decreases transepithelial electrical resistance, and increases epithelial 
permeability across the cell monolayer. Furthermore, results showed that the antiprotozoal 
drug metronidazole abolishes the effects of B. ratti WR1 on epithelial barrier function. 
Together, these findings suggest for the first time that Blastocystis-induced disruption of 
the epithelial barrier function may lead to the pathogenesis of Blastocystis-related 
gastrointestinal symptoms. 
 
A variety of intestinal pathogens have been shown to cause changes in F-actin 
arrangement in intestinal epithelial cells (Teoh et al. 2000) and it was reported that dynamic 
rearrangements of F-actin contribute to an increase in epithelial permeability (Hecht et al. 
1988) and affects regulation of epithelial salt and water transport (Matthews et al. 1994) 
which may consequently lead to diarrhea. Blastocystis has been shown to cause cytopathic 
effects in Chinese Hamster Ovary cells (Walderich et al. 1998) but its effects on intestinal 
epithelial cytoskeleton and barrier functions were not reported. The present study 
demonstrates for the first time that Blastocystis adversely affects the cytoskeletal proteins 
in intestinal epithelial cells, causing a rearrangement of F-actin distribution. IEC-6 cells 
exposed to live B. ratti WR1 and parasitic lysate showed enhanced formation of condensed 
actin filaments in cells. A significant number of IEC-6 cells exhibited the formation of 
stress fibers in cytoplasmic zone of cells. 
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Findings that B. ratti WR1 causes apoptosis of intestinal epithelial cells (previous 
chapter) and rearrangement of F-actin and ZO-1 distribution, prompted us to assess the 
effect of Blastocystis on transepithelial electrical resistance and permeability. An in vitro 
model involving confluent monolayers of IEC-6 cells grown on filters were used and 
findings demonstrated that on interactions with apical surface of the epithelial cells, B. ratti 
WR1 causes significant decrease in epithelial resistance and increase in permeability across 
monolayers. The intestinal mucosa forms a barrier that separates luminal contents from the 
interstitium and the intestinal barrier can become compromised in parasitic infections, 
bacterial infections, and in many intestinal diseases in particular inflammatory bowel 
disease (Clayburgh et al. 2004). Intestinal barrier function is mainly regulated by tight 
junctions and the function of tight junctions can be measured as a decrease in 
transepithelial electrical resistance and an increase in paracellular flux of macromolecules 
(Berkes et al. 2003).  
 
Studies have suggested that Blastocystis may interact with epithelial cells of the 
gastrointestinal tract to modulate their transport characteristics and increase intestinal 
permeability (Dagci et al. 2002). In vitro findings from this study show for the first time 
that Blastocystis has the ability to disrupt barrier function of the intestinal epithelium. 
Results consistently showed an increase in transepithelial flux of Lucifer yellow with 
decrease in TER in the IEC-6 monolayers exposed to live B. ratti WR1 and parasitic 
lysates. Results from experiments suggest that Blastocystis-induced F-actin and ZO-1 
rearrangement is associated with reduced TER and altered permeability. The cause of 
Blastocystis-associated diarrhea is so far unidentified, but an association between increase 
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in epithelial permeability and diarrhea has been described for other diseases (Madara 1988; 
Madara 1990). It is possible that Blastocystis induced changes in permeability may also 
occur in vivo and lead to electrolyte imbalance and diarrhea. 
 
It was observed that monolayers coincubated with B. ratti WR1 live parasite in the 
presence of metronidazole, did not show any change in barrier function and retained their 
normal TER and epithelial permeability. This finding suggests that the effect on monolayer 
barrier function was due to live parasite only and dead parasites cannot induce such effects 
on epithelial TER and permeability. Metronidazole is known to induce programmed cell 
death in Blastocystis and plasma membrane integrity of parasite remains preserved 
(Nasirudeen et al. 2004), therefore there is no leakage of intracellular parasitic proteases 
and other products that can induce an effect on TER and permeability. However, a change 
in TER and permeability was noticed in the monolayers coincubated with parasitic lysates 
as it contains all parasitic soluble or non-soluble products which would have resulted in the 
observed effect. G. lamblia live parasite and parasitic lysates were shown to exhibit similar 
effects on intestinal epithelial cytoskeleton and TER (Teoh et al. 2000). In this study, it was 
also found that B. ratti WR1 live parasite and parasitic lysates have similar effects on F-
actin distribution and epithelial barrier function. 
 
Previously, it has been reported that E. histolytica trophozoite can decrease TER of 
enteric monolayers (Leroy et al. 2000). In contrast to this study, coincubation of E. 
histolytica parasitic lysate with human colonic epithelial monolayer failed to lower 
epithelial resistance indicating that the increase in permeability was not due to the release 
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of proteinases or other cytotoxic molecules (Leroy et al. 2000). It appears that E. histolytica 
induces increase in permeability by invasion and thus directly damaging the epithelium.  
 
The need to treat Blastocystis infections is controversial because of its uncertain 
pathogenicity. There is a lack of standardized treatment for Blastocystis infections and 
studies have shown that metronidazole inhibits the growth of Blastocystis (Moghaddam et 
al. 2005). In clinical cases where Blastocystis is implicated for gastrointestinal symptoms, 
metronidazole is a drug of choice (Tan 2004). Results show that metronidazole can avert 
the adverse effects of Blastocystis on intestinal epithelial barrier function and suggest that 
metronidazole is a therapeutic drug for Blastocystis infections. 
 
In summary, results from the present study show for the first time that Blastocystis 
was able to rearrange F-actin and ZO-1 distribution and disrupt epithelial barrier function; 
and metronidazole could abrogate these effects. In addition, the current findings show that 
IEC-6 monolayers grown on permeable filters provide a useful in vitro model for studying 




























HOST CELL INTERLEUKIN-8 RESPONSE 






















In previous experiments, it was reported that the Blastocystis ratti WR1, an isolate 
of zoonotic potential (Yoshikawa et al. 2004a; Noël et al. 2005), can induce contact-
independent apoptosis and disrupt barrier function in IEC-6 cells. It was also showed that it 
possesses proteases a fraction of which could degrade human secretory immunoglobulin A 
(sIgA). Reports suggested that this parasite can cause acute and chronic gastroenteritis 
(Nimri and Batchoun 1994); and inflammation of intestinal mucosa was associated with 
Blastocystis infections (Kain et al. 1987; Russo et al. 1988; Garavelli et al. 1992; 
Zuckerman et al. 1994). Intense infiltration of inflammatory cells in the colon was shown 
after Blastocystis infection in mice (Moe et al. 1997) and it was reported that Blastocystis 
modulates interleukin-8 (IL-8) response in intestinal epithelial cells (Long et al. 2001), 
however nothing is known about the parasitic virulence factors and the early events 
occurring in host cells following Blastocystis-host interactions. Proteases from protozoan 
parasites are known to play significant roles in pathogenesis (McKerrow et al. 1993; Sajid 
and McKerrow 2002) and proteases from some pathogens have been reported to induce the 
production of proinflammatory cytokines from host cells (Borger et al. 1999). 
 
IL-8 (CXCL8) is a CXC chemokine which attracts polymorphonuclear leukocytes 
to the site of inflammation, activates monocytes and is considered to play an important role 
in the pathogenesis of inflammatory diseases (Oppenheim et al. 1991; Charo and Ransohoff 
2006). Expression of the IL-8 gene is regulated by a number of pathways and its promoter 
region has binding sequences for a range of transcription factors including NF-κB, NF-IL-6, 
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and AP-1 (Mukaida et al. 1994). In most cell types, activation of NF-κB is the most 
important step for IL-8 gene transcription (Mori et al. 1999). In unstimulated cells, NF-κB 
exists in an inactive form in the cytoplasm, bound to inhibitory proteins called IκBs. 
Stimulation by various inducers may activate a signaling cascade that culminates in the 
phosphorylation of IκBs, resulting in the degradation of IκB proteins (DiDonato et al. 1997) 
and the released NF-κB translocates to the nucleus to activate target genes. Numerous 
pathogens including Helicobactor pylori (Beswick et al. 2006), Escherichia coli (Dahan et 
al. 2002), and Bacteroides fragilis (Kim et al. 2002) have been shown to induce IL-8 
production from host cells via NF-κB activation. 
 
In this chapter, aim was to investigate if B. ratti WR1 is capable of inducing IL-8 
response from intestinal epithelial cells. Moreover, parasitic factors and molecular events 
responsible for this IL-8 induction were further investigated. It is demonstrated for the 
first time, that B. ratti WR1 cysteine proteases can activate IL-8 gene expression in 
human colonic epithelial cells. Furthermore, it is shown that NF-κB activation is involved 
in the production of IL-8. In addition, findings show that the antiprotozoal drug 
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6.2 MATERIALS AND METHODS 
 
6.2.1 Parasite culture and preparation of lysate 
 
 B. ratti WR1, an axenized zoonotic isolate was used in this study and cultured as 
described in previous chapters. In brief, parasites were cultured in pre-reduced Iscove’s 
Modified Dulbecco’s Medium (IMDM) supplemented with 10% inactivated horse serum 
(Gibco) and incubated anaerobically at 370C in an ANAEROJAR (Oxoid, UK). 4-5 days 
old parasites at log phase were washed 2 times in ice cold T84 cell complete medium at 
500 × g for 10 min at 40C. The pellet was resuspended in T84 cell medium supplemented 
with only 0.5% fetal bovine serum, parasites were counted with a hemocytometer and 
concentration was adjusted to 1×107 parasites/ml. Parasites were examined 
microscopically for their viability in this T84 cell medium and found to be viable for >48 
h in T84 growth conditions. Parasitic lysates were prepared by 3 freeze-thaw cycles in 
liquid nitrogen and 370C water bath respectively.  
 
6.2.2 Colonic cell culture, inoculation protocol and experimental planning 
 
T84 human colonic carcinoma epithelial cells were obtained from American Type 
Culture Collection. T84 cells are considered a good in vitro model to study IL-8 (Yu and 
Chadee 1997) and these cell lines have been widely used in other studies involving host 
cytokine responses (Yu and Chadee 1997; Zhou et al. 2004; Bandyopadhaya et al. 2007). 
T84 cell stock was maintained in T-75 flasks in a humidified 370C incubator with 5% CO2 
 142  
and passages 20-25 were used for all experiments. The complete growth medium consisted 
1:1 mixture of Dulbecco modified Eagle medium and Ham’s F-12 (DMEM/F-12) (Sigma) 
supplemented with 5 % heat inactivated fetal bovine serum (Gibco). Cell viability was 
analyzed by Trypan Blue assay and cell cultures with >95% viability were used for the 
experiments. Cells were trypsinized with 0.25% trypsin-EDTA (Gibco) and seeded in 6 
well plates (Costar) and grown to 75-80 % confluency for all experiments. In some assays, 
cells were grown to confluency on collagen (BD) coated 12 mm glass coverslips in 12 well 
tissue culture plates (Costar). As described previously, a concentration of 1×107 parasites or 
equal parasitic lysate per 1 ml medium was used for all experiments. Either live parasites or 
parasitic lysate were added to T84 cells grown in 6 well or 12 well plates and coincubated 
for indicated time points in humidified 370C incubator with 5% CO2. Culture medium was 
changed one day before experiments and fresh complete medium supplemented with only 
0.5 % heat inactivated fetal bovine serum was used during incubation with parasite or 
parasitic lysate. 
 
In protease inhibition experiments, parasitic lysates were preincubated for 1 hr in 
T84 complete medium containing one of the following inhibitors: EDTA, E-64, Pepstatin 
A (all 10µM); PMSF (1 µM), and iodoacetamide (50 µM). For antiprotozoal drug treatment, 
live parasites were pretreated in complete medium with 10 µg/ml metronidazole (Sigma) 
prior to experiments. In some experiments, for NF-κB inhibition, T84 cells were pretreated 
for 3 hr in complete medium containing 30 µM BAY11-7082 (Sigma). Cholera toxin (5 
µg/ml) was added in the medium in some experiments as a positive control for the 
production of IL-8. 
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In addition to T84 cells, just to study reproducibility in another cell line, human 
colon adenocarcinoma cells HT29 (ATCC) were used in NFκB nuclear translocation 
experiment. HT29 culture medium consisted of Dulbecco modified Eagle medium (DMEM, 
Sigma) and 10 % heat inactivated fetal bovine serum (Gibco). 
 
6.2.3 ELISA & real-time reverse transcription-polymerase chain reaction (RT-
PCR) for interleukin-8 
 
An IL-8 enzyme-linked immunosorbent assay (ELISA) kit (R & D) was used to 
measure IL-8 in the supernatants of T84 cell cultures co-incubated with B. ratti WR1 live 
parasite or parasitic lysates for various time points. For real-time PCR, total cellular RNA 
was extracted by single-step method using Trizol reagent (Invitrogen). First strand cDNA 
was synthesized with 1 µg RNA using SuperScript II RT (Invitrogen) following 
manufacturer’s instructions. The quantitative real-time PCR was performed with an 
Applied Biosystems 7500 instrument (Applied Biosystems) using SYBR Green PCR core 
reagents (Applied Biosystems). The reaction conditions were designed as follows: initial 
denaturation at 950 C for 10 min, followed by 40 cycles of 15 s at 950 C, 1 min at 600 C, 
and finally 15 s at 950 C, 1 min at 600 C and 15 s at 950 C. Relative quantitation of IL-8 
mRNA was calculated by ∆∆CT method and the amount of the target relative to the β-
actin mRNA was expressed as 2-(∆∆CT). The primers used were: IL-8 sense (5’ ATGACT 
TCCAAGCTGGCCGTGGCT 3’) and antisense (5’ TCTCAGCCCTCTTCAAAAAC 
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TTCTC 3’); β-actin sense (TGACGGGGTCACCCACACTGTGCCCATCTA 3’) and 
antisense (5’ CTAGAAGCATTGCGGTGGACGATGGAGGG  3’).  
 
6.2.4 Western blot for IκB-α 
 
T84 cells grown on 6 well plates were exposed to B. ratti WR1 live parasite and 
parasitic lysate for 6 h were first lysed in cell lysis buffer (50 mM Tris–HCl pH 8.0, 150 
mM EDTA, 1% Triton X-100, 0.5% SDS and protease inhibitor cocktail). Equal amounts 
of proteins were loaded on 10% polyacrylamide gel for SDS-PAGE in the Mini-
PROTEAN II system (Bio-Rad) and blotted onto nitrocellulose membrane (Amersham). 
After blocking with 5% nonfat milk in TBST (10 mM Tris–HCl, pH 7.5, 100 mM NaCl 
and 0.1% Tween-20), the membrane was probed first with rabbit anti-IκB-α antibody 
(Santa Cruz) and then with HRP-conjugated goat anti-rabbit secondary antibody (Santa 
Cruz). Rabbit anti-actin antibody (Sigma) was used as a loading control. Blots were 
developed on Hyperfilm ECL (Amersham) using chemi-luminescent ECL Plus Detection 
Reagent (Amersham). Density of bands was quantified by a gel documentation and 
analysis system (Gel Doc XR, Bio-Rad). 
 
6.2.5 EMSA and measurement of NF-κB activation by ELISA 
 
Nuclear extracts were prepared using a NE-PER nuclear and cytoplasmic 
extraction reagent kit (Pierce) and electrophoretic mobility shift assay was performed 
according to manufacturer’s protocol using LightShift chemiluminescent EMSA kit 
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(Pierce). Target DNA sequences were used as described previously (Sun et al. 2006). 
Oligonucleotide duplexes containing either wild-type NF-κB binding site (sense strand, 
5’ GATCCGTGGAATTTCCTCTG 3’) present in the IL-8 promoter or a mutant NF-κB 
binding site (sense strand, 5’ GATCCGTTAACTTTCCTCTG 3’) were biotinylated at 3’ 
end (synthesized by 1st Base, Singapore).  
 
In a separate experiment, the NF-κB activity was measured with a commercial 
ELISA kit (TransAM NF-κB p65 Assay Kit; Active Motif) as described by manufacturer. 
In brief, this assay uses a 96 well plate coated with an oligonucleotide containing the NF-
κB consensus binding site (5’-GGGACTTTCC-3’). The active form of NF-κB in the 
nuclear extracts binds to the consensus site and detected by a primary antibody specific 
for the activated p65 of NF-κB. A HRP-conjugated secondary antibody is then used for 
the colorimetric quatification by spectrophotometry at 450nm.  Results are expressed as 
fold increase over the control group. 
 
6.2.6 Immunostaining for NFκB nuclear translocation 
 
T84 cells grown on collagen coated glass coverslips were exposed to B. ratti WR1 
parasitic lysate for 6 h and fixed in 2 % paraformaldehyde for 30 min. All procedures 
were carried out at room temperature. Monolayers were permeabilized with 0.25 % 
Triton-X 100 for 15 minutes and washed 3 times with PBS (1 minute each). Monolayers 
were blocked with blocking solution (Protein Block, DAKO) for 10 minutes and solution 
was decanted. Monolayers were incubated for 1 h with 1:100 dilutions of rabbit anti-NF-
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κB p50 antibody (Santa Cruz) diluted in 0.2 % bovine serum albumin and were 
subsequently washed 3 times with PBS (5 minutes each). Cells were incubated for 30 
minutes in the dark with 1:200 dilutions of a Cy3-conjugated sheep anti-rabbit secondary 
antibody (Sigma) diluted in 0.2 % bovine serum albumin. Monolayers were washed 4 
times with PBS (5 minutes each) and mounted with mounting medium (Vectashield) with 
4’, 6-diamidino-2-phenylindole (DAPI) to counterstain the nucleus. Monolayers were 
visualized by fluorescent microscopy (Olympus) and images were captured using the 
Image Pro software. 
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6.3 RESULTS 
 
6.3.1 Cysteine proteases of B. ratti WR1 induce IL-8 production 
 
To assay for IL-8 protein in culture supernatants, T84 cells were incubated with B. 
ratti WR1 live cells or lysates for various time points. As shown in Fig. 6.1, significant 
production of IL-8 protein occurred 12, 24 and 48 h after stimulation with B. ratti WR1 
live parasite (166 ± 22, 482 ± 58, and 620 ± 60 pg/ml respectively; P < 0.05) and with 
parasitic lysates  (260 ± 25, 654 ± 64, and 802 ± 87 pg/ml respectively). B. ratti WR1 
induced-increase in IL-8 was significantly inhibited with the use of protease inhibitor 
cocktail for 12, 24, and 48 hrs (149 ± 16, 395 ± 27, 492 ± 34 pg/ml respectively; P < 0.05 
in comparison to lysate). These observations suggest that B. ratti WR1 proteases are 
involved in the induction of IL-8 from T84 cells. Pretreatment of live B. ratti WR1 
parasites with the antiprotozoal drug metronidazole significantly retarded the ability of 
parasites to induce increase in IL-8 production at 12, 24, and 48 h (111 ± 8, 289 ± 26, 429 
± 15 pg/ml respectively; P < 0.05). 
 
To study the type of particular protease involved, different protease inhibitors 
were used and it was found that cysteine protease inhibitors iodoacetamide (243 ± 9; P = 
0.002), and E-64 (265 ± 23 pg/ml; P = 0.007) significantly inhibited IL-8 increase 
induced by parasitic lysates at 24 h (Fig. 6.2). A less significant reduction in IL-8 
production is also seen with aspartic protease inhibitor pepstatin A (426 ± 57; P = 0.048). 
Insignificant inhibition is noticed with serine and metallo protease inhibitors, PMSF and 
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EDTA respectively. These findings suggest that B. ratti WR1 cysteine proteases are 
mainly responsible for the induction of increased IL-8 from T84 cells and aspartic 
proteases also contribute to some extent to IL-8 production. 
 
6.3.2 B. ratti WR1 cysteine proteases increase IL-8 mRNA levels in human colonic 
cells 
 
To determine whether B. ratti WR1 or its cysteine proteases can increase IL-8 
mRNA expression, T84 cells were co-cultured with B. ratti WR1 live parasite or lysate 
for 12 h. Total RNA extracted from the cells was used for real-time reverse-transcriptase 
(RT)-PCR and β-actin was used as a housekeeping gene. As shown in Fig. 6.3, there was 
a marked increase in the expression of IL-8 mRNA in T84 cells after co-incubation with 
B. ratti WR1 lysate (~4 fold) and live parasite (~3 fold). WR1 lysate induced IL-8 mRNA 
expression levels were significantly inhibited when a cysteine protease inhibitor 
iodoacetamide was used (~1.4 fold). To find out if the NF-κB pathway is activated upon 
exposure to B. ratti WR1, T84 cells were pretreated with a NF-κB inhibitor BAY11-7082 
and co-incubated with parasitic lysate. BAY11-7082 markedly decreased B. ratti WR1-
induced increase in mRNA levels (~1.7 fold). Altogether, these findings indicated that B. 
ratti WR1 cysteine proteases are capable of increasing IL-8 mRNA in human colonic 
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6.3.3 B. ratti WR1 degrades IκB-α and activates NF-Κb 
 
One of the key pathways for NF-κB activation involves the phosphorylation of 
IκBs, which is followed by degradation of IκBs and subsequent translocation of NF-κB 
dimers from the cytoplasm to the nucleus. Hence, kinetics of IκB-α degradation were 
examined by western blot analysis in T84 cells co-cultured with B. ratti WR1 live 
parasite or lysate for 5 h. As shown in Fig. 6.4, cells incubated with parasitic lysate and 
live parasite show significant degradation of IκB-α (74.7% and 55.8% degradation 
respectively). Use of cysteine protease inhibitor iodoacetamide decreased the B. ratti 
WR1 lysate induced degradation of IκB-α (43.5%). Similarly, pretreatment of T84 cells 
with NF-κB inhibitor BAY11-7082 also decreased the B. ratti WR1 lysate induced-
degradation of IκB-α (34.7 %). 
 
To determine NF-κB binding activity with the IL-8 promoter, oligonucleotide 
duplexes containing wild-type NF-κB binding site present in the IL-8 promoter were used 
in EMSA. Stimulation of T84 cells with B. ratti WR1 lysate for 6 h caused NF-κB/DNA 
binding activity in nuclear extracts of T84 cells (Fig. 6.5). EMSA with a mutant NF-κB 
oligo-duplex did not show any NF-κB/DNA binding. A decreased NF-κB/DNA binding 
activity was noticed when T84 cells were pretreated with NF-κB inhibitor BAY11-7082. 
To measure the NF-κB p65 activity, nuclear extracts were subjected to a specific ELISA. 
As shown in Fig. 6.6, coincubation of T84 cells with B. ratti WR1 lysate caused a 
significant increase in NF-κB p65 activity (P < 0.05). Pretreatment of T84 cells with NF-
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κB inhibitor BAY11-7082 significantly inhibited the B. ratti WR1 lysate induced 
increase in NF-κB p65 activity. 
 
6.3.4 Nuclear translocation of NF-κB 
 
The most commonly found form of NF-κB is a hetero-dimer composed of the p50 
and p65 subunits. In unstimulated cells, NF-κB resides in the cytosol in the inactive form 
bound to inhibitory IκB proteins. Various stimuli initiate a series of signaling events that 
culminate in the phosphorylation and degradation of IκBs. Activated free NF-κB 
translocates to the nucleus and stimulates transcription by binding to correlated κB sites 
in the promoter regions of various target genes. To visualize the nuclear translocation of 
NF-κB, immnohistochemistry was performed on T84 cell monolayers stimulated for 6 h 
with B. ratti WR1 lysates (Fig. 6.7). Monolayers were probed with rabbit anti-NF-κB p50 
antibody and a Cy3-conjugated sheep anti-rabbit secondary antibody was used for 
visualization. Nuclei were counterstained with DAPI to determine the cellular 
localizationof p50. T84 cells exposed to B. ratti WR1 lysate show nuclear translocation 
of p50 subunit (Fig. 6.7, image C). Control cells showed a normal cytosolic localization 
of p50 (Fig. 6.7, image F). A significant increase in the percentage of cells showing 
nuclear translocation of NF-κB p50 was observed after exposure to B. ratti WR1 lysate 
(P < 0.05) (Histogram, Fig. 6.7). 
 
 In addition to the T84 cells, it was investigated if Blastocystis can induce 
NF-κB activity in HT29 (human colon adenocarcinoma) cells. Fig. 6.8 shows the nuclear 
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translocation of NF-κB p50 in HT29. A significant increase in the percentage of cells 
showing nuclear translocation of NF-κB p50 was observed after exposure to B. ratti WR1 
lysate (P < 0.05 versus control) (Histogram, Fig. 6.8). 




























Fig. 6.1 Induction of IL-8 production in human intestinal epithelial T84 cells by 
Blastocystis ratti WR1. Cells were grown to confluency in 12 well tissue culture plates. 
T84 cells were co-incubated with Blastocystis ratti WR1 for 12, 24, and 48 h. The IL-8 
concentration in supernatants was measured by ELISA. WR1 live parasite and lysate 
induce significant increase in IL-8 production in a time-dependent manner (* P < 0.05 
versus negative control for each time point). Use of protease inhibitor cocktail reduced 
the WR1 lysate-induced IL-8 production significantly (** P < 0.05 versus WR1 lysate). 
Pretreatment of live parasites with antiprotozoal drug metronidazole significantly reduced 
the IL-8 production induced by WR1 live parasite (# P < 0.05 versus live WR1 parasite). 
Treatment of cells with only protease inhibitor cocktail did not show any significant 
effect on baseline production of IL-8. To know if experiment is working, purified cholera 






































Fig. 6.2 Effect of protease inhibitors on IL-8 production from T84 cells induced by 
Blastocystis ratti WR1. Cells were grown to confluency in 12 well tissue culture plates. 
T84 cells were co-incubated for 24 h with WR1 lysate pretreated with one of various 
protease inhibitors. The IL-8 concentration in supernatants was measured by ELISA. 
Cysteine protease inhibitors, iodoacetamide and E-64, most significantly reduce the WR1 
induced IL-8 production from T84 cells (* P = 0.002, ** P = 0.007; both versus WR1 
lysate). Considerable reduction in IL-8 production is seen with aspartic inhibitor pepstatin 
A (## P = 0.04 versus WR1 lysate). Minimal inhibition is observed with serine and 
metallo protease inhibitors, PMSF and EDTA respectively. Values are means ± SD (n = 


































Fig. 6.3 Blastocystis ratti WR1 induces up-regulation of IL-8 mRNA levels in T84 
cells. T84 cells were co-incubated with WR1 live parasite or parasitic lysate for 12 h.  
Total cellular RNA was isolated and IL-8 and β-actin mRNA levels were measured by 
quantitative real-time RT-PCR as described in ‘Materials and Methods’. WR1 lysate 
causes significant increase in IL-8 mRNA levels. Significant decrease in IL-8 mRNA 
levels is noticed after treatment with NF-κB inhibitor BAY11-7082 and cysteine protease 
inhibitor iodoacetamide. The fold increase in IL-8 mRNA relative to untreated T84 cells 
was calculated for each experiment based on internal β-actin controls. Values are means 






































Fig. 6.4 Blastocystis ratti WR1 exposure to intestinal epithelial cells causes IκB-α 
degradation.  WR1 live parasite or lysate co-incubation with T84 cells resulted in IκB-α 
degradation at 5 h shown in a representative result with a β-actin loading conrol. The cell 
lysates were analyzed by Western blot using an anti-IκB-α antibody. Pretreatment of cells 
with NF-κB inhibitor BAY11-7082 resulted in decreased IκB-α degradation. 
Iodoacetamide, a cysteine protease inhibitor, decreased WR1 lysate-induced degradation 
of IκB-α. Histogram represents densitometry values expressed as arbitary units 


































Fig. 6.5 Representative electrophoretic mobility shift assay (EMSA) shows NF-
κB/IL-8 promoter binding activity in nuclear extracts. Cells were grown to 
confluency in 12 well tissue culture plates. Nuclear extracts were prepared using a NE-
PER nuclear and cytoplasmic extraction reagent kit and electrophoretic mobility shift 
assay was performed using LightShift chemiluminescent EMSA kit. T84 cells co-
incubated with WR1 lysate for 6 h. No NF-κB/DNA binding is observed in mutant NF-
κB oligo-duplex incubated with nuclear extract, wild-type NF-κB oligo duplex without 
nuclear extract, and control. Pretreatment of T84 cells with NF-κB inhibitor BAY11-





































Fig. 6.6 Histogram showing fold increase in NF-κB activity in nuclear extracts of 
T84 cells. Cells were grown to confluency in 12 well tissue culture plates. Cells were co-
incubated with WR1 lysate for 6 h and NF-κB activity in the nuclear extracts was 
measured by specific ELISA. Exposure to parasitic lysates significantly increased the 
NF-κB activity in T84 cells. Pretreatment of cells with NF-κB inhibitor BAY11-7082 
resulted in decreased NF-κB activity. Values are means ± SD (n = 3). * P < 0.05 versus 



































Fig. 6.7 Representative micrographs showing nuclear translocation of NF-κB in 
intestinal epithelial T84 cells following exposure to Blastocystis ratti WR1. T84 cell 
monolayers were grown on collagen coated glass coverslips and co-incubated with WR1 
lysate for 6h. Monolayers were fixed and first incubated with rabbit anti-NF-κB p50 
antibody and then with Cy3 conjugated sheep anti-rabbit secondary antibody. 
Monolayers were mounted using mounting medium containing DAPI to counterstain 
nucleus and visualized by fluorescent microscopy. T84 cells exposed to WR1 lysate show 
nuclear translocation of the p50 subunit (A-C). Control cells exhibit normal perinuclear 
localization of p50 (D-F). All micrographs were obtained at a magnification of ×400. 
(Arrow: p50 localization; arrowhead: nucleus). From the histogram, a significant increase 
in the percentage of cells showing nuclear translocation of NF-κB p50 can be noticed in 
cells exposed to WR1 lysate. The percentage of cells with NF-κB p50 nuclear 
translocation was calculated from observation of 200 cells in three independent 






































































































Fig. 6.8  Representative micrographs showing nuclear translocation of NF-κB in 
intestinal epithelial HT29 cells following exposure to Blastocystis ratti WR1. HT29 
monolayers were grown on collagen coated glass coverslips and co-incubated with 
parasitic lysate for 6h. Monolayers were fixed and first incubated with rabbit anti-NF-κB 
p50 antibody and then with Cy3 conjugated sheep anti-rabbit secondary antibody. 
Monolayers were mounted using mounting medium containing DAPI to counterstain 
nucleus and visualized by fluorescent microscopy. HT29 cells exposed to WR1 lysate 
show nuclear translocation of the p50 subunit (A-C). Control cells exhibit normal 
perinuclear localization of p50 (D-F). All micrographs were obtained at a magnification 
of ×400. (Arrow: p50 localization; arrowhead: nucleus). Histogram shows a significant 
increase in the percentage of cells showing nuclear translocation of NF-κB p50 in cells 
exposed to WR1 lysate. The percentage of cells with NF-κB p50 nuclear translocation 
was calculated from observation of 200 cells in three independent experiments. Values 
are means ± SD. * P < 0.05 versus control. 

































































In previous chapters, the protease activity of B. ratti WR1 and B. hominis B was 
reported; and it was also shown that B. hominis B and B. ratti WR1 proteases can degrade 
human secretory immunoglobulin A. It was also demonstrated that B. ratti WR1 induces 
contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in 
IEC-6 cells. These studies suggested that B. ratti WR1 secretory products exert 
detrimental effects on host cells and warrant further investigations. Phylogenetic data 
suggest that Blastocystis is a zoonotic parasite and animal to human transmissions are 
common (Yoshikawa et al. 2004a; Noel et al. 2005). Intestinal inflammation and edema 
was reported in patients infected with Blastocystis (Kain et al. 1987; Russo et al. 1988; 
Garavelli et al. 1992; Zuckerman et al. 1994). In a murine model, intense infiltration of 
inflammatory cells in colon and inflammation with edematous lamina propria in the 
cecum and colon was reported following Blastocystis infection (Moe et al. 1997). One in 
vitro study showed that Blastocystis may modulate IL-8 response in intestinal epithelial 
cells (Long et al. 2001). Taken together, these observations suggest that Blastocystis-
induced intestinal inflammation is mediated by IL-8 recruitment of inflammatory cells 
and some secretory parasitic factors are responsible for this. 
 
It has been reported that E. histolytica cysteine proteases are involved in the 
production of IL-8 from intestinal epithelial cells and these proteases also induce gut 
inflammation (Zhang et al. 2000). Results demonstrate that B. ratti WR1 induces IL-8 
production from colonic epithelial T84 cells in a time-dependent manner. Use of protease 
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inhibitors showed that cysteine proteases of B. ratti WR1 were mainly responsible for the 
induction of IL-8 production. Moreover, increased cytokine production was paralleled by 
increase gene transcription. Numerous pathogenic gastrointestinal pathogens like E. 
histolytica (Eckmann et al. 1995), C. parvum (Seydel et al. 1998), Salmonella, E. coli 
(Eckmann et al. 1993), and Vibrio cholerae (Rodriguez et al. 2001) are known to induce 
IL-8 production from the intestinal epithelium. Intestinal epithelial cell production of IL-
8 causes influx of inflammatory cells into the intestinal mucosa with resultant tissue 
damage and gastrointestinal disturbances. It was reported that invasion of intestinal 
epithelium by pathogens is not necessary for the induction of inflammation (Berkes et al. 
2003) and since Blastocystis is non-invasive parasite, secreted products from the parasite 
might initiate the inflammatory process by activating cell surface receptors. Although, E. 
histolytica is an invasive protozoan, it can also induce IL-8 secretion from human colonic 
epithelial cells without parasite-enterocyte contact (Yu and Chadee 1997). Zhang et al. 
(2000) showed that the expression of cysteine proteinases by E. histolytica is crucial to 
cause intestinal inflammation and tissue damage in amoebic colitis. In a human intestinal 
xenograft model, they demonstrated that E. histolytica trophozoites deficient in cysteine 
proteinase production failed to induce IL-1B, IL-8 and subsequent gut inflammation. 
They showed that amoebic cysteine proteinases have IL-1 converting enzyme (ICE) 
activity which might stimulate the production of IL-8 in adjacent intestinal cells through 
induction of NF-kB and cause intestinal inflammation. Similarly, Blastocystis proteases, 
in a contact-independent manner, may initiate IL-8 mediated inflammatory processes that 
ultimately lead to gastrointestinal symptoms.  
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It was observed that metronidazole treatment of B. ratti WR1 live parasites 
markedly reduced the induction of IL-8 production from T84 cells. Metronidazole 
induces programmed cell death in Blastocystis and plasma membrane integrity of parasite 
remains preserved (Nasirudeen et al. 2004), therefore there is no leakage of intracellular 
parasitic proteases and other products that can induce high IL-8 response. As 
metronidazole inhibits nucleic acid synthesis in parasite, it will in turn inhibit the 
parasites ability to produce proteases. However, a pronounced IL-8 response was 
observed when T84 cells were exposed to parasitic lysates as it contains all parasitic 
soluble and non-soluble products. It was previously shown in chapter 5 that 
metronidazole can avert the adverse effects of B. ratti WR1 on intestinal epithelial barrier 
function. Altogether, these findings suggest the therapeutic potential of metronidazole in 
Blastocystis infections. 
 
This study investigated the molecular mechanisms by which IL-8 gene expression 
is regulated in colonic epithelial cells after exposure to B. ratti WR1. Firstly, it is 
demonstrated that B. ratti WR1 can degrade IκB-α and the use of a cysteine protease 
inhibitor markedly inhibited the degradation of IκB-α suggesting the involvement of a 
parasite-derived cysteine protease. Secondly, results from EMSA demonstrated that NF-
κB is involved in the induction of IL-8 promoter activity in colonic epithelial cells. NF-
κB plays a pivotal role in intestinal inflammation and both invasive and non-invasive 
enteric pathogens can trigger the inflammatory cascade through activation of NF-κB 
(Berkes et al. 2003). In most cells, including intestinal epithelial cells, activation of NF-
κB is critical for inducible expression of the proinflammatory response genes. NF-κB-
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mediated induction of IL-8 has been reported in numerous enteric pathogens like H. 
pylori (Beswick et al. 2006), E. coli (Dahan et al. 2002), and B. fragilis (Kim et al. 2002). 
Protozoan parasites like E. histolytica (Zhang et al. 2000) and C. parvum (Chen et al. 
2001) are also capable of activating NF-κB in host cells. Results from 
immunohistochemistry also support these findings and show nuclear translocation of NF-
κB. The finding that B. ratti WR1 has the ability to activate NF-κB has important 
implications since other NF-κB responsive genes like IL-1 and IL-6 may also be affected 
in Blastocystis infections, which may lead to altered intestinal homeostasis.  
 
In summary, present study demonstrates for the first time that B. ratti WR1 
cysteine proteases induce IL-8 production in colonic epithelial T84 cells and an NF-κB-
dependent transcriptional process is involved. In addition, findings show that 
metronidazole treatment can markedly inhibit the ability of B. ratti WR1 to induce IL-8 
production. These findings will contribute to an understanding of the pathobiology of a 















































 165  
7.1 GENERAL DISCUSSION 
 
Blastocystis infections have a worldwide distribution and incidences of up to 60 % 
have been reported in tropical, subtropical and developing countries. The clinical 
symptoms of Blastocystis infections are mainly diarrhea and abdominal pain as well as 
nonspecific gastrointestinal symptoms particularly nausea, vomiting, bloating and anorexia 
(Doyle et al. 1990; Nimri and Batchoun 1994, Sohail et al. 2005). Intriguingly, even though 
it was first described almost a century ago (Alexeieff 1911; Brumpt 1912), the pathogenic 
mechanisms of this enteric protozoan still remain elusive. In recent years, many reports 
have shown that Blastocystis is associated with intestinal disorders (Barahona-Rondon et al 
2003; Leelayoova et al. 2004; El-Shazly et al. 2005). Patients with HIV infections and 
immunosuppressive therapy were reported to be more susceptible to Blastocystis-associated 
diarrhea (Florez et al. 2003; Rao et al. 2003; Hailemariam et al. 2004). Similar to giardiasis, 
most of the people infected with Blastocystis are asymptomatic and infection frequently 
resolves spontaneously (Stenzel and Boreham 1996). 
 
So far, many epidemiological and clinical case reports have implicated 
Blastocystis as a cause of disease but only a small number of controlled experimental 
studies have been carried out to investigate its pathogenicity. Although lack of a suitable 
animal model remained a major impediment, there is scarcity of in vitro studies that have 
addressed this issue. In this study, using in vitro model systems, various aspects of 
Blastocystis pathogenicity were investigated. Different intestinal cell lines and zoonotic 
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isolates of Blastocystis were employed; and results from this study consistently suggested 
that this parasite has pathogenic potential.   
 
Parasite-derived proteases are important to the parasite life cycle and the 
pathogenesis of disease they produce. Proteases of Blastocystis were studied and it was 
demonstrated for the first time that Blastocystis ratti WR1 and Blastocystis hominis B 
possess high levels of protease activity, in particular of the cysteine protease. Protease 
activity has been well documented in many parasitic protozoa and a number of roles were 
assigned for protease function in host-parasite relationships (North 1982). Some of the 
roles of parasite proteases include immune evasion or modulation by degradation of host 
immune molecules, invasion of the host facilitated by catalyzing degradation of 
connective tissues, and metabolism within the host by taking advantage of specific host 
proteins.  
 
Cysteine proteases from E. histolytica were reported to degrade extracellular 
matrix proteins (Keene et al. 1986; Zhang et al. 2000) and their expression is necessary 
for intestinal inflammation and tissue damage in amoebic colitis. It would be interesting 
to investigate if Blastocystis proteases similarly degrade extracellular matrix proteins. 
The function of proteases in such infections is suggested to be hydrolysis of proteins of 
connective tissue in particular collagens and keratins, which then increases the 
invasiveness of organism. Intestinal permeability was found to be significantly increased 
in B. hominis patients and it was suggested that Blastocystis infections can cause damage 
to the intestinal wall (Dagci et al. 2002). Further studies on Blastocystis should include 
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the role of proteases in intestinal tissue damage. Additionally, characterization of 
Blastocystis proteases will lead to a better understanding of the parasite life cycle and its 
interactions with host. Parasite cysteine proteases are immunogenic and have been 
exploited as vaccine targets and diagnostic markers in serology. Because of the complex 
diversity of Blastocystis genotypes, proteases may be a good choice as diagnostic 
markers. Parasitic proteases are suggested to be promising targets for the development of 
new anti-parasitic chemotherapy (Sajid et al. 2002). It has also been shown that cysteine 
protease inhibitors are effective against numerous protozoan parasites (North 1994).  
 
There has been controversy over the role of the Blastocystis central vacuole. It 
was shown for the first time that central vacuole of Blastocystis contains cysteine 
proteases and this finding will certainly help to further elucidate the functional 
importance of Blastocystis organelles with respect to their localizations. As the central 
vacuole is quite a large organelle, there is a need to further investigate if it functions only 
as storage organelle or it also plays an important role in the synthesis of proteases. 
 
 It was further investigated if Blastocystis proteases can degrade secretory 
immunoglobulin A (S-IgA). Pathogen-produced immunoglobulin A (IgA) proteases 
cleave human secretory IgA which compromises IgA function. Directly, this may help 
the pathogen in mucosal adhesion or this might indirectly help other pathogens in 
adhesion and invasion. To study if the enteric protozoan Blastocystis degrades human 
secretory IgA, parasitic lysate and conditioned medium were exposed to secretory 
immunoglobulin A. Secretory IgA was degraded by both cell lysate and conditioned 
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medium with mainly cysteine proteinase activity in B. hominis B isolate and aspartic 
proteinase activity in B. ratii WR1 isolate. These findings suggest that, by degrading S-
IgA, Blastocystis proteases may play a role in parasite survival in vivo as S-IgA prevents 
the pathogens from colonizing in gut.  
 
 
Many infections with G. intestinalis, E. histolytica and other protozoans are 
subclinical but these may exhibit clinical symptoms if a particular isolate or sympathetic 
host immune milieu is involved. Blastocystis was found to be associated with clinical 
symptoms in many cases of HIV infection (Garavelli et al. 1990; Cirioni et al. 1999). The 
high prevalence of Blastocystis in AIDS patients may be attributable to the defective 
immune response (Rodgers and Kagnoff 1988) which leads to lower secretory IgA 
concentrations in mucosal secretions (Challacombe and Sweet 1997) of these patients and 
possibly provides a conducive environment for parasitic colonization. Numerous studies 
have demonstrated strong correlations between titers of specific SIgA in secretions and 
resistance to infections (Russel et al. 1999).  
   
Finding that Blastocystis degrades secretory immunoglobulin A has another 
significant implication in the use of specific pathogen free (SPF) laboratory animals. At 
present, SPF laboratory animals are not screened for the Blastocystis infections by animal 
suppliers (Charles River Laboratories). Up to 60 % SPF rats were found infected with 
Blastocystis in well maintained animal facilities (Chen et al. 1997). In Blastocystis 
infected SPF laboratory animals, degradation of secretory immunoglobulin A can 
interfere with other experimental gastrointestinal infection studies. This interference 
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could be in the form of a changed intestinal milieu due to reduced secretory 
immunoglobulin A levels in gut. Furthermore, Blastocystis proteases may modulate 
intestinal homeostasis and may directly affect the pathogen of study, ultimately 
generating misleading results. 
 
One of the most important functions of intestinal epithelium is to provide a barrier 
between the intestinal lumen and the underlying compartments. The host intestine houses 
a wide variety of microorganisms and a single layer of epithelial cells that lines the 
intestinal mucosa is the first site of interaction with pathogens. These epithelial cells 
work as a first line of defense against pathogens and elicit a variety of protection 
strategies through widespread communication with the innate and adaptive immune 
components. Any breach or insult of the epithelial integrity may expose underlying 
tissues to an array of antigens and might lead to a pathological host response. In this work, 
in vitro interactions of Blastocystis with the intestinal epithelium were studied and it was 
found that it induces apoptosis of intestinal epithelial cells, and disrupts the epithelial 
barrier function possibly by causing filamentous-actin rearrangements and ZO-1 
disruption. Enteric pathogens are known to adopt several strategies to disrupt the tight 
junctions of intestinal epithelial cells. They can either alter the cytoskeleton of cell or 
they can affect particular tight junction proteins. Tight junctions can be regulated via the 
cytoskeleton indirectly through changes in the perijunctional actomyosin ring or directly 
through changes in specific tight junction proteins (Berkes et al. 2003). These changes 
may lead to disturbances in epithelial functions particularly changes in paracellular 
permeability. The function of tight junctions can be studied as a change in transepithelial 
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electrical resistance or in the paracellular flux of macromolecules. Bacteroides fragilis is 
known to cause diarrhea and it can disrupt tight junctions by proteolytic degradation of 
tight junction proteins resulting in decrease in transepithelial electrical resistance and 
increase in permeability (Berkes et al. 2003). This study has shown that Blastocystis can 
displace ZO-1 proteins from tight junctions. Further investigations are needed to see if 
Blastocystis proteases can directly degrade ZO-1 or other tight junction proteins. 
 
It was found that Blastocystis can decrease transepithelial resistance and increase 
permeability of intestinal epithelial monolayer. This study supports the finding from other 
clinical reports where significantly increased intestinal permeability was reported after 
Blastocystis infections (Dagci et al. 2002). Some of these cytopathic effects are comparable 
to that of other pathogenic protozoans like G. lamblia and warrant further elucidation.  
 
Importantly, this study has shown that Blastocystis secretory products can induce 
apoptosis in intestinal epithelial cells. This suggest that contact with host cells is not 
required for Blastocystis to cause any cytopathic effects and being a non-invasive organism, 
this finding has significant implications for its pathogenicity. However, the role of 
pathogen-induced apoptosis in gut epithelial cells is not well understood. It’s not clear 
whether the host or pathogen benefits by this phenomenon. Pathogen-induced apoptosis 
can be significant in maintaining homeostasis by controlling inflammation and 
immunological silent removal of cells. At the same time, this response can benefit some 
extracellular pathogens but some pathogens may lose their colonization sites. It appears 
that only extensive dysregulated apoptosis may lead to pathology due to cytokine or Fas-
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FasL overexpression as in Shigella and Salmonella infections where apoptosis becomes 
pro-inflammatory and damage of host cells occurs. 
 
 
When exposed to certain toxins, the intestinal epithelium can be induced to 
undergo cell death via apoptosis or necrosis, which can in turn affect intestinal barrier 
function, resulting in decreased transepithelial permeability and increased permeability 
(Bojarski et al. 2000). In experiments, it was tested if Blastocystis induced apoptosis of 
IEC-6 cells has an effect on epithelial permeability by pretreating cell monolayers with 
general caspase inhibitor Z-VAD-fmk before coincubation with parasites. Results show 
that the inhibition of caspases in IEC-6 cells did not prevent reduction of TER and did not 
significantly decrease Lucifer yellow flux across cell monolayer. Therefore, in the case of 
Blastocystis infection, it appears that activation of host cell apoptosis in a contact-
independent manner does not play a major role in increasing epithelial permeability but 
there might be other factors responsible for increased permeability. In contrast, studies on 
G. lamblia have established that while Giardia is a non-invasive pathogen, it releases 
parasitic factors which may induce enterocyte apoptosis and increase epithelial 
permeability (Chin et al. 2002).  The apparent discrepancy in observation may be due to 
two factors. Firstly, the contribution of apoptosis to increased permeability may be minor 
because of the low percentage of apoptotic cells, evidenced by DAPI staining, as 
compared to cells with F-actin rearrangement. Secondly, Blastocystis may have induced 
non-apoptotic cell death, for example necrosis, autophagy or paraptosis (Broker et al. 
2005) that may have contributed to the impaired barrier function. 
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Gastrointestinal symptoms along with inflammation of gastrointestinal tract were 
associated with Blastocystis infections. However it was not clear how Blastocystis 
triggers the inflammatory response. Results show for the first time that Blastocystis 
cysteine proteases induce IL-8 production in colonic epithelial cells and an NF-κB-
dependent transcriptional process is involved. Production of IL-8 causes influx of 
inflammatory cells into the intestinal mucosa which causes tissue damage and 
gastrointestinal disturbances. E. histolytica cysteine proteases can induce the production 
of IL-8 from intestinal epithelial cells and these proteases also induce gut inflammation 
(Zhang et al. 2000). Protozoan parasites like E. histolytica (Eckmann et al. 1995) and C. 
parvum (Seydel et al. 1998) are capable of inducing IL-8 production from intestinal 
epithelial cells. E. histolytica can induce IL-8 from intestinal cells in a contact-
independent manner and it was reported that invasion of intestinal epithelium by 
pathogens is not necessary for the induction of inflammation (Berkes et al. 2003). As 
Blastocystis is non-invasive parasite, secreted products from parasite appears to initiate 
the inflammatory process by activating cell surface receptors. It would be interesting to 
investigate if proteinase activated receptors (PARs) of intestinal epithelial cells play a 
role in B. ratti WR1 cysteine protease-mediated induction of IL-8. PARs are seven 
transmembrane domain receptors that are activated by specific proteolytic cleavage of 
their N terminal extracellular domain (Vergnolle et al. 2005).  It is known that IL-1 may 
act as an intermediary factor for the induction of IL-8 secretion. Since T84 cells were 
used and they lack type-1 IL-1 receptors and IL-1β does not have significant role in T84 
cells (Yu and Chadee 1997), more studies need to be performed to ascertain if 
Blastocystis-induced IL-8 secretion involves IL-1. 
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Results show that treatment of Blastocystis with metronidazole can avert the 
adverse effects of Blastocystis on intestinal epithelial barrier function. Metronidazole 
treatment also resulted in reduced interleukin-8 activity from intestinal epithelial cells. 
This is controversial if there is a need to treat Blastocystis infections because of its 
doubtful pathogenicity. Treatment for Blastocystis infections is not yet standardized in 
clinics. Previous studies have shown that metronidazole inhibits the in vitro growth of 
Blastocystis (Moghaddam et al. 2005). Reports show that metronidazole is a drug of 
choice in cases where Blastocystis is suspected for gastrointestinal symptoms (Tan 2004). 
Taken together, this suggests that metronidazole has a therapeutic potential for 
Blastocystis infections and treatment with anitprotozoal drugs, in particular 
metronidazole, is warranted if no other cause of disease is observable. 
 
Accumulating evidence over the last decade suggests association of Blastocystis 
with gastrointestinal disorders (Sohail et al. 2005). Mostly inconclusive clinical and 
epidemiological studies implicated or exonerated Blastocystis as an etiology of disease. 
Unlike most other enteric pathogens, Blastocystis is essentially considered non-invasive 
and does not cause any consistent inflammatory response. However, it was observed that 
Blastocystis infections may cause gastrointestinal symptoms similar to irritable bowel 
syndrome (IBS) involving diarrhea, abdominal pain, constipation, nausea and fatigue 
(Tungtrongchitr et al. 2004; Boorom 2007). Approximately 4 billion diarrhea episodes 
occur worldwide each year which account for 4% of all deaths and 5% of days lost to 
disability (Sazawal et al. 2006). The pathophysiological basis of diarrhea in Blastocystis 
 174  
infections can be multifactorial and may involve at least in part intestinal epithelial 
damage, compromised barrier function, as well as induction proinflammatory cytokine 
production. In figure 7.1, a model is proposed for the pathogenic potential of Blastocystis 
that shows a relationship between in vitro experimental findings of this study and their 
patho-physiological correlation to gastrointestinal symptoms. 
 
Although discovered almost a century ago, scientific knowledge on this parasite has 
increased significantly only in last few years. It is now known that humans can be 
infected by numerous Blastocystis genotypes and many of these genotypes can be 
zoonotic. All mammalian and avian isolates are now classified in nine subtypes 
(Stensvold et al. 2007b). Previously conflicting observations on Blastocystis pathogenesis 
are possibly due to the existence of pathogenic and non-pathogenic genotypes. 
Laboratory rats appear to be reasonably good animal models for infection studies and 
fecal-oral route has been established as the mode of transmission. There is a need to 
further identify and characterize Blastocystis virulence factors and associated genes. Most 
importantly, major efforts should be directed to elucidate the subtype linked differences 
in pathogenesis of this interesting parasite. 
 





























Fig 7.1 Proposed model for the pathogenic potential of Blastocystis. This model 
correlates in vitro findings from this study and their patho-physiological relevance 
to gastrointestinal symptoms. Results from this study show that Blastocystis 
secretes protease that can degrade S-IgA that may facilitate colonization of 
Blastocystis or may assist other pathogens in invasion. Blastocystis proteases also 
induce interleukin-8 production and may lead to neutrophil recruitment and 
intestinal inflammation. In addition, Blastocystis can also alter the intestinal barrier 
function by disturbing tight junctions and cytoskeleton. In addition, Blastocystis can 
induce apoptosis in intestinal epithelial cells which may directly affect intestinal 
homeostasis or indirectly facilitate invasion of other pathogens. Altogether, these 
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7.2 CONCLUSIONS 
 
1. This study has showed for the first time, that Blastocystis possesses high levels of 
protease activity, in particular of the cysteine protease type. It was also 
demonstrated that central vacuole of Blastocystis contains cysteine proteases (Sio 
et al. 2006; Puthia et al. 2008). 
 
2. Present study showed for the first time that Blastocystis has proteases that can 
degrade secretory immunoglobulin A (Puthia et al. 2005). The degradation effect 
is shown in both subtypes of IgA, IgA1 and IgA2. 
 
3. This study reported for the first time that Blastocystis induces apoptosis in 
enterocytes and there is active involvement of caspase-3.  In addition, this 
apoptosis occurred in a contact-independent manner (Puthia et al. 2006). 
 
4. This study demonstrated for the first time that Blastocystis can rearrange F-actin 
and ZO-1 distribution and disrupt epithelial barrier function; and metronidazole 
can abrogate these effects. In addition, findings showed that IEC-6 monolayers 
grown on permeable filters provide a useful in vitro model for studying the 
interactions of Blastocystis with intestinal epithelial cells (Puthia et al. 2006). 
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5. This study showed for the first time that Blastocystis cysteine proteases induce 
interleukin-8 production in colonic epithelial cells and an NF-κB-dependent 
transcriptional process is involved. In addition, it was demonstrated that 
metronidazole treatment can markedly inhibit the ability of Blastocystis to induce 
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Appendix I 
 
Medium for culturing Blastocystis  
 
For culturing Blastocystis, each 15 ml culture test-tube contained the following: 
a) Iscove’s Modified Dulbecco’s Media (IMDM) (Gibco) 9ml 
b) Inactivated horse serum (Gibco) 1ml 
Loose capped tubes with medium were kept for 24 h in anaerobic jar with gas pack inside 
to remove oxygen (prereduction of medium). Prereduced medium was inoculated with a 
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Appendix II 
 
Medium for culturing Trichomonas vaginalis 
 
For culturing Trichomonas vaginalis, each screw-capped test-tube contained the 
following: 
a) Hollander’s Medium 9ml 
b) Inactivated foetal-calf serum 1ml 
Once the test-tubes containing the medium were inoculated with Trichomonas vaginalis, 
they were placed in a test-tube holder and incubated at 37ºC. Sub-culturing was 
performed every three to five days by inoculating 0.5ml of the turbid suspension into a 
fresh test-tube containing medium. 
 
Preparation of Hollander’s Medium 
Trypticase peptone:  20.0g  
Yeast extract:  10.0g  
Maltose:    5.0g  
Ascorbic acid:   1.0g  
KCl:    1.0g  
KHC03:    1.0g  
Kh2PO4:    1.0g  
FeSO4:    0.1g  
Purified agar:    0.5g  
 
1) Dissolve in 900ml of water  
2) Autoclave at 15lb, 15 mins  
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Appendix III 
 
Poly-L-lysine coating of glass coverslips 
 
1. Acid wash glass coverslips  
a. Soak coverslips in hydrochloric acid overnight (keep in fume hood) 
b. Rinse under tap water for 15-30 minutes 
c. Rinse in sterile water, autoclave and dry  
d. Coverslips are ready for coating 
2. Add 50 ml of sterile tissue culture grade water to 5 mg of poly-L-lysine. 
3. Aseptically coat culture surface of coverslips with poly-L-lysine solution enough 
to cover surface 
4. Rock gently to ensure even coating of the culture surface 
5. After 5 minutes, remove solution by aspiration and thoroughly rinse surface with 
sterile tissue culture grade water. 
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Appendix IV 
 
Coomassie (Bradford) Protein Assay (Pierce) 
 
Micro Microplate Protocol (Working Range = 1-25 µg/ml) 
1. Pipette 150 µl of each standard or unknown sample into the appropriate 
microplate wells. 
2. Add 150 µl of the Coomassie Reagent to each well and mix with plate shaker for 
30 seconds. 
3. Remove plate from shaker and incubate plate for 10 minutes at room temperature 
for consistent results. 
4. Measure the absorbance at 595 nm on a plate reader. 
5. Subtract the average 595 nm measurements for the Blank replicates from the 595 
nm measurements of all other individual standard and unknown sample replicates. 
6. Prepare a standard curve by plotting the average blank corrected 595 nm 
measurement for each BSA standard vs. its concentration in µg/ml. 
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Appendix V 
 
Measuring cell monolayer resistance by Millicell-ERS  
(http://www.millipore.com) 
 
Set up the laminar flow hood with a:  
• Millicell-ERS  
• Millicell culture plate insert without cells  
• Millicell culture plate insert with cells  
• 70% ethanol solution  
 
Procedure:  
To sterilize electrodes, immerse the electrodes in 70% ethanol for 15 minutes. Allow 
them to air dry for 15 seconds. 
1. Rinse the electrodes in sterile cell culture medium or in 0.1–0.15 M KCl or NaCl. 
2. For resistance measurements, the electrode is now ready to use. 
3. Switch the MODE switch to “R.” 
4. Turn the POWER switch to “ON.” 
5. Immerse the electrodes so that the shorter electrode is in the Millicell culture plate 
insert and the longer electrode is in the outer well. The shorter electrode should 
not contact cells growing on the membrane. 
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6. Do not push the “R” button while the electrodes are outside solution or the meter 
could be damaged. Completely immerse the metal sheath at the electrode tips in 
solution to obtain accurate resistance measurements. 
7. Press the MEASURE button. The meter should indicate a stable resistance 
reading of the solution. 
8. Record the resistance. 
9. The blank resistance must be measured and then substracted from the resistance 
reading across monolayer in order to obtain the true tissue resistance. 
10. The unit area resistance is obtained by multiplying the meter readings by the 
effective surface area of the filter membrane.  
11. Resistance of a unit area = Resistance (W) x Effective Membrane Area (cm2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
